Close

Form 10-Q HEALTHCARE TRUST OF AMER For: Mar 31

April 27, 2016 4:11 PM EDT
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________
FORM 10-Q
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2016
or
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from            to            
Commission File Number: 001-35568 (Healthcare Trust of America, Inc.)
Commission File Number: 333-190916 (Healthcare Trust of America Holdings, LP)
_________________________ 
HEALTHCARE TRUST OF AMERICA, INC.
HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
(Exact name of registrant as specified in its charter)
Maryland (Healthcare Trust of America, Inc.)
 
20-4738467
Delaware (Healthcare Trust of America Holdings, LP)
 
20-4738347
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
16435 N. Scottsdale Road, Suite 320
Scottsdale, Arizona 85254
(Address of principal executive offices)
(480) 998-3478
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    
Healthcare Trust of America, Inc.
x Yes
¨ No
 
Healthcare Trust of America Holdings, LP
x Yes
¨ No
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    
Healthcare Trust of America, Inc.
x Yes
¨ No
 
Healthcare Trust of America Holdings, LP
x Yes
¨ No
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Healthcare Trust of America, Inc.
Large-accelerated filer x
Accelerated filer ¨
Non-accelerated filer ¨
Smaller reporting company ¨
 
 
 
(Do not check if a smaller reporting company)
 
Healthcare Trust of America Holdings, LP
Large-accelerated filer ¨
Accelerated filer ¨
Non-accelerated filer x
Smaller reporting company ¨
 
 
 
(Do not check if a smaller reporting company)
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    
Healthcare Trust of America, Inc.
¨ Yes
x No
 
Healthcare Trust of America Holdings, LP
¨ Yes
x No
 

As of April 25, 2016, there were 136,625,278 shares of Class A common stock of Healthcare Trust of America, Inc. outstanding.
 




Explanatory Note
This Quarterly Report combines the Quarterly Reports on Form 10-Q (“Quarterly Report”) for the quarter ended March 31, 2016 of Healthcare Trust of America, Inc. (“HTA”), a Maryland corporation, and Healthcare Trust of America Holdings, LP (“HTALP”), a Delaware limited partnership. Unless otherwise indicated or unless the context requires otherwise, all references in this Quarterly Report to “we,” “us,” “our,” “the Company” or “our Company” refer to HTA and HTALP, collectively, and all references to “common stock” shall refer to the Class A common stock of HTA.
HTA operates as a real estate investment trust (“REIT”) and is the general partner of HTALP. As of March 31, 2016, HTA owned a 98.6% partnership interest in HTALP, and other limited partners, including some of HTA’s directors, executive officers and their affiliates, owned the remaining partnership interest (including the long-term incentive plan (“LTIP”) units) in HTALP. As the sole general partner of HTALP, HTA has the full, exclusive and complete responsibility for HTALP’s day-to-day management and control, including its compliance with the Securities and Exchange Commission (“SEC”) filing requirements.
We believe it is important to understand the few differences between HTA and HTALP in the context of how we operate as an integrated consolidated company. HTA operates in an umbrella partnership REIT structure in which HTALP and its subsidiaries hold substantially all of the assets. HTA’s only material asset is its ownership of partnership interests of HTALP. As a result, HTA does not conduct business itself, other than acting as the sole general partner of HTALP, issuing public equity from time to time and guaranteeing certain debts of HTALP. HTALP conducts the operations of the business and issues publicly-traded debt, but has no publicly-traded equity. Except for net proceeds from public equity issuances by HTA, which are generally contributed to HTALP in exchange for partnership units of HTALP, HTALP generates the capital required for the business through its operations and by direct or indirect incurrence of indebtedness or through the issuance of its partnership units.
Noncontrolling interests, stockholders’ equity and partners’ capital are the primary areas of difference between the condensed consolidated financial statements of HTA and HTALP. Limited partnership units in HTALP are accounted for as partners’ capital in HTALP’s condensed consolidated balance sheets and as noncontrolling interest reflected within equity in HTA’s condensed consolidated balance sheets. The differences between HTA’s stockholders’ equity and HTALP’s partners’ capital are due to the differences in the equity issued by HTA and HTALP, respectively.
The Company believes combining the Quarterly Reports of HTA and HTALP, including the notes to the condensed consolidated financial statements, into this single Quarterly Report results in the following benefits:
enhances stockholders’ understanding of HTA and HTALP by enabling stockholders to view the business as a whole in the same manner that management views and operates the business;
eliminates duplicative disclosure and provides a more streamlined and readable presentation since a substantial portion of the disclosure in this Quarterly Report applies to both HTA and HTALP; and
creates time and cost efficiencies through the preparation of a single combined Quarterly Report instead of two separate Quarterly Reports.
In order to highlight the material differences between HTA and HTALP, this Quarterly Report includes sections that separately present and discuss areas that are materially different between HTA and HTALP, including:
the condensed consolidated financial statements;
certain accompanying notes to the condensed consolidated financial statements, including Note 6 - Debt, Note 8 - Stockholders’ Equity and Partners’ Capital, Note 10 - Per Share Data of HTA and Note 11 - Per Unit Data of HTALP;
the Funds From Operations (“FFO”) and Normalized FFO in Part 1, Item 2 of this Quarterly Report;
the controls and procedures in Part 1, Item 4 of this Quarterly Report; and
the certifications of the Chief Executive Officer and the Chief Financial Officer included as Exhibits 31 and 32 to this Quarterly Report.
In the sections of this Quarterly Report that combine disclosure for HTA and HTALP, this Quarterly Report refers to actions or holdings as being actions or holdings of the Company. Although HTALP (directly or indirectly through one of its subsidiaries) is generally the entity that enters into contracts, holds assets and issues or incurs debt, management believes this presentation is appropriate for the reasons set forth above and because the business of the Company is a single integrated enterprise operated through HTALP.

2



HEALTHCARE TRUST OF AMERICA, INC. AND
HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
TABLE OF CONTENTS
 
 
 
Page
Healthcare Trust of America, Inc.
 
 
 
 
 
Healthcare Trust of America Holdings, LP
 
 
 
 
 
Notes for Healthcare Trust of America, Inc. and Healthcare Trust of America Holdings, LP
 
 
 
 
 
 
 
 
 






3



PART I - FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)

HEALTHCARE TRUST OF AMERICA, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)
 
 
March 31, 2016
 
December 31, 2015
ASSETS
 
 
 
 
Real estate investments:
 
 
 
 
Land
 
$
321,021

 
$
303,706

Building and improvements
 
3,038,674

 
2,901,157

Lease intangibles
 
446,511

 
430,749

 
 
3,806,206

 
3,635,612

Accumulated depreciation and amortization
 
(712,381
)
 
(676,144
)
Real estate investments, net
 
3,093,825

 
2,959,468

Cash and cash equivalents
 
13,827

 
13,070

Restricted cash and escrow deposits
 
16,687

 
15,892

Receivables and other assets, net
 
143,012

 
141,703

Other intangibles, net
 
43,168

 
42,167

Total assets
 
$
3,310,519

 
$
3,172,300

LIABILITIES AND EQUITY
 
 
 
 
Liabilities:
 
 
 
 
Debt
 
$
1,667,320

 
$
1,590,696

Accounts payable and accrued liabilities
 
85,453

 
94,933

Derivative financial instruments - interest rate swaps
 
4,735

 
2,370

Security deposits, prepaid rent and other liabilities
 
47,993

 
46,295

Intangible liabilities, net
 
31,538

 
26,611

Total liabilities
 
1,837,039

 
1,760,905

Commitments and contingencies
 

 

Redeemable noncontrolling interests
 
4,429

 
4,437

Equity:
 
 
 
 
Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding
 

 

Class A common stock, $0.01 par value; 1,000,000,000 shares authorized; 130,662,036 and 127,026,839 shares issued and outstanding as of March 31, 2016 and December 31, 2015, respectively
 
1,307

 
1,270

Additional paid-in capital
 
2,422,138

 
2,328,806

Cumulative dividends in excess of earnings
 
(979,332
)
 
(950,652
)
Total stockholders’ equity
 
1,444,113

 
1,379,424

Noncontrolling interests
 
24,938

 
27,534

Total equity
 
1,469,051

 
1,406,958

Total liabilities and equity
 
$
3,310,519

 
$
3,172,300

 
 
 
 
 
The accompanying notes are an integral part of these condensed consolidated financial statements.

4



HEALTHCARE TRUST OF AMERICA, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)
 
 
Three Months Ended March 31,
 
 
2016
 
2015
Revenues:
 
 
 
 
Rental income
 
$
107,250

 
$
98,452

Interest and other operating income
 
65

 
68

Total revenues
 
107,315

 
98,520

Expenses:
 
 
 
 
Rental
 
33,353

 
30,697

General and administrative
 
6,773

 
6,575

Acquisition-related 
 
1,813

 
1,357

Depreciation and amortization
 
37,828

 
36,595

Total expenses
 
79,767

 
75,224

Income before other income (expense)
 
27,548

 
23,296

Interest expense:
 
 
 
 
Interest related to derivative financial instruments
 
(645
)
 
(555
)
Loss on change in fair value of derivative financial instruments, net
 
(2,792
)
 
(2,010
)
Total interest related to derivative financial instruments, including net change in fair value of derivative financial instruments
 
(3,437
)
 
(2,565
)
Interest related to debt
 
(14,128
)
 
(13,804
)
Other income
 
53

 
15

Net income
 
$
10,036

 
$
6,942

Net income attributable to noncontrolling interests (1) 
 
(176
)
 
(138
)
Net income attributable to common stockholders
 
$
9,860

 
$
6,804

Earnings per common share - basic:
 
 
 
 
Net income attributable to common stockholders
 
$
0.08

 
$
0.05

Earnings per common share - diluted:
 
 
 
 
Net income attributable to common stockholders
 
$
0.08

 
$
0.05

Weighted average common shares outstanding:
 
 
 
 
Basic
 
129,336

 
125,175

Diluted
 
131,240

 
127,105

Dividends declared per common share
 
$
0.295

 
$
0.290

 
 
 
 
 
(1) Includes amounts attributable to redeemable noncontrolling interests.
The accompanying notes are an integral part of these condensed consolidated financial statements.

5



HEALTHCARE TRUST OF AMERICA, INC.
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(In thousands)
(Unaudited)
 
Class A Common Stock
 
Additional Paid-In Capital
 
Cumulative Dividends in Excess of Earnings
 
Total Stockholders’ Equity
 
Noncontrolling Interest
 
Total Equity
 
Shares
 
Amount
Balance as of December 31, 2014
125,087

 
$
1,251

 
$
2,281,932

 
$
(836,044
)
 
$
1,447,139

 
$
29,282

 
$
1,476,421

Share-based award transactions, net
164

 
1

 
1,913

 

 
1,914

 

 
1,914

Repurchase and cancellation of common stock
(48
)
 

 
(1,292
)
 

 
(1,292
)
 

 
(1,292
)
Dividends declared

 

 

 
(36,309
)
 
(36,309
)
 
(564
)
 
(36,873
)
Net income

 

 

 
6,804

 
6,804

 
105

 
6,909

Balance as of March 31, 2015
125,203

 
$
1,252

 
$
2,282,553

 
$
(865,549
)
 
$
1,418,256

 
$
28,823

 
$
1,447,079

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance as of December 31, 2015
127,027

 
$
1,270

 
$
2,328,806

 
$
(950,652
)
 
$
1,379,424

 
$
27,534

 
$
1,406,958

Issuance of common stock
3,418

 
34

 
91,235

 

 
91,269

 

 
91,269

Share-based award transactions, net
191

 
2

 
1,801

 

 
1,803

 

 
1,803

Repurchase and cancellation of common stock
(70
)
 

 
(1,901
)
 

 
(1,901
)
 

 
(1,901
)
Redemption of noncontrolling interest and other
96

 
1

 
2,197

 

 
2,198

 
(2,198
)
 

Dividends declared

 

 

 
(38,540
)
 
(38,540
)
 
(543
)
 
(39,083
)
Net income

 

 

 
9,860

 
9,860

 
145

 
10,005

Balance as of March 31, 2016
130,662

 
$
1,307

 
$
2,422,138

 
$
(979,332
)
 
$
1,444,113

 
$
24,938

 
$
1,469,051

The accompanying notes are an integral part of these condensed consolidated financial statements.

6



HEALTHCARE TRUST OF AMERICA, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
 
 
Three Months Ended March 31,
 
 
2016
 
2015
Cash flows from operating activities:
 
 
 
 
Net income
 
$
10,036

 
$
6,942

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
Depreciation, amortization and other
 
37,091

 
35,788

Share-based compensation expense
 
1,803

 
1,914

Bad debt expense
 
92

 
146

Change in fair value of derivative financial instruments
 
2,792

 
2,010

Changes in operating assets and liabilities:
 
 
 
 
Receivables and other assets, net
 
(1,438
)
 
(723
)
Accounts payable and accrued liabilities
 
(10,370
)
 
(13,172
)
Security deposits, prepaid rent and other liabilities
 
446

 
4,290

Net cash provided by operating activities
 
40,452

 
37,195

Cash flows from investing activities:
 
 
 
 
Investments in real estate
 
(158,686
)
 
(35,300
)
Capital expenditures
 
(8,824
)
 
(6,524
)
Restricted cash, escrow deposits and other assets
 
(799
)
 
(321
)
Net cash used in investing activities
 
(168,309
)
 
(42,145
)
Cash flows from financing activities:
 
 
 
 
Borrowings on unsecured revolving credit facility
 
166,000

 
82,000

Payments on unsecured revolving credit facility
 
(88,000
)
 
(81,000
)
Borrowings on unsecured term loans
 

 
65,000

Payments on secured real estate term loan and mortgage loans
 
(1,761
)
 
(19,960
)
Deferred financing costs
 

 
(31
)
Security deposits
 
729

 
(17
)
Proceeds from issuance of common stock
 
91,757

 

Repurchase and cancellation of common stock
 
(1,901
)
 
(1,292
)
Dividends paid
 
(37,473
)
 
(36,275
)
Distributions paid to noncontrolling interest of limited partners
 
(737
)
 
(371
)
Net cash provided by financing activities
 
128,614

 
8,054

Net change in cash and cash equivalents
 
757

 
3,104

Cash and cash equivalents - beginning of period
 
13,070

 
10,413

Cash and cash equivalents - end of period
 
$
13,827

 
$
13,517

The accompanying notes are an integral part of these condensed consolidated financial statements.

7



HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except unit data)
(Unaudited)
 
 
March 31, 2016
 
December 31, 2015
ASSETS
 
 
 
 
Real estate investments:
 
 
 
 
Land
 
$
321,021

 
$
303,706

Building and improvements
 
3,038,674

 
2,901,157

Lease intangibles
 
446,511

 
430,749

 
 
3,806,206

 
3,635,612

Accumulated depreciation and amortization
 
(712,381
)
 
(676,144
)
Real estate investments, net
 
3,093,825

 
2,959,468

Cash and cash equivalents
 
13,827

 
13,070

Restricted cash and escrow deposits
 
16,687

 
15,892

Receivables and other assets, net
 
143,012

 
141,703

Other intangibles, net
 
43,168

 
42,167

Total assets
 
$
3,310,519

 
$
3,172,300

LIABILITIES AND PARTNERS’ CAPITAL
 
 
 
 
Liabilities:
 
 
 
 
Debt
 
$
1,667,320

 
$
1,590,696

Accounts payable and accrued liabilities
 
85,453

 
94,933

Derivative financial instruments - interest rate swaps
 
4,735

 
2,370

Security deposits, prepaid rent and other liabilities
 
47,993

 
46,295

Intangible liabilities, net
 
31,538

 
26,611

Total liabilities
 
1,837,039

 
1,760,905

Commitments and contingencies
 


 


Redeemable noncontrolling interests
 
4,429

 
4,437

Partners’ Capital:
 
 
 
 
Limited partners’ capital, 1,833,849 and 1,929,942 units issued and outstanding as of March 31, 2016 and December 31, 2015, respectively
 
24,668

 
27,264

General partners’ capital, 130,662,036 and 127,026,839 units issued and outstanding as of March 31, 2016 and December 31, 2015, respectively
 
1,444,383

 
1,379,694

Total partners’ capital
 
1,469,051

 
1,406,958

Total liabilities and partners’ capital
 
$
3,310,519

 
$
3,172,300

The accompanying notes are an integral part of these condensed consolidated financial statements.


8



HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per unit data)
(Unaudited)
 
 
Three Months Ended March 31,
 
 
2016
 
2015
Revenues:
 
 
 
 
Rental income
 
$
107,250

 
$
98,452

Interest and other operating income
 
65

 
68

Total revenues
 
107,315

 
98,520

Expenses:
 
 
 
 
Rental
 
33,353

 
30,697

General and administrative
 
6,773

 
6,575

Acquisition-related 
 
1,813

 
1,357

Depreciation and amortization
 
37,828

 
36,595

Total expenses
 
79,767

 
75,224

Income before other income (expense)
 
27,548

 
23,296

Interest expense:
 
 
 
 
Interest related to derivative financial instruments
 
(645
)
 
(555
)
Loss on change in fair value of derivative financial instruments, net
 
(2,792
)
 
(2,010
)
Total interest related to derivative financial instruments, including net change in fair value of derivative financial instruments
 
(3,437
)
 
(2,565
)
Interest related to debt
 
(14,128
)
 
(13,804
)
Other income
 
53

 
15

Net income
 
$
10,036

 
$
6,942

Net income attributable to noncontrolling interests
 
(31
)
 
(33
)
Net income attributable to common unitholders
 
$
10,005

 
$
6,909

Earnings per common unit - basic:
 
 
 
 
Net income attributable to common unitholders
 
$
0.08

 
$
0.05

Earnings per common unit - diluted:
 
 
 
 
Net income attributable to common unitholders
 
$
0.08

 
$
0.05

Weighted average common units outstanding: 
 
 
 
 
Basic
 
131,242

 
126,330

Diluted
 
131,242

 
126,330

Dividends declared per common unit
 
$
0.295

 
$
0.290

The accompanying notes are an integral part of these condensed consolidated financial statements.

9



HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN PARTNERS CAPITAL
(In thousands)
(Unaudited)
 
General Partners’ Capital
 
Limited Partners’ Capital
 
Total Partners’ Capital
 
Units
 
Amount
 
Units
 
Amount
 
Balance as of December 31, 2014
125,087

 
$
1,447,409

 
2,155

 
$
29,012

 
$
1,476,421

Share-based award transactions, net
164

 
1,914

 

 

 
1,914

Redemption and cancellation of general partner units
(48
)
 
(1,292
)
 

 

 
(1,292
)
Distributions declared

 
(36,309
)
 

 
(564
)
 
(36,873
)
Net income

 
6,804

 

 
105

 
6,909

Balance as of March 31, 2015
125,203

 
$
1,418,526

 
2,155

 
$
28,553

 
$
1,447,079

 
 
 
 
 
 
 
 
 
 
Balance as of December 31, 2015
127,027

 
$
1,379,694

 
1,930

 
$
27,264

 
$
1,406,958

Issuance of general partner units
3,418

 
91,269

 

 

 
91,269

Share-based award transactions, net
191

 
1,803

 

 

 
1,803

Redemption and cancellation of general partner units
(70
)
 
(1,901
)
 

 

 
(1,901
)
Redemption of limited partner units and other
96

 
2,198

 
(96
)
 
(2,198
)
 

Distributions declared

 
(38,540
)
 

 
(543
)
 
(39,083
)
Net income

 
9,860

 

 
145

 
10,005

Balance as of March 31, 2016
130,662

 
$
1,444,383

 
1,834

 
$
24,668

 
$
1,469,051

The accompanying notes are an integral part of these condensed consolidated financial statements.


10



HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
 
 
Three Months Ended March 31,
 
 
2016
 
2015
Cash flows from operating activities:
 
 
 
 
Net income
 
$
10,036

 
$
6,942

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
Depreciation, amortization and other
 
37,091

 
35,788

Share-based compensation expense
 
1,803

 
1,914

Bad debt expense
 
92

 
146

Change in fair value of derivative financial instruments
 
2,792

 
2,010

Changes in operating assets and liabilities:
 
 
 
 
Receivables and other assets, net
 
(1,438
)
 
(723
)
Accounts payable and accrued liabilities
 
(10,370
)
 
(13,172
)
Security deposits, prepaid rent and other liabilities
 
446

 
4,290

Net cash provided by operating activities
 
40,452

 
37,195

Cash flows from investing activities:
 
 
 
 
Investments in real estate
 
(158,686
)
 
(35,300
)
Capital expenditures
 
(8,824
)
 
(6,524
)
Restricted cash, escrow deposits and other assets
 
(799
)
 
(321
)
Net cash used in investing activities
 
(168,309
)
 
(42,145
)
Cash flows from financing activities:
 
 
 
 
Borrowings on unsecured revolving credit facility
 
166,000

 
82,000

Payments on unsecured revolving credit facility
 
(88,000
)
 
(81,000
)
Borrowings on unsecured term loans
 

 
65,000

Payments on secured real estate term loan and mortgage loans
 
(1,761
)
 
(19,960
)
Deferred financing costs
 

 
(31
)
Security deposits
 
729

 
(17
)
Proceeds from issuance of general partner units
 
91,757

 

Repurchase and cancellation of general partner units
 
(1,901
)
 
(1,292
)
Distributions paid to general partner
 
(37,473
)
 
(36,275
)
Distributions paid to limited partners and redeemable noncontrolling interests
 
(737
)
 
(371
)
Net cash provided by financing activities
 
128,614

 
8,054

Net change in cash and cash equivalents
 
757

 
3,104

Cash and cash equivalents - beginning of period
 
13,070

 
10,413

Cash and cash equivalents - end of period
 
$
13,827

 
$
13,517

The accompanying notes are an integral part of these condensed consolidated financial statements.

11



HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unless otherwise indicated or unless the context requires otherwise the use of the words “we,” “us” or “our” refers to Healthcare Trust of America, Inc. and Healthcare Trust of America Holdings, LP, collectively.
1. Organization and Description of Business
HTA, a Maryland corporation, and HTALP, a Delaware limited partnership, were incorporated or formed, as applicable, on April 20, 2006. HTA operates as a REIT and is the general partner of HTALP, which is the operating partnership. As of March 31, 2016, HTA owned a 98.6% partnership interest and other limited partners, including some of HTA’s directors, executive officers and their affiliates, owned the remaining partnership interest (including the LTIP units) in HTALP. As the sole general partner of HTALP, HTA has the full, exclusive and complete responsibility for HTALP’s day-to-day management and control. HTA operates in an umbrella partnership REIT structure in which HTALP and its subsidiaries hold substantially all of the assets. HTA’s only material asset is its ownership of partnership interests of HTALP. As a result, HTA does not conduct business itself, other than acting as the sole general partner of HTALP, issuing public equity from time to time and guaranteeing certain debts of HTALP. HTALP conducts the operations of the business and issues publicly-traded debt, but has no publicly-traded equity.
HTA is one of the largest publicly-traded REITs focused on medical office buildings (“MOBs”) in the United States (“U.S.”) based on gross leasable area (“GLA”). We are primarily focused on acquiring, owning and operating high quality MOBs that are predominantly located on the campuses of, or aligned with, nationally or regionally recognized healthcare systems. In addition, we have strong industry relationships, a stable and diversified tenant mix, and an extensive and active acquisition network. Our primary objective is to maximize stockholder value with disciplined growth through strategic investments that provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we: (i) seek internal growth through proactive asset management, leasing and property management oversight; (ii) target mid-sized acquisitions of MOBs in markets with dominant healthcare systems, and with attractive demographics that complement our existing portfolio; and (iii) actively manage our balance sheet to maintain flexibility with conservative leverage. HTA has qualified to be taxed as a REIT for federal income tax purposes and intends to continue to be taxed as a REIT.
We primarily invest in MOBs that are located on health system campuses, in community-core locations, or around university medical centers which we believe are core, critical real estate. We also focus on our key markets that have certain demographic and macro-economic trends and where we can utilize our institutional property management and leasing platform to generate strong tenant relationships and operating cost efficiencies. Our portfolio consists of MOBs and other facilities that serve the healthcare industry with an aggregate purchase price of $3.7 billion through March 31, 2016.
Our principal executive office is located at 16435 North Scottsdale Road, Suite 320, Scottsdale, Arizona, 85254.
2. Summary of Significant Accounting Policies
The summary of significant accounting policies presented below is designed to assist in understanding our condensed consolidated financial statements. Such condensed consolidated financial statements and the accompanying notes are the representations of our management, who are responsible for their integrity and objectivity. These accounting policies conform to U.S. generally accepted accounting principles (“GAAP”) in all material respects and have been consistently applied in preparing our accompanying condensed consolidated financial statements.
Basis of Presentation
Our accompanying condensed consolidated financial statements include our accounts and those of our subsidiaries and any consolidated variable interest entities (“VIEs”). All inter-company balances and transactions have been eliminated in the accompanying condensed consolidated financial statements.

12


HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Interim Unaudited Financial Data
Our accompanying condensed consolidated financial statements have been prepared by us in accordance with GAAP in conjunction with the rules and regulations of the SEC. Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, our accompanying condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. Our accompanying condensed consolidated financial statements reflect all adjustments, which are, in our opinion, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Interim results of operations are not necessarily indicative of the results to be expected for the full year; such results may be less favorable for the full year. Our accompanying condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our 2015 Annual Report on Form 10-K. There have been no significant changes to the Company’s significant accounting policies during the three months ended March 31, 2016, except as noted below regarding the adoption of U.S. Financial Accounting Standards Board (the “FASB”) Accounting Standards Update (“ASU”) 2015-02, Amendments to the Consolidation Analysis and ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments.
Principles of Consolidation
As of January 1, 2016, the Company adopted FASB ASU 2015-02, Amendments to the Consolidation Analysis, as described below in “Recently Issued or Adopted Accounting Pronouncements”, which simplifies consolidation accounting by reducing the number of consolidation models and changing various aspects of current GAAP, including certain consolidation criteria for VIEs. The consolidated financial statements include the accounts of HTA and its subsidiaries and consolidated joint venture arrangements. The portions of the consolidated joint venture arrangements not owned by HTA are presented as non-controlling interests in HTA’s consolidated balance sheets and statements of operations, consolidated statements of equity, and consolidated statements of changes in partners’ capital. In addition, as described in Note 1 - Organization and Description of Business, certain third parties have been issued limited partner units in HTALP (“OP Units”). Holders of OP Units are considered to be non-controlling interest holders in HTALP and their ownership interests are reflected as equity in the consolidated balance sheets. Further, a portion of the earnings and losses of HTALP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of common shares issued and the carrying value of the OP Units converted is recorded as a component of equity. As of March 31, 2016 and December 31, 2015, there were approximately 1.8 million and 1.9 million, respectively, of OP Units issued and outstanding.
VIEs are entities where investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support or where equity investors, as a group, lack one of the following: (i) the power to direct the activities that most significantly impact the entity’s economic performance; (ii) the obligation to absorb the expected losses of the entity; and (iii) the right to receive the expected returns of the entity. We consolidate our investment in VIEs when we determine that we are the primary beneficiary. A primary beneficiary is one that has both: (i) the power to direct the activities of the VIE that most significantly impacts the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The Company will evaluate on an ongoing basis the need to consolidate entities based on the standards set forth in GAAP as described above.
Investments in Real Estate
Depreciation expense of buildings and improvements for the three months ended March 31, 2016 and 2015, was $25.7 million and $23.3 million, respectively.
Recently Issued or Adopted Accounting Pronouncements
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive new revenue recognition model requiring a company to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration (i.e., payment) to which the company expects to be entitled in exchange for those goods or services. In adopting ASU 2014-09, companies may use either a full retrospective or a modified retrospective approach. In July 2015, the FASB deferred the effective date of ASU 2014-09 to the first interim period within annual reporting periods beginning after December 15, 2017 along with the ability to early adopt as of the original effective date. We do not anticipate early adoption and we are evaluating the impact of adopting ASU 2014-09 on our consolidated financial statements.

13


HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

In February 2015, the FASB issued ASU 2015-02, Amendments to the Consolidation Analysis. ASU 2015-02 affects reporting entities that are required to evaluate whether they should consolidate certain legal entities. The amendments in ASU 2015-02 affect the following areas: (i) limited partnerships and similar legal entities; (ii) evaluating fees paid to a decision maker or a service provider as a variable interest; (iii) the effect of fee arrangements on the primary beneficiary determination; (iv) the effect of related parties on the primary beneficiary determination; and (v) certain investment funds. ASU 2015-02 is effective for fiscal years and for interim periods within those fiscal years, beginning after December 15, 2015 with early adoption permitted. We adopted ASU 2015-02 as of January 1, 2016. The adoption had no material impact on our interests in joint venture arrangements. Accordingly, there was no material impact on previous or current reporting periods’ consolidated financial statements.
In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs. ASU 2015-03 changes the presentation of debt issuance costs by requiring these costs related to a recognized debt liability to be presented in the consolidated balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. In August 2015, the FASB issued ASU 2015-15 to include the presentation and subsequent measurement of debt issuance costs associated with line-of-credit arrangements. ASU 2015-03 and 2015-15 are effective for the fiscal years beginning after December 15, 2015, and requires retrospective application with early adoption permitted. We adopted ASU 2015-03 and 2015-15 as of December 31, 2015. As a result of the adoption, all deferred financing costs, excluding costs related to the unsecured revolving credit facility, were reclassed to debt. Unsecured revolving credit facility costs remain classified as an asset on our consolidated balance sheets and will continue to be amortized over the remaining term. The guidance requires retrospective adoption for all prior periods presented.
In September 2015, the FASB issued ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments. ASU 2015-16 eliminates the requirement that an acquirer in a business combination has to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amount of the adjustment, including the effect on earnings of any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. ASU 2015-16 is effective for fiscal years beginning after December 15, 2015. We adopted ASU 2015-16 as of January 1, 2016. As a result of the adoption there was no impact in the previous or current reporting periods’ consolidated financial statements.
In February 2016, the FASB issued ASU 2016-02, Leases. ASU 2016-02 will supersede the existing guidance for lease accounting and states that companies will be required to recognize lease assets and lease liabilities on the balance sheet and disclose key information about leasing arrangements. ASU 2016-02 requires qualitative and quantitative disclosures to supplement the amounts recorded in the financial statements so that users can understand the nature of the entity’s leasing activities, including significant judgments and changes in judgments. Within ASU 2016-02 lessor accounting remained fairly unchanged. In adopting ASU 2016-02, companies will be required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. ASU 2016-02 is effective for the fiscal years beginning after December 15, 2018 with early adoption permitted. We do not anticipate early adoption and are evaluating the impact of adopting ASU 2016-02 on our consolidated financial statements.

14


HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

3. Investments in Real Estate
For the three months ended March 31, 2016, our investments had an aggregate purchase price of $162.0 million. We incurred $0.6 million of costs attributable to these investments, which were recorded in acquisition-related expenses in the accompanying condensed consolidated statements of operations.
The following investments were determined to be individually not significant, but significant on a collective basis. The actual revenues and earnings since the investment dates as well as the supplementary proforma information assuming these investments occurred as of the beginning of the prior periods, were not material to us. The allocations for these investments are set forth below in the aggregate for the three months ended March 31, 2016 and 2015 (in thousands):
 
Three Months Ended March 31,
 
2016
 
2015
Land
$
17,315

 
$
748

Building and improvements
128,945

 
30,086

Below market leasehold interests
1,099

 
2,350

Above market leases
840

 
398

In place leases
15,919

 
2,181

Below market leases
(5,382
)
 
(463
)
Above market leasehold interests
(50
)
 

Net assets acquired
158,686

 
35,300

Other, net
3,321

 

Aggregate purchase price
$
162,007

 
$
35,300

The acquired intangible assets and liabilities referenced above had weighted average lives of the following for the three months ended March 31, 2016 and 2015 (in years):
 
Three Months Ended March 31,
 
2016
 
2015
Acquired intangible assets
10.5
 
16.9
Acquired intangible liabilities
8.9
 
9.9
Subsequent to March 31, 2016, we completed investments with an aggregate purchase price of $204.8 million. The purchase prices of these buildings are subject to certain post-closing adjustments. Due to the recent nature of these investments, we have not completed our initial purchase price allocations with respect to these investments and therefore cannot provide disclosures at this time similar to those contained in Note 3 - Investments in Real Estate to our condensed consolidated financial statements.

15


HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

4. Intangible Assets and Liabilities
Intangible assets and liabilities consisted of the following as of March 31, 2016 and December 31, 2015 (in thousands, except weighted average remaining amortization):
 
March 31, 2016
 
December 31, 2015
 
Balance
 
Weighted Average Remaining
Amortization in Years
 
Balance
 
Weighted Average Remaining
Amortization in Years
Assets:
 
 
 
 
 
 
 
In place leases
$
265,666

 
10.5
 
$
249,824

 
11.0
Tenant relationships
180,845

 
10.4
 
180,925

 
10.4
Above market leases
25,203

 
6.0
 
24,974

 
6.0
Below market leasehold interests
35,706

 
63.2
 
34,606

 
63.0
 
507,420

 
 
 
490,329

 
 
Accumulated amortization
(230,271
)
 
 
 
(219,334
)
 
 
Total
$
277,149

 
16.5
 
$
270,995

 
16.6
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
Below market leases
$
27,622

 
22.5
 
$
22,240

 
27.2
Above market leasehold interests
11,632

 
53.6
 
11,582

 
53.7
 
39,254

 
 
 
33,822

 
 
Accumulated amortization
(7,716
)
 
 
 
(7,211
)
 
 
Total
$
31,538

 
33.2
 
$
26,611

 
38.0
The following is a summary of the net intangible amortization for the three months ended March 31, 2016 and 2015 (in thousands):
 
Three Months Ended March 31,
 
2016
 
2015
Amortization recorded against rental income related to above or below market leases
$
337

 
$
475

Rental expense related to above or below market leasehold interests
96

 
105

Amortization expense related to in place leases and tenant relationships
10,767

 
11,956

5. Receivables and Other Assets
Receivables and other assets consisted of the following as of March 31, 2016 and December 31, 2015 (in thousands):
 
March 31, 2016
 
December 31, 2015
Tenant receivables, net
$
7,902

 
$
5,820

Other receivables, net
10,069

 
11,882

Deferred financing costs, net
5,192

 
5,524

Deferred leasing costs, net
18,402

 
17,923

Straight-line rent receivables, net
67,907

 
65,543

Prepaid expenses, deposits, equipment and other, net
33,540

 
34,584

Derivative financial instruments - interest rate swaps

 
427

Total
$
143,012

 
$
141,703


16


HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The following is a summary of the amortization of deferred leasing costs and financing costs for the three months ended March 31, 2016 and 2015 (in thousands):
 
Three Months Ended March 31,
 
2016
 
2015
Amortization expense related to deferred leasing costs
$
1,052

 
$
986

Interest expense related to deferred financing costs (1)
331

 
327

 
 
 
 
(1) For the three months ended March 31, 2015, amounts have been adjusted to reflect the retrospective presentation of the early adoption of ASU 2015-03 and 2015-15 as of December 31, 2015.
6. Debt
Debt consisted of the following as of March 31, 2016 and December 31, 2015 (in thousands):
 
March 31, 2016
 
December 31, 2015
Unsecured revolving credit facility
$
296,000

 
$
218,000

Unsecured term loans
455,000

 
455,000

Unsecured senior notes
600,000

 
600,000

Fixed rate mortgages
296,392

 
298,030

Variable rate mortgages
28,864

 
28,988

 
1,676,256

 
1,600,018

Deferred financing costs, net
(7,963
)
 
(8,411
)
Discount, net
(973
)
 
(911
)
Total
$
1,667,320

 
$
1,590,696

Unsecured Credit Agreement
Unsecured Revolving Credit Facility
On February 11, 2015, we executed an amendment to the unsecured revolving credit and term loan facility (the “Unsecured Credit Agreement”) which added an additional lender and increased the amount available under the unsecured revolving credit facility from $800.0 million to $850.0 million. The other existing terms of the Unsecured Credit Agreement were unchanged. The actual amount of credit available to us is a function of certain loan-to-value and debt service coverage ratios set forth in the unsecured revolving credit facility. The maximum principal amount of the unsecured revolving credit facility may be increased, subject to additional financing being provided by our existing lenders or new lenders being added to the unsecured revolving credit facility. The unsecured revolving credit facility matures on January 31, 2020 and is guaranteed by HTA.
Borrowings under the unsecured revolving credit facility accrue interest equal to adjusted LIBOR, plus a margin ranging from 0.88% to 1.55% per annum based on our credit rating. We also pay a facility fee ranging from 0.13% to 0.30% per annum on the aggregate commitments under the unsecured revolving credit facility. As of March 31, 2016, the margin associated with our borrowings was 1.05% per annum and the facility fee was 0.20% per annum.
Unsecured Term Loan
As of March 31, 2016, we had a $300.0 million unsecured term loan outstanding that was guaranteed by HTA. Borrowings accrue interest equal to adjusted LIBOR, plus a margin ranging from 0.90% to 1.80% per annum based on our credit rating. The margin associated with our borrowings as of March 31, 2016 was 1.15% per annum. Including the impact of the interest rate swaps associated with our unsecured term loan, the interest rate was 1.73% per annum, based on our current credit rating. The unsecured term loan matures on January 31, 2019, and includes a one-year extension exercisable at the option of the borrower, subject to certain conditions.

17


HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

$155.0 Million Unsecured Term Loan
As of March 31, 2016, HTALP had a $155.0 million unsecured term loan outstanding that is guaranteed by HTA. The loan matures on July 19, 2019, and the interest rate thereon is equal to LIBOR, plus a margin ranging from 1.55% to 2.40% per annum based on our credit rating. The margin associated with our borrowings as of March 31, 2016 was 1.70% per annum. We have interest rate swaps in place that fix the interest rate at 2.99% per annum, based on our current credit rating. The maximum principal amount under this unsecured term loan may be increased by us, subject to such additional financing being provided by our existing lender.
$300.0 Million Unsecured Senior Notes due 2021
As of March 31, 2016, HTALP had $300.0 million of unsecured senior notes outstanding that are guaranteed by HTA and mature on July 15, 2021. The unsecured senior notes are registered under the Securities Act of 1933, as amended (the “Securities Act”), bear interest at 3.38% per annum and are payable semi-annually. The unsecured senior notes were offered at 99.21% of the principal amount thereof, with an effective yield to maturity of 3.50% per annum.
$300.0 Million Unsecured Senior Notes due 2023
As of March 31, 2016, HTALP had $300.0 million of unsecured senior notes outstanding that are guaranteed by HTA and mature on April 15, 2023. The unsecured senior notes are registered under the Securities Act, bear interest at 3.70% per annum and are payable semi-annually. The unsecured senior notes were offered at 99.19% of the principal amount thereof, with an effective yield to maturity of 3.80% per annum.
Fixed and Variable Rate Mortgages
As of March 31, 2016, HTALP and its subsidiaries had fixed and variable rate mortgages with interest rates ranging from 1.89% to 6.49% per annum and a weighted average interest rate of 5.39% per annum. Including the impact of the interest rate swap associated with our variable rate mortgage, the weighted average interest rate was 5.67% per annum.
Future Debt Maturities
The following table summarizes the debt maturities and scheduled principal repayments of our indebtedness as of March 31, 2016 (in thousands):
Year
 
Amount
2016
 
$
51,013

2017
 
116,626

2018
 
14,428

2019
 
464,281

2020
 
344,904

Thereafter
 
685,004

Total
 
$
1,676,256

The above scheduled debt maturities do not include the extension available to us under the Unsecured Credit Agreement as discussed above.
Deferred Financing Costs
As of March 31, 2016, the future amortization of deferred financing costs is as follows (in thousands):
Year
 
Amount
2016
 
$
1,344

2017
 
1,640

2018
 
1,547

2019
 
1,442

2020
 
893

Thereafter
 
1,097

Total
 
$
7,963


18


HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

We are required by the terms of our applicable debt agreements to meet various affirmative and negative covenants that we believe are customary for these types of facilities, such as limitations on the incurrence of debt by us and our subsidiaries that own unencumbered assets, limitations on the nature of HTALP’s business, and limitations on distributions by HTALP and its subsidiaries that own unencumbered assets. Our debt agreements also impose various financial covenants on us, such as a maximum ratio of total indebtedness to total asset value, a minimum ratio of EBITDA to fixed charges, a minimum tangible net worth covenant, a maximum ratio of unsecured indebtedness to unencumbered asset value, rent coverage ratios and a minimum ratio of unencumbered net operating income to unsecured interest expense. As of March 31, 2016, we believe that we were in compliance with all such financial covenants and reporting requirements. In addition, certain of our debt agreements include events of default provisions that we believe are customary for these types of facilities, including restricting HTA from making dividend distributions to its stockholders in the event HTA is in default thereunder, except to the extent necessary for HTA to maintain its REIT status.
7. Derivative Financial Instruments
The following table lists the derivative financial instrument assets and (liabilities) held by us as of March 31, 2016 (in thousands):
Notional Amount
 
Index
 
Rate
 
Fair Value
 
Instrument
 
Maturity
$
100,000

 
LIBOR
 
0.86
%
 
$
(76
)
 
Swap
 
6/15/2016
50,000

 
LIBOR
 
1.39

 
(860
)
 
Swap
 
7/17/2019
105,000

 
LIBOR
 
1.24

 
(1,270
)
 
Swap
 
7/17/2019
25,892

 
LIBOR + 1.45%
 
4.98

 
(2,529
)
 
Swap
 
5/1/2020
The following table lists the derivative financial instrument assets and (liabilities) held by us as of December 31, 2015 (in thousands):
Notional Amount
 
Index
 
Rate
 
Fair Value
 
Instrument
 
Maturity
$
100,000

 
LIBOR
 
0.86
%
 
$
(142
)
 
Swap
 
6/15/2016
50,000

 
LIBOR
 
1.39

 
(71
)
 
Swap
 
7/17/2019
105,000

 
LIBOR
 
1.24

 
427

 
Swap
 
7/17/2019
26,092

 
LIBOR + 1.45%
 
4.98

 
(2,157
)
 
Swap
 
5/1/2020
As of March 31, 2016 and December 31, 2015, the gross fair value of our derivative financial instruments was as follows (in thousands):
 
 
Asset Derivatives
 
Liability Derivatives
  
 
 
 
Fair Value
 
 
 
Fair Value
Derivatives Not Designated as Hedging Instruments:
 
Balance Sheet
Location
 
March 31, 2016
 
December 31, 2015
 
Balance Sheet
Location
 
March 31, 2016
 
December 31, 2015
Interest rate swaps
 
Receivables and other assets
 
$

 
$
427

 
Derivative financial instruments
 
$
4,735

 
$
2,370

There were no derivatives offset in our accompanying condensed consolidated balance sheets as of March 31, 2016 and December 31, 2015. As of March 31, 2016 and December 31, 2015, we had derivatives subject to enforceable master netting arrangements which allowed for net cash settlement with the respective counterparties (in thousands):
 
March 31, 2016
 
December 31, 2015
 
Gross Amounts
 
Amounts Subject to Enforceable Master Netting Arrangements
 
Net Amounts
 
Gross Amounts
 
Amounts Subject to Enforceable Master Netting Arrangements
 
Net Amounts
Asset derivatives
$

 
$

 
$

 
$
427

 
$
(427
)
 
$

Liability derivatives
4,735

 

 
4,735

 
2,370

 
(427
)
 
1,943


19


HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

We have agreements with each of our interest rate swap derivative counterparties which provide that if we default on certain of our unsecured indebtedness, our counterparties could declare us in default on our interest rate swap derivative obligations resulting in an acceleration of the indebtedness. In addition, we are exposed to credit risk in the event of non-performance by our derivative counterparties. We believe we mitigate the credit risk by entering into agreements with credit-worthy counterparties. We record counterparty credit risk valuation adjustments on interest rate swap derivative assets in order to properly reflect the credit quality of the counterparty. In addition, our fair value of interest rate swap derivative liabilities is adjusted to reflect the impact of our credit quality. As of March 31, 2016, there have been no termination events or events of default related to our interest rate swaps.
8. Stockholders’ Equity and Partners’ Capital
HTALP’s partnership agreement provides that it will distribute cash flow from operations and net sale proceeds to its partners in accordance with their overall ownership interests at such times and in such amounts as the general partner determines. Dividend distributions are made such that a holder of one partnership unit in HTALP will receive distributions from HTALP in an amount equal to the dividend distributions paid to the holder of one share of HTA’s common stock. In addition, for each share of common stock issued or redeemed by HTA, HTALP issues or redeems a corresponding number of partnership units.
Common Stock Offerings
In January 2016, HTA entered into a new equity distribution agreement with respect to its at-the-market (“ATM”) offering program of common stock with an aggregate sales price of up to $300.0 million. During the three months ended March 31, 2016, HTA issued and sold 3,418,571 shares of common stock, at an average price of $27.25 per share and as of March 31, 2016, $206.8 million remained available for issuance under the ATM.
In April 2016, HTA completed an underwritten public offering of 5,980,000 shares of common stock at a price of $28.75 per share.
Common Stock Dividends
See our accompanying condensed consolidated statements of operations for the dividends declared during the three months ended March 31, 2016 and 2015. On April 25, 2016, HTA declared a quarterly cash dividend of $0.295 per share to be paid on July 8, 2016 to stockholders of record for its common stock on July 1, 2016.
Incentive Plan
HTA’s Amended and Restated 2006 Incentive Plan (the “Plan”) permits the grant of incentive awards to our employees, officers, non-employee directors and consultants as selected by our Board of Directors. The Plan authorizes the granting of awards in any of the following forms: options; stock appreciation rights; restricted stock; restricted or deferred stock units; performance awards; dividend equivalents; other stock-based awards, including units in HTALP; and cash-based awards. Subject to adjustment as provided in the Plan, the aggregate number of awards reserved and available for issuance under the Plan is 5,000,000. As of March 31, 2016, there were 2,123,422 awards available for grant under the Plan.
LTIP Units
Awards under the LTIP consist of Series C units in HTALP and were subject to the achievement of certain performance and market conditions in order to vest. Once vested, the Series C units were converted into common units of HTALP, which may be converted into shares of HTA’s common stock. The LTIP awards were fully expensed in 2013, except for 225,000 units that were forfeited in 2015.
Restricted Common Stock
For the three months ended March 31, 2016 and 2015, we recognized compensation expense of $1.8 million and $1.9 million, respectively, which were recorded in general and administrative expenses in the accompanying condensed consolidated statements of operations.
As of March 31, 2016, there was $6.7 million of unrecognized compensation expense net of estimated forfeitures, which will be recognized over a remaining weighted average period of 1.8 years.

20


HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The following is a summary of our restricted common stock activity during the three months ended March 31, 2016 and 2015:
 
March 31, 2016
 
March 31, 2015
 
Restricted Common Stock
 
Weighted
Average Grant
Date Fair Value
 
Restricted Common Stock
 
Weighted
Average Grant
Date Fair Value
Beginning balance
487,850

 
$
23.13

 
463,050

 
$
20.90

Granted
194,151

 
27.17

 
172,115

 
26.98

Vested
(162,140
)
 
22.65

 
(113,029
)
 
21.99

Forfeited
(3,244
)
 
24.23

 
(8,000
)
 
22.08

Ending Balance
516,617

 
$
24.79

 
514,136

 
$
22.60

9. Fair Value of Financial Instruments
Financial Instruments Reported at Fair Value - Recurring
The table below presents our assets and liabilities measured at fair value on a recurring basis as of March 31, 2016, aggregated by the applicable level in the fair value hierarchy (in thousands):
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
Derivative financial instruments
 
$

 
$

 
$

 
$

Liabilities:
 
 
 
 
 
 
 
 
Derivative financial instruments
 
$

 
$
4,735

 
$

 
$
4,735

The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2015, aggregated by the applicable level in the fair value hierarchy (in thousands):
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
Derivative financial instruments
 
$


$
427


$

 
$
427

Liabilities:
 
 
 
 
 
 
 
 
Derivative financial instruments
 
$

 
$
2,370

 
$

 
$
2,370

Financial Instruments Reported at Fair Value - Non-Recurring
As of March 31, 2016, there were no assets measured at fair value on a non-recurring basis. The table below presents our assets measured at fair value on a non-recurring basis as of December 31, 2015, aggregated by the applicable level in the fair value hierarchy (in thousands):
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
MOB (1)
 
$

 
$
547

 
$

 
$
547

 
 
 
 
 
 
 
 
 
(1) During the year ended December 31, 2015, we recognized a $0.9 million impairment charge to the carrying value of an MOB. The estimated fair value as of December 31, 2015 was based upon a pending sales agreement on this MOB.
There have been no transfers of assets or liabilities between levels. We will record any such transfers at the end of the reporting period in which a change of event occurs that results in a transfer. Although we have determined that the majority of the inputs used to value our interest rate swap derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with these instruments utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. However, we have assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our interest rate swap derivative positions and have determined that the credit valuation adjustments are not significant to their overall valuation. As a result, we have determined that our interest rate swap derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy. 

21


HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Financial Instruments Disclosed at Fair Value
We consider the carrying values of cash and cash equivalents, tenant and other receivables, restricted cash and escrow deposits and accounts payable, and accrued liabilities, to approximate fair value for these financial instruments because of the short period of time between origination of the instruments and their expected realization. All of these financial instruments are considered Level 2.
The fair value of debt is estimated using borrowing rates available to us with similar terms and maturities, which is considered a Level 2 input. As of March 31, 2016, the fair value of the debt was $1,710.1 million compared to the carrying value of $1,667.3 million. As of December 31, 2015, the fair value of the debt was $1,619.7 million compared to the carrying value of $1,590.7 million.
10. Per Share Data of HTA
HTA includes unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents as “participating securities” pursuant to the two-class method. The resulting classes are our common stock and restricted stock. For the three months ended March 31, 2016 and 2015, all of HTA’s earnings were distributed and the calculated earnings per share amount would be the same for all classes.
The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per share of HTA for the three months ended March 31, 2016 and 2015 (in thousands, except per share data):
 
Three Months Ended March 31,
 
2016
 
2015
Numerator:
 
 
 
Net income
$
10,036

 
$
6,942

Net income attributable to noncontrolling interests
(176
)
 
(138
)
Net income attributable to common stockholders
$
9,860

 
$
6,804

Denominator:
 
 
 
Weighted average shares outstanding - basic
129,336

 
125,175

Dilutive shares
1,904

 
1,930

Weighted average shares outstanding - diluted
131,240

 
127,105

Earnings per common share - basic
 
 
 
Net income attributable to common stockholders
$
0.08

 
$
0.05

Earnings per common share - diluted
 
 
 
Net income attributable to common stockholders
$
0.08

 
$
0.05


22


HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

11. Per Unit Data of HTALP
The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per unit of HTALP for the three months ended March 31, 2016 and 2015 (in thousands, except per unit data):
 
Three Months Ended March 31,
 
2016
 
2015
Numerator:
 
 
 
Net income
$
10,036

 
$
6,942

Net income attributable to noncontrolling interests
(31
)
 
(33
)
Net income attributable to common unitholders
$
10,005

 
$
6,909

Denominator: 
 
 
 
Weighted average units outstanding - basic
131,242

 
126,330

Dilutive units

 

Weighted average units outstanding - diluted
131,242

 
126,330

Earnings per common unit - basic:
 
 
 
Net income attributable to common unitholders
$
0.08

 
$
0.05

Earnings per common unit - diluted:
 
 
 
Net income attributable to common unitholders
$
0.08

 
$
0.05

12. Supplemental Cash Flow Information
The following is the supplemental cash flow information for the three months ended March 31, 2016 and 2015 (in thousands):
 
Three Months Ended March 31,
 
2016
 
2015
Interest paid
$
13,062

 
$
13,238

Income taxes paid
88

 
99

 
 
 
 
Supplemental Disclosure of Noncash Activities:
 
 
 
Investing Activities:
 
 
 
Accrued capital expenditures
$
5,688

 
$
1,464

Financing Activities:
 
 
 
Dividend distributions declared, but not paid
$
38,784

 
$
36,309


23



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The use of the words “we,” “us” or “our” refers to HTA and HTALP, collectively.
The following discussion should be read in conjunction with our condensed consolidated financial statements and notes appearing elsewhere in this Quarterly Report, as well as with the audited consolidated financial statements, accompanying notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our 2015 Annual Report on Form 10-K. Such condensed consolidated financial statements and information have been prepared to reflect HTA’s and HTALP’s financial position as of March 31, 2016 and December 31, 2015, together with results of operations and cash flows for the three months ended March 31, 2016 and 2015.
The information set forth below is intended to provide readers with an understanding of our financial condition, changes in financial condition and results of operations.
Forward-Looking Statements;
Executive Summary;
Company Highlights;
Critical Accounting Policies;
Recently Issued or Adopted Accounting Pronouncements;
Factors Which May Influence Results of Operations;
Results of Operations;
Non-GAAP Financial Measures;
Liquidity and Capital Resources;
Commitments and Contingencies;
Debt Service Requirements;
Off-Balance Sheet Arrangements; and
Inflation.
Forward-Looking Statements
Certain statements contained in this Quarterly Report constitute forward-looking statements within the meaning of the safe harbor from civil liability provided for such statements by the Private Securities Litigation Reform Act of 1995 (set forth in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”)). Such statements include, in particular, statements about our plans, strategies and prospects and estimates regarding future MOB market performance. Additionally, such statements are subject to certain risks and uncertainties, as well as known and unknown risks, which could cause actual results to differ materially and in adverse ways from those projected or anticipated. Therefore, such statements are not intended to be a guarantee of our performance in future periods. Forward-looking statements are generally identifiable by the use of such terms as “expect,” “project,” “may,” “should,” “could,” “would,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “opinion,” “predict,” “potential,” “pro forma” or the negative of such terms and other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date this Quarterly Report is filed with the SEC. We cannot guarantee the accuracy of any such forward-looking statements contained in this Quarterly Report, and we do not intend to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
Any such forward-looking statements reflect our current views about future events, are subject to unknown risks, uncertainties, and other factors, and are based on a number of assumptions involving judgments with respect to, among other things, future economic, competitive and market conditions, all of which are difficult or impossible to predict accurately. To the extent that our assumptions differ from actual results, our ability to meet such forward-looking statements, including our ability to generate positive cash flow from operations, provide dividends to stockholders and maintain the value of our real estate properties, may be significantly hindered. Factors that might impair our ability to meet such forward-looking statements include, without limitation, those discussed in Part I, Item 1A - Risk Factors in our 2015 Annual Report on Form 10-K, which is incorporated herein.

24



Forward-looking statements express expectations of future events. All forward-looking statements are inherently uncertain as they are based on various expectations and assumptions concerning future events and they are subject to numerous known and unknown risks and uncertainties that could cause actual events or results to differ materially from those projected. Due to these inherent uncertainties, our stockholders are urged not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date made. In addition, we undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to projections over time, except as required by law.
These risks and uncertainties should be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements. Additional information concerning us and our business, including additional factors that could materially affect our financial results, is included herein and in our other filings with the SEC.
Executive Summary
HTA is one of the largest publicly-traded REITs focused on MOBs in the U.S. based on GLA. HTA conducts substantially all of its operations through HTALP. We are primarily focused on acquiring, owning and operating high quality MOBs that are predominantly located on the campuses of, or aligned with, nationally or regionally recognized healthcare systems. Our primary objective is to maximize stockholder value with disciplined growth through strategic investments and to provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective we: (i) generate internal growth through proactive asset management, leasing and property management; (ii) target accretive investments in MOBs that are on the campuses of, or aligned with, healthcare systems and located in markets with attractive demographics that complement our existing portfolio; and (iii) actively manage our balance sheet to maintain flexibility with low leverage.
Since 2006, we have invested $3.7 billion to create a portfolio of MOBs and other healthcare assets consisting of approximately 16.2 million square feet of GLA throughout the U.S. Approximately 97% of our portfolio, based on GLA, was located on the campuses of, or aligned with, nationally or regionally recognized healthcare systems. We continue to focus on building relationships with strong tenants and healthcare systems that are leaders in their markets. The leased rate for our portfolio was 92.1% (includes leases which have been executed, but which have not yet commenced) and the occupancy rate was 91.4% as of March 31, 2016. Approximately 60% of our annualized base rent as of March 31, 2016 was derived from tenants that have (or whose parent companies have) a credit rating from a nationally recognized rating agency.
Our portfolio is diversified geographically across 29 states, with no state having more than 14% of our total GLA as of March 31, 2016. We are concentrated in locations that we have determined to be strategic based on demographic trends and projected demand for MOBs, and we expect to continue to invest in these markets. We have concentrations in the following key markets and Top 75 metropolitan statistical areas (“MSAs”): Albany, Atlanta, Austin, Boston, Charleston, Columbus, Dallas, Denver, Greenville, Honolulu, Houston, Indianapolis, Miami, Orlando, Phoenix, Pittsburgh, Raleigh, Tampa and White Plains.
Company Highlights
Portfolio Operating Performance
For the three months ended March 31, 2016, net income was $0.08 per diluted share, or $10.0 million, compared to $0.05 per diluted share, or $6.9 million, for the three months ended March 31, 2015.
For the three months ended March 31, 2016, HTA’s Normalized FFO was $0.40 per diluted share, or $52.1 million, an increase of $0.03 per diluted share, or 8.1%, compared to the three months ended March 31, 2015. For the three months ended March 31, 2016, HTALP’s Normalized FFO was $0.40 per diluted unit, or $52.1 million, an increase of $0.03 per diluted unit, or 8.1%, compared to the three months ended March 31, 2015.
For additional information on Normalized FFO, see “FFO and Normalized FFO” below, which includes a reconciliation to net income attributable to common stockholders/unitholders and an explanation of why we present this non-GAAP financial measure.
For the three months ended March 31, 2016, our total revenue increased 8.9%, or $8.8 million, to $107.3 million, compared to the three months ended March 31, 2015.
For the three months ended March 31, 2016, our Net Operating Income (“NOI”) increased 9.1%, or $6.1 million, to $74.0 million, compared to the three months ended March 31, 2015.
For the three months ended March 31, 2016, our Same-Property Cash NOI increased 3.0%, or $1.9 million, to $64.4 million, compared to the three months ended March 31, 2015.
For additional information on NOI and Same-Property Cash NOI, see “NOI, Cash NOI and Same-Property Cash NOI” below, which includes a reconciliation to net income and an explanation of why we present these non-GAAP financial measures.

25



Internal Growth Through Proactive Asset Management Leasing and Property Management
As of March 31, 2016, our leased rate (includes leases which have been executed, but which have not yet commenced) was 92.1% by GLA and our occupancy rate was 91.4% by GLA.
We entered into new and renewal leases on approximately 254,000 square feet of GLA, or 1.6% of our portfolio, during the three months ended March 31, 2016.
Tenant retention for the Same-Property portfolio was 82% for the quarter, which we believe is indicative of our commitment to maintaining buildings in desirable locations and fostering strong tenant relationships. Tenant retention is defined as the sum of the total leased GLA of tenants that renewed a lease during the period over the total GLA of leases that renewed or expired during the period.
As of March 31, 2016, our in-house property management and leasing platform operated approximately 15.7 million square feet of GLA, or 97% of our total portfolio.
Key Market Focused Strategy and Investments
We have been one of the most active investors in the medical office sector over the last ten years and have developed a strong presence across 15 to 20 key markets. In each of these markets we have established a strong asset management and leasing platform that has allowed us to develop valuable relationships with health systems, physician practices, universities, and regional development firms that have led to investment and leasing opportunities. Our local platforms have also enabled us to focus on generating cost efficiencies as we gain scale across individual markets and regions.
As of March 31, 2016, we had approximately 700,000 to 1.0 million square feet of GLA in each of our top ten markets. We expect to establish this scale across 20 to 25 key markets as our portfolio expands.
Our key markets represent top MSAs with strong growth metrics in jobs and population, low unemployment and mature healthcare infrastructures.
Our investment strategy includes the alignment with key healthcare systems, hospitals and leading academic medical universities.
Over the last several years, our investments have been focused in our key markets, with the majority of our investments also being located either on the campuses of, or aligned with, nationally and regionally recognized healthcare systems.
During the three months ended March 31, 2016, we acquired investments of $162.0 million located in our key markets of Charleston and Houston, and in New England where we strategically expanded our presence in New Haven, Connecticut. The majority of these investments were located on the campuses of, or aligned with, nationally and regionally recognized healthcare systems.
Financial Strategy and Balance Sheet Flexibility
As of March 31, 2016, we had total liquidity of $562.3 million, including cash and cash equivalents of $13.8 million and $548.5 million available on our unsecured revolving credit facility (includes the impact of $5.5 million of outstanding letters of credit). Our leverage ratio of debt to capitalization was 30.0% as of March 31, 2016.
During the three months ended March 31, 2016, we issued and sold approximately $93.2 million of common stock through the ATM, at an average price of $27.25 per share.
Critical Accounting Policies
The complete list of our critical accounting policies was disclosed in our 2015 Annual Report on Form 10-K. There have been no material changes to our critical accounting policies as disclosed herein.
Recently Issued or Adopted Accounting Pronouncements
See Note 2 - Summary of Significant Accounting Policies to our accompanying condensed consolidated financial statements for a discussion of recently issued or adopted accounting pronouncements.
Factors Which May Influence Results of Operations
We are not aware of any material trends or uncertainties, other than national economic conditions affecting real estate generally and the risk factors previously listed in Part I, Item 1A - Risk Factors, in our 2015 Annual Report on Form 10-K that may reasonably be expected to have a material impact, favorable or unfavorable, on revenues or income from the investment, management and operation of our properties.

26



Rental Income
The amount of rental income generated by our properties depends principally on our ability to maintain the occupancy rates of currently leased space and to lease currently available space and space that will become available from unscheduled lease terminations at the then applicable rental rates. Negative trends in one or more of these factors could adversely affect our rental income in future periods.
Investment Activity
During the three months ended March 31, 2016, we had investments with an aggregate purchase price of $162.0 million and no dispositions. During the three months ended March 31, 2015, we had investments with an aggregate purchase price of $35.3 million and no dispositions. The amount of any future acquisitions or dispositions could have a significant impact on our results of operations in future periods.
Results of Operations
Comparison of the Three Months Ended March 31, 2016 and 2015
As of March 31, 2016, we owned and operated approximately 16.2 million square feet of GLA, with a 92.1% leased rate (includes leases which have been executed, but which have not yet commenced) and a 91.4% occupancy rate. As of March 31, 2015, we owned and operated approximately 15.0 million square feet of GLA, with a 91.7% leased rate (includes leases which have been executed, but which have not yet commenced) and a 91.3% occupancy rate. All explanations are applicable to both HTA and HTALP unless otherwise noted.
Rental Income
For the three months ended March 31, 2016 and 2015, rental income was comprised of the following (in thousands):
 
 
Three Months Ended March 31,
 
 
2016
 
2015
Contractual rental income
 
$
103,812

 
$
95,243

Straight-line rent and amortization of above/below market leases
 
2,073

 
2,131

Other operating revenue
 
1,365

 
1,078

Total
 
$
107,250

 
$
98,452

Contractual rental income, which includes expense reimbursements, increased $8.6 million for the three months ended March 31, 2016, compared to the three months ended March 31, 2015. This increase was primarily due to $10.1 million of additional contractual rental income from our 2015 and 2016 acquisitions (including properties owned in both periods) and contractual rent increases, partially offset by a decrease in contractual rent as a result of buildings we sold during 2015. For the three months ended March 31, 2016, we entered into new and renewal leases of approximately 254,000 square feet of GLA. The new and renewal leases commenced at an average starting annual base rent of $22.37 per square foot of GLA. Expiring leases had an average ending annual base rent that was $22.06 per square foot of GLA. Lease rates can vary between markets and rates that are considered above or below current market rent may change over time. Leases that expired in 2016 had rents that we believed were generally at market rates. Generally, leasing concessions vary depending on lease type and term. For the three months ended March 31, 2016, new leases had tenant improvements, leasing commissions and tenant concessions of $27.38, $4.34 and $5.05 per square foot of GLA, respectively, compared to $23.49, $4.81 and $5.93 per square foot of GLA, respectively, for the three months ended March 31, 2015. The average term for new leases executed was 5.8 years and 7.2 years for the three months ended March 31, 2016 and 2015, respectively. Renewal leases had tenant improvements, leasing commissions and tenant concessions of $6.00, $1.09 and $1.07 per square foot of GLA, respectively, for the three months ended March 31, 2016, compared to $3.17, $0.82 and $0.36 per square foot of GLA, respectively, for the three months ended March 31, 2015. The average term for renewal leases executed was 3.7 years and 4.4 years for the three months ended March 31, 2016 and 2015, respectively.
Rental Expenses
For the three months ended March 31, 2016 and 2015, rental expenses attributable to our properties were $33.4 million and $30.7 million, respectively. The increase in rental expenses was primarily due to $5.0 million of additional rental expenses associated with our 2015 and 2016 acquisitions, partially offset by improved operating efficiencies and a decrease in rental expenses as a result of the buildings we sold during 2015.
General and Administrative Expenses
For the three months ended March 31, 2016 and 2015, general and administrative expenses were $6.8 million and $6.6 million, respectively. General and administrative expenses include such costs as salaries, corporate overhead and professional fees, among other items.

27



Acquisition-Related Expenses
For the three months ended March 31, 2016 and 2015, acquisition-related expenses were $1.8 million and $1.4 million, respectively. The increase in acquisition-related expenses was primarily due to increased acquisition activity during 2016.
Depreciation and Amortization Expense
For the three months ended March 31, 2016 and 2015, depreciation and amortization expense was $37.8 million and $36.6 million, respectively. The increase in depreciation and amortization expense was primarily due to the increase in the size of our portfolio.
Interest Expense and Net Change in Fair Value of Derivative Financial Instruments
Interest expense excluding the impact of the net change in fair value of derivative financial instruments increased by $0.4 million during the three months ended March 31, 2016, compared to the three months ended March 31, 2015. This increase was primarily due to the change in our debt composition from the payoff of fixed rate mortgage loans using our variable rate unsecured revolving credit facility which has a lower interest rate, partially offset by net borrowings we had on our Unsecured Credit Agreement. During the three months ended March 31, 2016, the fair market value of our derivatives decreased $2.8 million, compared to a net decrease of $2.0 million during the three months ended March 31, 2015.
To achieve our objectives, we borrow at both fixed and variable rates. We also enter into derivative financial instruments, such as interest rate swaps, in order to mitigate our interest rate risk on a related financial instrument. We do not enter into derivative or interest rate transactions for speculative purposes. Derivatives not designated as hedges are not speculative and are used to manage our exposure to interest rate movements.
NOI and Same-Property Cash NOI
NOI increased $6.1 million to $74.0 million for the three months ended March 31, 2016, compared to the three months ended March 31, 2015. This increase was primarily due to $6.2 million of additional NOI from our 2015 and 2016 acquisitions, partially offset by a decrease in NOI as a result of the buildings we sold during 2015 and a reduction in straight-line rent from properties we owned more than a year.
Same-Property Cash NOI increased $1.9 million to $64.4 million for the three months ended March 31, 2016, compared to the three months ended March 31, 2015. The increase was primarily the result of rent escalations, an increase in average occupancy and improved operating efficiencies.
Non-GAAP Financial Measures
FFO and Normalized FFO
We compute FFO in accordance with the current standards established by the National Association of Real Estate Investment Trusts (“NAREIT”). NAREIT defines FFO as net income or loss attributable to common stockholders/unitholders (computed in accordance with GAAP), excluding gains or losses from the sales of real estate property and impairment write-downs of depreciable assets, plus depreciation and amortization related to investments in real estate, and after adjustments for unconsolidated partnerships and joint ventures. We present this non-GAAP financial measure because we consider it an important supplemental measure of our operating performance and believe it is frequently used by securities analysts, investors and other interested parties in the evaluation of REITs. Historical cost accounting assumes that the value of real estate assets diminishes ratably over time. Since real estate values have historically risen or fallen based on market conditions, many industry investors have considered the presentation of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. Because FFO excludes depreciation and amortization unique to real estate, among other items, it provides a perspective not immediately apparent from net income or loss attributable to common stockholders/unitholders.
Our methodology for calculating FFO may be different from methods utilized by other REITs and, accordingly, may not be comparable to such other REITs. FFO should not be considered as an alternative to net income or loss attributable to common stockholders/unitholders (computed in accordance with GAAP) as an indicator of our financial performance, nor is it indicative of cash available to fund cash needs. FFO should be reviewed in connection with other GAAP measurements.

28



We also compute Normalized FFO, which excludes from FFO: (i) acquisition-related expenses; (ii) gain or loss on change in fair value of derivative financial instruments; (iii) noncontrolling income or loss from partnership units included in diluted shares (only applicable to HTA); and (iv) other normalizing items, which include items that are unusual and infrequent in nature. We present this non-GAAP financial measure because it allows for the comparison of our operating performance to other REITs and between periods on a consistent basis. Our methodology for calculating Normalized FFO may be different from the methods utilized by other REITs and, accordingly, may not be comparable to other REITs. Normalized FFO should not be considered as an alternative to net income or loss attributable to common stockholders/unitholders (computed in accordance with GAAP) as an indicator of our financial performance, nor is it indicative of cash available to fund cash needs. Normalized FFO should be reviewed in connection with other GAAP measurements.
The amounts included in the calculation of FFO and Normalized FFO are generally the same for HTALP and HTA, except for net income or loss attributable to common stockholders/unitholders, noncontrolling income or loss from partnership units included in diluted shares (only applicable to HTA) and the weighted average shares of HTA common stock or HTALP partnership units outstanding.
The following is the reconciliation of HTA’s FFO and Normalized FFO to net income attributable to common stockholders for the three months ended March 31, 2016 and 2015 (in thousands, except per share data):
 
 
Three Months Ended March 31,
 
 
2016
 
2015
Net income attributable to common stockholders
 
$
9,860

 
$
6,804

Depreciation and amortization expense related to investments in real estate
 
37,521

 
36,280

FFO attributable to common stockholders
 
$
47,381

 
$
43,084

Acquisition-related expenses
 
1,813

 
1,357

Loss on change in fair value of derivative financial instruments, net
 
2,792

 
2,010

Noncontrolling income from partnership units included in diluted shares
 
145

 
105

Other normalizing items, net
 
(16
)
 
89

Normalized FFO attributable to common stockholders
 
$
52,115

 
$
46,645

 
 
 
 
 
Net income attributable to common stockholders per diluted share
 
$
0.08

 
$
0.05

FFO adjustments per diluted share, net
 
0.28

 
0.29

FFO attributable to common stockholders per diluted share
 
$
0.36

 
$
0.34

Normalized FFO adjustments per diluted share, net
 
0.04

 
0.03

Normalized FFO attributable to common stockholders per diluted share
 
$
0.40

 
$
0.37

 
 
 
 
 
Weighted average diluted common shares outstanding
 
131,240

 
127,105

The following is the reconciliation of HTALP’s FFO and Normalized FFO to net income attributable to common unitholders for the three months ended March 31, 2016 and 2015 (in thousands, except per unit data):
 
 
Three Months Ended March 31,
 
 
2016
 
2015
Net income attributable to common unitholders
 
$
10,005

 
$
6,909

Depreciation and amortization expense related to investments in real estate
 
37,521

 
36,280

FFO attributable to common unitholders
 
$
47,526

 
$
43,189

Acquisition-related expenses
 
1,813

 
1,357

Loss on change in fair value of derivative financial instruments, net
 
2,792

 
2,010

Other normalizing items, net
 
(16
)
 
89

Normalized FFO attributable to common unitholders
 
$
52,115

 
$
46,645

 
 
 
 
 
Net income attributable to common unitholders per diluted unit
 
$
0.08

 
$
0.05

FFO adjustments per diluted unit, net
 
0.28

 
0.29

FFO attributable to common unitholders per diluted unit
 
$
0.36

 
$
0.34

Normalized FFO adjustments per diluted unit, net
 
0.04

 
0.03

Normalized FFO attributable to common unitholders per diluted unit
 
$
0.40

 
$
0.37

 
 
 
 
 
Weighted average diluted common units outstanding
 
131,242

 
126,330


29



NOI, Cash NOI and Same-Property Cash NOI
NOI is a non-GAAP financial measure that is defined as net income or loss (computed in accordance with GAAP) before: (i) general and administrative expenses; (ii) acquisition-related expenses; (iii) depreciation and amortization expense; (iv) interest expense and net change in fair value of derivative financial instruments; and (v) other income or expense. We believe that NOI provides an accurate measure of the operating performance of our operating assets because NOI excludes certain items that are not associated with the management of our properties. Additionally, we believe that NOI is a widely accepted measure of comparative operating performance of REITs. However, our use of the term NOI may not be comparable to that of other REITs as they may have different methodologies for computing this amount. NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of our financial performance. NOI should be reviewed in connection with other GAAP measurements.
Cash NOI is a non-GAAP financial measure which excludes from NOI: (i) straight-line rent adjustments; (ii) amortization of below and above market leases/leasehold interests; and (iii) lease termination fees. We believe that Cash NOI provides another measurement of the operating performance of our operating assets. Additionally, we believe that Cash NOI is a widely accepted measure of comparative operating performance of REITs. However, our use of the term Cash NOI may not be comparable to that of other REITs as they may have different methodologies for computing this amount. Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of our financial performance. Cash NOI should be reviewed in connection with other GAAP measurements.
To facilitate the comparison of Cash NOI between periods, we calculate comparable amounts for a subset of our owned properties referred to as “Same-Property”. Same-Property Cash NOI excludes properties which have not been owned and operated during the entire span of all periods presented excluding properties intended for disposition in the near term, notes receivable interest income and certain non-routine items. Same-Property Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of our financial performance. Same-Property Cash NOI should be reviewed in connection with other GAAP measurements.
The following is the reconciliation of HTA’s and HTALP’s NOI, Cash NOI and Same-Property Cash NOI to net income for the three months ended March 31, 2016 and 2015 (in thousands):
 
 
Three Months Ended March 31,
 
 
2016
 
2015
Net income
 
$
10,036

 
$
6,942

General and administrative expenses
 
6,773

 
6,575

Acquisition-related expenses
 
1,813

 
1,357

Depreciation and amortization expense
 
37,828

 
36,595

Interest expense and net change in fair value of derivative financial instruments
 
17,565

 
16,369

Other income
 
(53
)
 
(15
)
NOI
 
$
73,962

 
$
67,823

Straight-line rent adjustments, net
 
(1,451
)
 
(2,019
)
Amortization of below and above market leases/leasehold interests, net
 
433

 
580

Lease termination fees
 
(16
)
 
(11
)
Cash NOI
 
$
72,928

 
$
66,373

Non Same-Property Cash NOI
 
(8,521
)
 
(3,867
)
Same-Property Cash NOI (1)
 
$
64,407

 
$
62,506

 
 
 
 
 
(1) Same-Property includes 278 buildings for the three months ended March 31, 2016 and 2015.
Liquidity and Capital Resources
Our primary sources of cash include: (i) cash flow from operations; (ii) borrowings under our unsecured revolving credit facility; (iii) net proceeds from the issuances of debt and equity securities; and (iv) proceeds from the dispositions of non-core buildings or buildings located outside our key markets. During the next 12 months our primary uses of cash are expected to include: (i) the funding of acquisitions of MOBs and other facilities that serve the healthcare industry; (ii) capital expenditures; (iii) the payment of operating expenses; (iv) debt service payments including principal payments; and (v) the payment of dividends to our stockholders. We anticipate cash flow from operations, restricted cash and reserve accounts and our unsecured revolving credit facility, if needed, will be sufficient to fund our operating expenses, capital expenditures and dividends to stockholders. Investments and maturing indebtedness may require funds from the issuance of debt and/or equity securities or proceeds from sales of real estate.

30



As of March 31, 2016, we had liquidity of $562.3 million, including $548.5 million available on our unsecured revolving credit facility (includes the impact of $5.5 million of outstanding letters of credit) and $13.8 million of cash and cash equivalents. In April 2016, we completed an underwritten public offering of 5,980,000 shares of common stock at a price of $28.75 per share.
As of March 31, 2016, $206.8 million was available for issuance under our $300.0 million ATM program. In addition, we had unencumbered properties with a gross book value of $3.1 billion. The unencumbered properties may be used as collateral to secure additional financings in future periods or refinance our current debt as it becomes due. Our ability to raise funds from future debt and equity issuances is dependent on our investment grade credit ratings, general economic and market conditions and our operating performance.
When we acquire a property, we prepare a capital plan that contemplates the estimated capital needs of that investment. In addition to operating expenses, capital needs may also include costs of refurbishment, tenant improvements or other major capital expenditures. The capital plan for each investment will be adjusted through ongoing, regular reviews of our portfolio or as necessary to respond to unanticipated additional capital needs. As of March 31, 2016, we estimate that our expenditures for capital improvements for the remainder of 2016 will range from $15 million to $20 million depending on leasing activity. As of March 31, 2016, we had $10.5 million of restricted cash and reserve accounts for such capital expenditures. We cannot provide assurance, however, that we will not exceed these estimated expenditure levels.
If we experience lower occupancy levels, reduced rental rates, reduced revenues as a result of asset sales, or increased capital expenditures and leasing costs compared to historical levels due to competitive market conditions for new and renewal leases, the effect would be a reduction of net cash provided by operating activities. If such a reduction of net cash provided by operating activities is realized, we may have a cash flow deficit in subsequent periods. Our estimate of net cash available is based on various assumptions which are difficult to predict, including the levels of our leasing activity and related leasing costs. Any changes in these assumptions could impact our financial results and our ability to fund working capital and unanticipated cash needs.
Cash Flows
The following is a summary of our cash flows for the three months ended March 31, 2016 and 2015 (in thousands):
 
Three Months Ended March 31,
 
 
 
2016
 
2015
 
Change
Cash and cash equivalents - beginning of period
$
13,070

 
$
10,413

 
$
2,657

Net cash provided by operating activities
40,452

 
37,195

 
3,257

Net cash used in investing activities
(168,309
)
 
(42,145
)
 
(126,164
)
Net cash provided by financing activities
128,614

 
8,054

 
120,560

Cash and cash equivalents - end of period
$
13,827

 
$
13,517

 
$
310

Net cash provided by operating activities increased in 2016 primarily due to the impact of our 2015 and 2016 acquisitions, contractual rent increases and improved operating efficiencies, partially offset by our 2015 dispositions. We anticipate cash flows from operating activities to increase as a result of the above items and continued leasing activity in our existing portfolio.
For the three months ended March 31, 2016, net cash used in investing activities primarily related to the investment in real estate of $158.7 million and capital expenditures of $8.8 million. For the three months ended March 31, 2015, net cash used in investing activities primarily related to the investment in real estate of $35.3 million and capital expenditures of $6.5 million. We anticipate cash flows used in investing activities to increase as we continue to acquire more properties.
For the three months ended March 31, 2016, net cash provided by financing activities primarily related to net borrowings of $78.0 million on our Unsecured Credit Agreement and the net proceeds of shares of common stock issued of $91.8 million, partially offset by dividends paid to holders of our common stock of $37.5 million. For the three months ended March 31, 2015, net cash provided by financing activities primarily related to net borrowings of $66.0 million on our Unsecured Credit Agreement, partially offset by dividends paid to holders of our common stock of $36.3 million and payments on our mortgage and term loans of $20.0 million.

31



Dividends
The amount of dividends HTA pays to its stockholders is determined by its Board of Directors, in its sole discretion, and is dependent on a number of factors, including funds available, our financial condition, capital expenditure requirements and annual dividend distribution requirements needed to maintain our status as a REIT under the Internal Revenue Code of 1986, as amended. HTA has paid monthly or quarterly dividends since February 2007, and if our investments produce sufficient cash flow, we expect to continue to pay dividends to our stockholders. Because our cash available for dividend distributions in any year may be less than 90% of our taxable income for the year, we may obtain the necessary funds through borrowings, issuing new securities or selling assets to pay out enough of our taxable income to satisfy our dividend distribution requirement. HTA’s organizational documents do not establish a limit on dividends that may constitute a return of capital for federal income tax purposes. The dividend HTA pays to its stockholders is equal to the distributions received from HTALP in accordance with the terms of HTALP’s partnership agreement. It is HTA’s intention to continue to pay dividends. However, HTA’s Board of Directors may reduce our dividend rate and HTA cannot guarantee the timing and amount of dividends that it may pay in the future, if any.
For the three months ended March 31, 2016, HTA paid cash dividends of $37.5 million. In April 2016, HTA paid cash dividends of $38.5 million for the quarter ended March 31, 2016. On April 25, 2016, HTA declared a quarterly cash dividend of $0.295 per share to be paid on July 8, 2016 to stockholders of record on July 1, 2016.
Financing
We have historically maintained a low leveraged balance sheet and intend to continue to maintain this structure over the long run. However, our total leverage may fluctuate on a short term basis as we execute our business strategy. As of March 31, 2016, our leverage ratio of debt to capitalization was 30.0%.
As of March 31, 2016, we had debt outstanding of $1.7 billion and the weighted average interest rate was 3.21% per annum, inclusive of the impact of our interest rate swaps. The following is a summary of our unsecured and secured debt. See Note 6 - Debt to our accompanying condensed consolidated financial statements for a further discussion of our debt.
Unsecured Revolving Credit Facility
As of March 31, 2016, $548.5 million was available on our unsecured revolving credit facility. Our unsecured revolving credit facility matures in January 2020. In February 2015, we executed an amendment to the Unsecured Credit Agreement which added an additional lender and increased the amount available under the unsecured revolving credit facility by $50.0 million to $850.0 million. The other existing terms of the Unsecured Credit Agreement were unchanged.
Unsecured Term Loans
As of March 31, 2016, we had $455.0 million of unsecured term loans outstanding, comprised of a $300.0 million term loan under our Unsecured Credit Agreement and a $155.0 million term loan, both maturing in 2019. The $300.0 million term loan includes a one-year extension exercisable at the option of the borrower, subject to certain conditions.
Unsecured Senior Notes
As of March 31, 2016, we had $300.0 million of unsecured senior notes that mature in July 2021 and $300.0 million of unsecured senior notes that mature in April 2023.
Mortgage Loans
During the three months ended March 31, 2016, we made payments of $1.8 million on our mortgage loans and have $51.0 million of principal payments due on current outstanding indebtedness during the remainder of 2016.
Commitments and Contingencies
There have been no material changes from the commitments and contingencies disclosed in our 2015 Annual Report on Form 10-K.
Debt Service Requirements
We are required by the terms of our applicable loan agreements to meet certain financial covenants, such as minimum net worth and liquidity, and reporting requirements, among others. As of March 31, 2016, we believe that we were in compliance with all such covenants and we are not aware of any covenants that are reasonably likely that we would not be able to meet.
Off-Balance Sheet Arrangements
As of and during the three months ended March 31, 2016, we had no off-balance sheet arrangements.

32



Inflation
We are exposed to inflation risk as income from future long-term leases is the primary source of our cash flows from operations. There are provisions in the majority of our tenant leases that protect us from the impact of normal inflation. These provisions include rent escalations, reimbursement billings for operating expense pass-through charges and real estate tax and insurance reimbursements on a per square foot allowance. However, due to the long-term nature of our leases, among other factors, the leases may not reset frequently enough to cover inflation.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There were no material changes in the information regarding market risk that was provided in our 2015 Annual Report on Form 10-K. The table below presents, as of March 31, 2016, the principal amounts of our fixed and variable debt and the weighted average interest rates, excluding the impact of interest rate swaps, by year of expected maturity to evaluate the expected cash flows and sensitivity to interest rate changes (in thousands, except interest rates):
 
Expected Maturity Date
 
2016
 
2017
 
2018
 
2019
 
2020
 
Thereafter
 
Total
Fixed rate debt 
$
50,614

 
$
116,062

 
$
13,820

 
$
8,626

 
$
22,266

 
$
685,004

 
$
896,392

Weighted average interest rate on fixed rate debt (per annum)
5.79
%
 
5.92
%
 
6.23
%
 
5.58
%
 
6.14
%
 
3.75
%
 
4.26
%
Variable rate debt
$
399

 
$
564

 
$
608

 
$
455,655

 
$
322,638

 
$

 
$
779,864

Weighted average interest rate on variable rate debt based on forward rates in effect as of March 31, 2016 (per annum)
1.91
%
 
2.18
%
 
2.40
%
 
2.53
%
 
2.51
%
 
%
 
1.67
%
As of March 31, 2016, we had $1.7 billion fixed and variable rate debt with interest rates ranging from 1.49% to 6.49% per annum and a weighted average interest rate of 3.06% per annum, excluding the impact of interest rate swaps. We had $896.4 million (excluding net premium/discount and deferred financing costs) of fixed rate debt with a weighted average interest rate of 4.26% per annum and $779.9 million (excluding net premium/discount and deferred financing costs) of variable rate debt with a weighted average interest rate of 1.67% per annum as of March 31, 2016, excluding the impact of interest rate swaps.
As of March 31, 2016, the fair value of our fixed rate debt was $922.8 million and the fair value of our variable rate debt was $787.3 million based upon prevailing market rates as of March 31, 2016.
As of March 31, 2016, we had interest rate swaps outstanding that effectively fix $280.9 million of our variable rate debt. Including the impact of these interest rate swaps, the effective rate on our variable rate and total debt is 2.01% and 3.21% per annum, respectively.
In addition to changes in interest rates, the value of our future properties is subject to fluctuations based on changes in local and regional economic conditions and changes in the creditworthiness of tenants, which may affect our ability to refinance our debt if necessary.

33



Item 4. Controls and Procedures
Healthcare Trust of America, Inc.
HTA’s management is responsible for establishing and maintaining disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to HTA’s management, including HTA’s Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer and principal accounting officer), to allow timely decisions regarding required disclosure.
As of March 31, 2016, an evaluation was conducted by HTA under the supervision and with the participation of its management, including HTA’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of its disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, HTA’s Chief Executive Officer and the Chief Financial Officer concluded that HTA’s disclosure controls and procedures were effective.
There were no changes in HTA’s internal control over financial reporting that occurred during the quarter ended March 31, 2016 that have materially affected, or are reasonably believed to be likely to materially affect, HTA’s internal control over financial reporting.
April 27, 2016

Healthcare Trust of America Holdings, LP
HTALP’s management is responsible for establishing and maintaining disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to HTALP’s management, including HTA’s Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer and principal accounting officer), to allow timely decisions regarding required disclosure.
As of March 31, 2016, an evaluation was conducted by HTALP under the supervision and with the participation of its management, including HTA’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of its disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, HTA’s Chief Executive Officer and the Chief Financial Officer, on behalf of HTA in its capacity as general partner of HTALP, concluded that HTALP’s disclosure controls and procedures were effective.
There were no changes in HTALP’s internal control over financial reporting that occurred during the quarter ended March 31, 2016 that have materially affected, or are reasonably believed to be likely to materially affect, HTALP’s internal control over financial reporting.
April 27, 2016


34



PART II - OTHER INFORMATION
Item 1. Legal Proceedings
We are subject to claims and litigation arising in the ordinary course of business. We do not believe any liability from any reasonably foreseeable disposition of such claims and litigation, individually or in the aggregate, would have a material adverse effect on our accompanying condensed consolidated financial statements.
Item 1A. Risk Factors
There have been no material changes from the risk factors previously disclosed in our 2015 Annual Report on Form 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
During the three months ended March 31, 2016, HTA repurchased shares of its common stock as follows:
Period
 
Total Number of
Shares Purchased (1) (2)
 
Average Price
Paid per Share (1) (2)
 
Total Number of
Shares Purchased
as Part of
Publicly Announced
Plan or Program
 
Maximum Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs
January 1, 2016 to January 31, 2016
 
60,910

 
$
26.90

 

 

February 1, 2016 to February 29, 2016
 
9,464

 
27.71

 

 

March 1, 2016 to March 31, 2016
 

 

 

 

 
 
 
 
 
 
 
 
 
(1) Purchases mainly represent shares withheld to satisfy withholding obligations on the vesting of restricted shares. The price paid per share was the then closing price of our common stock on the NYSE.
(2) For each share of common stock redeemed by HTA, HTALP redeems a corresponding number of units in the operating partnership. Therefore, the units in the operating partnership repurchased by HTALP are the same as the shares of common stock repurchased by HTA as shown above.
Item 6. Exhibits
The exhibits listed on the Exhibit Index (following the signatures section of this Quarterly Report) are included, and incorporated by reference, in this Quarterly Report.


35



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized.
 
Healthcare Trust of America, Inc.
 
 
 
 
By:
/s/ Scott D. Peters
 
Chief Executive Officer, President and Chairman
 
 Scott D. Peters
 
(Principal Executive Officer)
Date:
April 27, 2016
 
 
 
 
 
 
By:
/s/ Robert A. Milligan
 
Chief Financial Officer
 
 Robert A. Milligan
 
(Principal Financial Officer and Principal Accounting Officer)
Date:
April 27, 2016
 
 
 
 
 
 

 
Healthcare Trust of America Holdings, LP
 
 
 
 
By:
Healthcare Trust of America, Inc.,
 
its General Partner
 
 
 
 
 
 
By:
/s/ Scott D. Peters
 
Chief Executive Officer, President and Chairman
 
 Scott D. Peters
 
(Principal Executive Officer)
Date:
April 27, 2016
 
 
 
 
 
 
By:
/s/ Robert A. Milligan
 
Chief Financial Officer
 
 Robert A. Milligan
 
(Principal Financial Officer and Principal Accounting Officer)
Date:
April 27, 2016
 
 



36



EXHIBIT INDEX
The following exhibits are included, or incorporated by reference, in this Quarterly Report for the quarter ended March 31, 2016 (and are numbered in accordance with Item 601 of Regulation S-K).
31.1*
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America, Inc.
31.2*
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America, Inc.
31.3*
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America Holdings, LP.
31.4*
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America Holdings, LP.
32.1**
Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America Inc.
32.2**
Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America, Inc.
32.3**
Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America Holdings, LP.
32.4**
Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002 for Healthcare Trust of America Holdings, LP.
101.INS*
XBRL Instance Document.
101.SCH*
XBRL Taxonomy Extension Schema Document.
101.CAL*
XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*
XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*
XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*
XBRL Taxonomy Extension Presentation Linkbase Document.
 
 
*
Filed herewith.
**
Furnished herewith.


37



Exhibit 31.1
CERTIFICATION
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Scott D. Peters, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Healthcare Trust of America, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
By:
/s/ Scott D. Peters  
 
 
 
Scott D. Peters 
 
 
 
Chief Executive Officer, President and Chairman
 

Date: April 27, 2016





Exhibit 31.2
CERTIFICATION
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Robert A. Milligan, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Healthcare Trust of America, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
By:
/s/ Robert A. Milligan
 
 
 
Robert A. Milligan
 
 
 
Chief Financial Officer
 

Date: April 27, 2016





Exhibit 31.3
CERTIFICATION
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Scott D. Peters, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Healthcare Trust of America Holdings, LP;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
By:
/s/ Scott D. Peters  
 
 
 
Scott D. Peters 
 
 
 
Chief Executive Officer, President and Chairman of Healthcare Trust of America, Inc., general partner of Healthcare Trust of America Holdings, LP

 

Date: April 27, 2016





Exhibit 31.4
CERTIFICATION
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Robert A. Milligan, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Healthcare Trust of America Holdings, LP;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
By:
/s/ Robert A. Milligan
 
 
 
Robert A. Milligan
 
 
 
Chief Financial Officer of Healthcare Trust of America, Inc., general partner of Healthcare Trust of America Holdings, LP

 

Date: April 27, 2016





Exhibit 32.1
CERTIFICATION
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report on Form 10-Q of Healthcare Trust of America, Inc., or the Company, for the quarter ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Scott D. Peters, Chief Executive Officer, President and Chairman of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(i) the Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
By:
/s/ Scott D. Peters  
 
 
 
Scott D. Peters
 
 
 
Chief Executive Officer, President and Chairman
 
Date: April 27, 2016


A signed original of this written statement required by Section 906 has been provided to Healthcare Trust of America, Inc. and will be retained by Healthcare Trust of America, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.




Exhibit 32.2
CERTIFICATION
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report on Form 10-Q of Healthcare Trust of America, Inc., or the Company, for the quarter ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Robert A. Milligan, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(i) the Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
By:
/s/ Robert A. Milligan
 
 
 
Robert A. Milligan
 
 
 
Chief Financial Officer
 
Date: April 27, 2016


A signed original of this written statement required by Section 906 has been provided to Healthcare Trust of America, Inc. and will be retained by Healthcare Trust of America, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.





Exhibit 32.3
CERTIFICATION
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report on Form 10-Q of Healthcare Trust of America Holdings, LP, or the Company, for the quarter ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Scott D. Peters, Chief Executive Officer, President and Chairman of Healthcare Trust of America, Inc., general partner of Healthcare Trust of America Holdings, LP, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(i) the Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
By:
/s/ Scott D. Peters  
 
 
 
Scott D. Peters
 
 
 
Chief Executive Officer, President and Chairman of Healthcare Trust of America, Inc., general partner of Healthcare Trust of America Holdings, LP
 
Date: April 27, 2016

A signed original of this written statement required by Section 906 has been provided to Healthcare Trust of America, Inc. and will be retained by Healthcare Trust of America, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.





Exhibit 32.4
CERTIFICATION
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report on Form 10-Q of Healthcare Trust of America Holdings, LP, or the Company, for the quarter ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Robert A. Milligan, Chief Financial Officer of Healthcare Trust of America, Inc., general partner of Healthcare Trust of America Holdings, LP, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(i) the Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
By:
/s/ Robert A. Milligan
 
 
 
Robert A. Milligan
 
 
 
Chief Financial Officer of Healthcare Trust of America, Inc., general partner of Healthcare Trust of America Holdings, LP
 
Date: April 27, 2016

A signed original of this written statement required by Section 906 has been provided to Healthcare Trust of America, Inc. and will be retained by Healthcare Trust of America, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.



v3.4.0.3
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2016
Apr. 25, 2016
Entity Information [Line Items]    
Entity Registrant Name HEALTHCARE TRUST OF AMERICA, INC.  
Entity Central Index Key 0001360604  
Document Type 10-Q  
Document Period End Date Mar. 31, 2016  
Amendment Flag false  
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q1  
Current Fiscal Year End Date --12-31  
Entity Filer Category Large Accelerated Filer  
Entity Common Stock, Shares Outstanding   136,625,278
Healthcare Trust of America Holdings, LP (HTALP)    
Entity Information [Line Items]    
Entity Registrant Name Healthcare Trust of America Holdings, LP  
Entity Central Index Key 0001495491  
Document Type 10-Q  
Document Period End Date Mar. 31, 2016  
Amendment Flag false  
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus FY  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
v3.4.0.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Real estate investments:    
Land $ 321,021 $ 303,706
Building and improvements 3,038,674 2,901,157
Lease intangibles 446,511 430,749
Real estate investments, gross 3,806,206 3,635,612
Accumulated depreciation and amortization (712,381) (676,144)
Real estate investments, net 3,093,825 2,959,468
Cash and cash equivalents 13,827 13,070
Restricted cash and escrow deposits 16,687 15,892
Receivables and other assets, net 143,012 141,703
Other intangibles, net 43,168 42,167
Total assets 3,310,519 3,172,300
Liabilities:    
Debt 1,667,320 1,590,696
Accounts payable and accrued liabilities 85,453 94,933
Derivative financial instruments - interest rate swaps 4,735 2,370
Security deposits, prepaid rent and other liabilities 47,993 46,295
Intangible liabilities, net 31,538 26,611
Total liabilities $ 1,837,039 $ 1,760,905
Commitments and contingencies
Redeemable noncontrolling interests $ 4,429 $ 4,437
Equity/Partners' Capital:    
Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding 0 0
Class A common stock, $0.01 par value; 1,000,000,000 shares authorized; 130,662,036 and 127,026,839 shares issued and outstanding as of March 31, 2016 and December 31, 2015, respectively 1,307 1,270
Additional paid-in capital 2,422,138 2,328,806
Cumulative dividends in excess of earnings (979,332) (950,652)
Total stockholders’ equity 1,444,113 1,379,424
Noncontrolling interests 24,938 27,534
Total equity 1,469,051 1,406,958
Total liabilities and equity/partners' capital 3,310,519 3,172,300
Healthcare Trust of America Holdings, LP (HTALP)    
Real estate investments:    
Land 321,021 303,706
Building and improvements 3,038,674 2,901,157
Lease intangibles 446,511 430,749
Real estate investments, gross 3,806,206 3,635,612
Accumulated depreciation and amortization (712,381) (676,144)
Real estate investments, net 3,093,825 2,959,468
Cash and cash equivalents 13,827 13,070
Restricted cash and escrow deposits 16,687 15,892
Receivables and other assets, net 143,012 141,703
Other intangibles, net 43,168 42,167
Total assets 3,310,519 3,172,300
Liabilities:    
Debt 1,667,320 1,590,696
Accounts payable and accrued liabilities 85,453 94,933
Derivative financial instruments - interest rate swaps 4,735 2,370
Security deposits, prepaid rent and other liabilities 47,993 46,295
Intangible liabilities, net 31,538 26,611
Total liabilities $ 1,837,039 $ 1,760,905
Commitments and contingencies
Redeemable noncontrolling interests $ 4,429 $ 4,437
Equity/Partners' Capital:    
Limited partners’ capital, 1,833,849 and 1,929,942 units issued and outstanding as of March 31, 2016 and December 31, 2015, respectively 24,668 27,264
General partners’ capital, 130,662,036 and 127,026,839 units issued and outstanding as of March 31, 2016 and December 31, 2015, respectively 1,444,383 1,379,694
Total partners’ capital 1,469,051 1,406,958
Total liabilities and equity/partners' capital $ 3,310,519 $ 3,172,300
v3.4.0.3
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares
Mar. 31, 2016
Dec. 31, 2015
Equity:    
Preferred stock, par value (usd per share) $ 0.01 $ 0.01
Preferred stock, shares authorized 200,000,000 200,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Class A Common Stock    
Equity:    
Common stock, par value (usd per share) $ 0.01 $ 0.01
Common stock, shares authorized 1,000,000,000 1,000,000,000
Common stock, shares issued 130,662,036 127,026,839
Common stock, shares outstanding 130,662,036 127,026,839
Healthcare Trust of America Holdings, LP (HTALP)    
Partners’ Capital:    
Limited partner's capital, units issued 1,833,849 1,929,942
Limited partner's capital, units outstanding 1,833,849 1,929,942
General partner's capital, units issued 130,662,036 127,026,839
General partner's capital, units outstanding 130,662,036 127,026,839
v3.4.0.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Revenues:    
Rental income $ 107,250 $ 98,452
Interest and other operating income 65 68
Total revenues 107,315 98,520
Expenses:    
Rental 33,353 30,697
General and administrative 6,773 6,575
Acquisition-related 1,813 1,357
Depreciation and amortization 37,828 36,595
Total expenses 79,767 75,224
Income before other income (expense) 27,548 23,296
Interest expense:    
Interest related to derivative financial instruments (645) (555)
Loss on change in fair value of derivative financial instruments, net (2,792) (2,010)
Total interest related to derivative financial instruments, including net change in fair value of derivative financial instruments (3,437) (2,565)
Interest related to debt (14,128) (13,804)
Other income 53 15
Net income 10,036 6,942
Net income attributable to noncontrolling interests [1] (176) (138)
Net income attributable to common stockholders/unitholders $ 9,860 $ 6,804
Earnings per common share/unit - basic:    
Net income attributable to common stockholders/unitholders (in usd per share) $ 0.08 $ 0.05
Earnings per common share/unit - diluted:    
Net income attributable to common stockholders/unitholders (in usd per share) $ 0.08 $ 0.05
Weighted average common shares/units outstanding:    
Basic (in shares/units) 129,336 125,175
Diluted (in shares/units) 131,240 127,105
Dividends declared per common share (in usd per share) $ 0.295 $ 0.290
Healthcare Trust of America Holdings, LP (HTALP)    
Revenues:    
Rental income $ 107,250 $ 98,452
Interest and other operating income 65 68
Total revenues 107,315 98,520
Expenses:    
Rental 33,353 30,697
General and administrative 6,773 6,575
Acquisition-related 1,813 1,357
Depreciation and amortization 37,828 36,595
Total expenses 79,767 75,224
Income before other income (expense) 27,548 23,296
Interest expense:    
Interest related to derivative financial instruments (645) (555)
Loss on change in fair value of derivative financial instruments, net (2,792) (2,010)
Total interest related to derivative financial instruments, including net change in fair value of derivative financial instruments (3,437) (2,565)
Interest related to debt (14,128) (13,804)
Other income 53 15
Net income 10,036 6,942
Net income attributable to noncontrolling interests (31) (33)
Net income attributable to common stockholders/unitholders $ 10,005 $ 6,909
Earnings per common share/unit - basic:    
Net income attributable to common stockholders/unitholders (in usd per share) $ 0.08 $ 0.05
Earnings per common share/unit - diluted:    
Net income attributable to common stockholders/unitholders (in usd per share) $ 0.08 $ 0.05
Weighted average common shares/units outstanding:    
Basic (in shares/units) 131,242 126,330
Diluted (in shares/units) 131,242 126,330
Dividends declared per common share (in usd per share) $ 0.295 $ 0.290
[1] Includes amounts attributable to redeemable noncontrolling interests.
v3.4.0.3
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Class A Common Stock
Common Stock
Class A Common Stock
Additional Paid-In Capital
Cumulative Dividends in Excess of Earnings
Total Stockholders’ Equity
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2014     125,087,000        
Beginning balance at Dec. 31, 2014 $ 1,476,421   $ 1,251 $ 2,281,932 $ (836,044) $ 1,447,139 $ 29,282
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based award transactions, net (in shares)     164,000        
Share-based award transactions, net 1,914   $ 1 1,913   1,914  
Repurchase and cancellation of common stock (in shares)     (48,000)        
Repurchase and cancellation of common stock (1,292)     (1,292)   (1,292)  
Dividends declared (36,873)       (36,309) (36,309)  
Dividends declared             (564)
Net income 6,909       6,804 6,804 105
Ending balance (in shares) at Mar. 31, 2015     125,203,000        
Ending balance at Mar. 31, 2015 1,447,079   $ 1,252 2,282,553 (865,549) 1,418,256 28,823
Beginning balance (in shares) at Dec. 31, 2015   127,026,839 127,027,000        
Beginning balance at Dec. 31, 2015 1,406,958   $ 1,270 2,328,806 (950,652) 1,379,424 27,534
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock (in shares)     3,418,000        
Issuance of common stock 91,269   $ 34 91,235   91,269  
Share-based award transactions, net (in shares)     191,000        
Share-based award transactions, net 1,803   $ 2 1,801   1,803  
Repurchase and cancellation of common stock (in shares)     (70,000)        
Repurchase and cancellation of common stock (1,901)     (1,901)   (1,901)  
Redemption of noncontrolling interest and other (in shares)     96,000        
Redemption of noncontrolling interest and other 0   $ 1 2,197   2,198 (2,198)
Dividends declared (39,083)       (38,540) (38,540)  
Dividends declared             (543)
Net income 10,005       9,860 9,860 145
Ending balance (in shares) at Mar. 31, 2016   130,662,036 130,662,000        
Ending balance at Mar. 31, 2016 $ 1,469,051   $ 1,307 $ 2,422,138 $ (979,332) $ 1,444,113 $ 24,938
v3.4.0.3
Condensed Consolidated Statements of Changes In Partners' Capital (Unaudited) - USD ($)
$ in Thousands
Total
Healthcare Trust of America Holdings, LP (HTALP)
Healthcare Trust of America Holdings, LP (HTALP)
General Partners’ Capital
Healthcare Trust of America Holdings, LP (HTALP)
Limited Partners’ Capital
Balance as of beginning of period (in units) at Dec. 31, 2014     125,087,000 2,155,000
Balance as of beginning of period at Dec. 31, 2014   $ 1,476,421 $ 1,447,409 $ 29,012
Increase (Decrease) in Partners' Capital [Roll Forward]        
Share-based award transactions, net (in units)     164,000  
Share-based award transactions, net   1,914 $ 1,914  
Redemption and cancellation of general partner units (in units)     (48,000)  
Redemption and cancellation of general partner units   (1,292) $ (1,292)  
Distributions declared   (36,873) (36,309) (564)
Net income $ 6,804 6,909 $ 6,804 $ 105
Balance as of end of period (in units) at Mar. 31, 2015     125,203,000 2,155,000
Balance as of end of period at Mar. 31, 2015   1,447,079 $ 1,418,526 $ 28,553
Balance as of beginning of period (in units) at Dec. 31, 2015     127,027,000 1,930,000
Balance as of beginning of period at Dec. 31, 2015   1,406,958 $ 1,379,694 $ 27,264
Increase (Decrease) in Partners' Capital [Roll Forward]        
Issuance of general partner units (in units)     3,418,000  
Issuance of general partner units   91,269 $ 91,269  
Share-based award transactions, net (in units)     191,000  
Share-based award transactions, net   1,803 $ 1,803  
Redemption and cancellation of general partner units (in units)     (70,000)  
Redemption and cancellation of general partner units   (1,901) $ (1,901)  
Redemption of limited partner units and other (in units)     96,000 (96,000)
Redemption of limited partner units and other   0 $ 2,198 $ (2,198)
Distributions declared   (39,083) (38,540) (543)
Net income $ 9,860 10,005 $ 9,860 $ 145
Balance as of end of period (in units) at Mar. 31, 2016     130,662,000 1,834,000
Balance as of end of period at Mar. 31, 2016   $ 1,469,051 $ 1,444,383 $ 24,668
v3.4.0.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net income $ 10,036 $ 6,942
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and other 37,091 35,788
Share-based compensation expense 1,803 1,914
Bad debt expense 92 146
Change in fair value of derivative financial instruments 2,792 2,010
Changes in operating assets and liabilities:    
Receivables and other assets, net (1,438) (723)
Accounts payable and accrued liabilities (10,370) (13,172)
Security deposits, prepaid rent and other liabilities 446 4,290
Net cash provided by operating activities 40,452 37,195
Cash flows from investing activities:    
Investments in real estate (158,686) (35,300)
Capital expenditures (8,824) (6,524)
Restricted cash, escrow deposits and other assets (799) (321)
Net cash used in investing activities (168,309) (42,145)
Cash flows from financing activities:    
Borrowings on unsecured revolving credit facility 166,000 82,000
Payments on unsecured revolving credit facility (88,000) (81,000)
Borrowings on unsecured term loans 0 65,000
Payments on secured real estate term loan and mortgage loans (1,761) (19,960)
Deferred financing costs 0 (31)
Security deposits 729 (17)
Proceeds from issuance of common stock 91,757 0
Repurchase and cancellation of common stock (1,901) (1,292)
Dividends paid (37,473) (36,275)
Distributions paid to noncontrolling interest of limited partners (737) (371)
Net cash provided by financing activities 128,614 8,054
Net change in cash and cash equivalents 757 3,104
Cash and cash equivalents - beginning of period 13,070 10,413
Cash and cash equivalents - end of period 13,827 13,517
Healthcare Trust of America Holdings, LP (HTALP)    
Cash flows from operating activities:    
Net income 10,036 6,942
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and other 37,091 35,788
Share-based compensation expense 1,803 1,914
Bad debt expense 92 146
Change in fair value of derivative financial instruments 2,792 2,010
Changes in operating assets and liabilities:    
Receivables and other assets, net (1,438) (723)
Accounts payable and accrued liabilities (10,370) (13,172)
Security deposits, prepaid rent and other liabilities 446 4,290
Net cash provided by operating activities 40,452 37,195
Cash flows from investing activities:    
Investments in real estate (158,686) (35,300)
Capital expenditures (8,824) (6,524)
Restricted cash, escrow deposits and other assets (799) (321)
Net cash used in investing activities (168,309) (42,145)
Cash flows from financing activities:    
Borrowings on unsecured revolving credit facility 166,000 82,000
Payments on unsecured revolving credit facility (88,000) (81,000)
Borrowings on unsecured term loans 0 65,000
Payments on secured real estate term loan and mortgage loans (1,761) (19,960)
Deferred financing costs 0 (31)
Security deposits 729 (17)
Proceeds from issuance of general partner units 91,757 0
Repurchase and cancellation of general partner units (1,901) (1,292)
Distributions paid to general partner (37,473) (36,275)
Distributions paid to limited partners and redeemable noncontrolling interests (737) (371)
Net cash provided by financing activities 128,614 8,054
Net change in cash and cash equivalents 757 3,104
Cash and cash equivalents - beginning of period 13,070 10,413
Cash and cash equivalents - end of period $ 13,827 $ 13,517
v3.4.0.3
Organization and Description of Business
3 Months Ended
Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Description of Business
Organization and Description of Business
HTA, a Maryland corporation, and HTALP, a Delaware limited partnership, were incorporated or formed, as applicable, on April 20, 2006. HTA operates as a REIT and is the general partner of HTALP, which is the operating partnership. As of March 31, 2016, HTA owned a 98.6% partnership interest and other limited partners, including some of HTA’s directors, executive officers and their affiliates, owned the remaining partnership interest (including the LTIP units) in HTALP. As the sole general partner of HTALP, HTA has the full, exclusive and complete responsibility for HTALP’s day-to-day management and control. HTA operates in an umbrella partnership REIT structure in which HTALP and its subsidiaries hold substantially all of the assets. HTA’s only material asset is its ownership of partnership interests of HTALP. As a result, HTA does not conduct business itself, other than acting as the sole general partner of HTALP, issuing public equity from time to time and guaranteeing certain debts of HTALP. HTALP conducts the operations of the business and issues publicly-traded debt, but has no publicly-traded equity.
HTA is one of the largest publicly-traded REITs focused on medical office buildings (“MOBs”) in the United States (“U.S.”) based on gross leasable area (“GLA”). We are primarily focused on acquiring, owning and operating high quality MOBs that are predominantly located on the campuses of, or aligned with, nationally or regionally recognized healthcare systems. In addition, we have strong industry relationships, a stable and diversified tenant mix, and an extensive and active acquisition network. Our primary objective is to maximize stockholder value with disciplined growth through strategic investments that provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we: (i) seek internal growth through proactive asset management, leasing and property management oversight; (ii) target mid-sized acquisitions of MOBs in markets with dominant healthcare systems, and with attractive demographics that complement our existing portfolio; and (iii) actively manage our balance sheet to maintain flexibility with conservative leverage. HTA has qualified to be taxed as a REIT for federal income tax purposes and intends to continue to be taxed as a REIT.
We primarily invest in MOBs that are located on health system campuses, in community-core locations, or around university medical centers which we believe are core, critical real estate. We also focus on our key markets that have certain demographic and macro-economic trends and where we can utilize our institutional property management and leasing platform to generate strong tenant relationships and operating cost efficiencies. Our portfolio consists of MOBs and other facilities that serve the healthcare industry with an aggregate purchase price of $3.7 billion through March 31, 2016.
Our principal executive office is located at 16435 North Scottsdale Road, Suite 320, Scottsdale, Arizona, 85254.
v3.4.0.3
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2016
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies
The summary of significant accounting policies presented below is designed to assist in understanding our condensed consolidated financial statements. Such condensed consolidated financial statements and the accompanying notes are the representations of our management, who are responsible for their integrity and objectivity. These accounting policies conform to U.S. generally accepted accounting principles (“GAAP”) in all material respects and have been consistently applied in preparing our accompanying condensed consolidated financial statements.
Basis of Presentation
Our accompanying condensed consolidated financial statements include our accounts and those of our subsidiaries and any consolidated variable interest entities (“VIEs”). All inter-company balances and transactions have been eliminated in the accompanying condensed consolidated financial statements.
Interim Unaudited Financial Data
Our accompanying condensed consolidated financial statements have been prepared by us in accordance with GAAP in conjunction with the rules and regulations of the SEC. Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, our accompanying condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. Our accompanying condensed consolidated financial statements reflect all adjustments, which are, in our opinion, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Interim results of operations are not necessarily indicative of the results to be expected for the full year; such results may be less favorable for the full year. Our accompanying condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our 2015 Annual Report on Form 10-K. There have been no significant changes to the Company’s significant accounting policies during the three months ended March 31, 2016, except as noted below regarding the adoption of U.S. Financial Accounting Standards Board (the “FASB”) Accounting Standards Update (“ASU”) 2015-02, Amendments to the Consolidation Analysis and ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments.
Principles of Consolidation
As of January 1, 2016, the Company adopted FASB ASU 2015-02, Amendments to the Consolidation Analysis, as described below in “Recently Issued or Adopted Accounting Pronouncements”, which simplifies consolidation accounting by reducing the number of consolidation models and changing various aspects of current GAAP, including certain consolidation criteria for VIEs. The consolidated financial statements include the accounts of HTA and its subsidiaries and consolidated joint venture arrangements. The portions of the consolidated joint venture arrangements not owned by HTA are presented as non-controlling interests in HTA’s consolidated balance sheets and statements of operations, consolidated statements of equity, and consolidated statements of changes in partners’ capital. In addition, as described in Note 1 - Organization and Description of Business, certain third parties have been issued limited partner units in HTALP (“OP Units”). Holders of OP Units are considered to be non-controlling interest holders in HTALP and their ownership interests are reflected as equity in the consolidated balance sheets. Further, a portion of the earnings and losses of HTALP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of common shares issued and the carrying value of the OP Units converted is recorded as a component of equity. As of March 31, 2016 and December 31, 2015, there were approximately 1.8 million and 1.9 million, respectively, of OP Units issued and outstanding.
VIEs are entities where investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support or where equity investors, as a group, lack one of the following: (i) the power to direct the activities that most significantly impact the entity’s economic performance; (ii) the obligation to absorb the expected losses of the entity; and (iii) the right to receive the expected returns of the entity. We consolidate our investment in VIEs when we determine that we are the primary beneficiary. A primary beneficiary is one that has both: (i) the power to direct the activities of the VIE that most significantly impacts the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The Company will evaluate on an ongoing basis the need to consolidate entities based on the standards set forth in GAAP as described above.
Investments in Real Estate
Depreciation expense of buildings and improvements for the three months ended March 31, 2016 and 2015, was $25.7 million and $23.3 million, respectively.
Recently Issued or Adopted Accounting Pronouncements
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive new revenue recognition model requiring a company to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration (i.e., payment) to which the company expects to be entitled in exchange for those goods or services. In adopting ASU 2014-09, companies may use either a full retrospective or a modified retrospective approach. In July 2015, the FASB deferred the effective date of ASU 2014-09 to the first interim period within annual reporting periods beginning after December 15, 2017 along with the ability to early adopt as of the original effective date. We do not anticipate early adoption and we are evaluating the impact of adopting ASU 2014-09 on our consolidated financial statements.
In February 2015, the FASB issued ASU 2015-02, Amendments to the Consolidation Analysis. ASU 2015-02 affects reporting entities that are required to evaluate whether they should consolidate certain legal entities. The amendments in ASU 2015-02 affect the following areas: (i) limited partnerships and similar legal entities; (ii) evaluating fees paid to a decision maker or a service provider as a variable interest; (iii) the effect of fee arrangements on the primary beneficiary determination; (iv) the effect of related parties on the primary beneficiary determination; and (v) certain investment funds. ASU 2015-02 is effective for fiscal years and for interim periods within those fiscal years, beginning after December 15, 2015 with early adoption permitted. We adopted ASU 2015-02 as of January 1, 2016. The adoption had no material impact on our interests in joint venture arrangements. Accordingly, there was no material impact on previous or current reporting periods’ consolidated financial statements.
In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs. ASU 2015-03 changes the presentation of debt issuance costs by requiring these costs related to a recognized debt liability to be presented in the consolidated balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. In August 2015, the FASB issued ASU 2015-15 to include the presentation and subsequent measurement of debt issuance costs associated with line-of-credit arrangements. ASU 2015-03 and 2015-15 are effective for the fiscal years beginning after December 15, 2015, and requires retrospective application with early adoption permitted. We adopted ASU 2015-03 and 2015-15 as of December 31, 2015. As a result of the adoption, all deferred financing costs, excluding costs related to the unsecured revolving credit facility, were reclassed to debt. Unsecured revolving credit facility costs remain classified as an asset on our consolidated balance sheets and will continue to be amortized over the remaining term. The guidance requires retrospective adoption for all prior periods presented.
In September 2015, the FASB issued ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments. ASU 2015-16 eliminates the requirement that an acquirer in a business combination has to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amount of the adjustment, including the effect on earnings of any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. ASU 2015-16 is effective for fiscal years beginning after December 15, 2015. We adopted ASU 2015-16 as of January 1, 2016. As a result of the adoption there was no impact in the previous or current reporting periods’ consolidated financial statements.
In February 2016, the FASB issued ASU 2016-02, Leases. ASU 2016-02 will supersede the existing guidance for lease accounting and states that companies will be required to recognize lease assets and lease liabilities on the balance sheet and disclose key information about leasing arrangements. ASU 2016-02 requires qualitative and quantitative disclosures to supplement the amounts recorded in the financial statements so that users can understand the nature of the entity’s leasing activities, including significant judgments and changes in judgments. Within ASU 2016-02 lessor accounting remained fairly unchanged. In adopting ASU 2016-02, companies will be required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. ASU 2016-02 is effective for the fiscal years beginning after December 15, 2018 with early adoption permitted. We do not anticipate early adoption and are evaluating the impact of adopting ASU 2016-02 on our consolidated financial statements.
v3.4.0.3
Investments in Real Estate
3 Months Ended
Mar. 31, 2016
Investments [Abstract]  
Investments in Real Estate
Investments in Real Estate
For the three months ended March 31, 2016, our investments had an aggregate purchase price of $162.0 million. We incurred $0.6 million of costs attributable to these investments, which were recorded in acquisition-related expenses in the accompanying condensed consolidated statements of operations.
The following investments were determined to be individually not significant, but significant on a collective basis. The actual revenues and earnings since the investment dates as well as the supplementary proforma information assuming these investments occurred as of the beginning of the prior periods, were not material to us. The allocations for these investments are set forth below in the aggregate for the three months ended March 31, 2016 and 2015 (in thousands):
 
Three Months Ended March 31,
 
2016
 
2015
Land
$
17,315

 
$
748

Building and improvements
128,945

 
30,086

Below market leasehold interests
1,099

 
2,350

Above market leases
840

 
398

In place leases
15,919

 
2,181

Below market leases
(5,382
)
 
(463
)
Above market leasehold interests
(50
)
 

Net assets acquired
158,686

 
35,300

Other, net
3,321

 

Aggregate purchase price
$
162,007

 
$
35,300


The acquired intangible assets and liabilities referenced above had weighted average lives of the following for the three months ended March 31, 2016 and 2015 (in years):
 
Three Months Ended March 31,
 
2016
 
2015
Acquired intangible assets
10.5
 
16.9
Acquired intangible liabilities
8.9
 
9.9

Subsequent to March 31, 2016, we completed investments with an aggregate purchase price of $204.8 million. The purchase prices of these buildings are subject to certain post-closing adjustments. Due to the recent nature of these investments, we have not completed our initial purchase price allocations with respect to these investments and therefore cannot provide disclosures at this time similar to those contained in Note 3 - Investments in Real Estate to our condensed consolidated financial statements.
v3.4.0.3
Intangible Assets and Liabilities
3 Months Ended
Mar. 31, 2016
Identified Intangibles, Net [Abstract]  
Intangible Assets and Liabilities
Intangible Assets and Liabilities
Intangible assets and liabilities consisted of the following as of March 31, 2016 and December 31, 2015 (in thousands, except weighted average remaining amortization):
 
March 31, 2016
 
December 31, 2015
 
Balance
 
Weighted Average Remaining
Amortization in Years
 
Balance
 
Weighted Average Remaining
Amortization in Years
Assets:
 
 
 
 
 
 
 
In place leases
$
265,666

 
10.5
 
$
249,824

 
11.0
Tenant relationships
180,845

 
10.4
 
180,925

 
10.4
Above market leases
25,203

 
6.0
 
24,974

 
6.0
Below market leasehold interests
35,706

 
63.2
 
34,606

 
63.0
 
507,420

 
 
 
490,329

 
 
Accumulated amortization
(230,271
)
 
 
 
(219,334
)
 
 
Total
$
277,149

 
16.5
 
$
270,995

 
16.6
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
Below market leases
$
27,622

 
22.5
 
$
22,240

 
27.2
Above market leasehold interests
11,632

 
53.6
 
11,582

 
53.7
 
39,254

 
 
 
33,822

 
 
Accumulated amortization
(7,716
)
 
 
 
(7,211
)
 
 
Total
$
31,538

 
33.2
 
$
26,611

 
38.0

The following is a summary of the net intangible amortization for the three months ended March 31, 2016 and 2015 (in thousands):
 
Three Months Ended March 31,
 
2016
 
2015
Amortization recorded against rental income related to above or below market leases
$
337

 
$
475

Rental expense related to above or below market leasehold interests
96

 
105

Amortization expense related to in place leases and tenant relationships
10,767

 
11,956

v3.4.0.3
Receivables and Other Assets
3 Months Ended
Mar. 31, 2016
Receivables and Other Assets [Abstract]  
Receivables and Other Assets
Receivables and Other Assets
Receivables and other assets consisted of the following as of March 31, 2016 and December 31, 2015 (in thousands):
 
March 31, 2016
 
December 31, 2015
Tenant receivables, net
$
7,902

 
$
5,820

Other receivables, net
10,069

 
11,882

Deferred financing costs, net
5,192

 
5,524

Deferred leasing costs, net
18,402

 
17,923

Straight-line rent receivables, net
67,907

 
65,543

Prepaid expenses, deposits, equipment and other, net
33,540

 
34,584

Derivative financial instruments - interest rate swaps

 
427

Total
$
143,012

 
$
141,703


The following is a summary of the amortization of deferred leasing costs and financing costs for the three months ended March 31, 2016 and 2015 (in thousands):
 
Three Months Ended March 31,
 
2016
 
2015
Amortization expense related to deferred leasing costs
$
1,052

 
$
986

Interest expense related to deferred financing costs (1)
331

 
327

 
 
 
 
(1) For the three months ended March 31, 2015, amounts have been adjusted to reflect the retrospective presentation of the early adoption of ASU 2015-03 and 2015-15 as of December 31, 2015.
v3.4.0.3
Debt
3 Months Ended
Mar. 31, 2016
Debt Disclosure [Abstract]  
Debt
Debt
Debt consisted of the following as of March 31, 2016 and December 31, 2015 (in thousands):
 
March 31, 2016
 
December 31, 2015
Unsecured revolving credit facility
$
296,000

 
$
218,000

Unsecured term loans
455,000

 
455,000

Unsecured senior notes
600,000

 
600,000

Fixed rate mortgages
296,392

 
298,030

Variable rate mortgages
28,864

 
28,988

 
1,676,256

 
1,600,018

Deferred financing costs, net
(7,963
)
 
(8,411
)
Discount, net
(973
)
 
(911
)
Total
$
1,667,320

 
$
1,590,696


Unsecured Credit Agreement
Unsecured Revolving Credit Facility
On February 11, 2015, we executed an amendment to the unsecured revolving credit and term loan facility (the “Unsecured Credit Agreement”) which added an additional lender and increased the amount available under the unsecured revolving credit facility from $800.0 million to $850.0 million. The other existing terms of the Unsecured Credit Agreement were unchanged. The actual amount of credit available to us is a function of certain loan-to-value and debt service coverage ratios set forth in the unsecured revolving credit facility. The maximum principal amount of the unsecured revolving credit facility may be increased, subject to additional financing being provided by our existing lenders or new lenders being added to the unsecured revolving credit facility. The unsecured revolving credit facility matures on January 31, 2020 and is guaranteed by HTA.
Borrowings under the unsecured revolving credit facility accrue interest equal to adjusted LIBOR, plus a margin ranging from 0.88% to 1.55% per annum based on our credit rating. We also pay a facility fee ranging from 0.13% to 0.30% per annum on the aggregate commitments under the unsecured revolving credit facility. As of March 31, 2016, the margin associated with our borrowings was 1.05% per annum and the facility fee was 0.20% per annum.
Unsecured Term Loan
As of March 31, 2016, we had a $300.0 million unsecured term loan outstanding that was guaranteed by HTA. Borrowings accrue interest equal to adjusted LIBOR, plus a margin ranging from 0.90% to 1.80% per annum based on our credit rating. The margin associated with our borrowings as of March 31, 2016 was 1.15% per annum. Including the impact of the interest rate swaps associated with our unsecured term loan, the interest rate was 1.73% per annum, based on our current credit rating. The unsecured term loan matures on January 31, 2019, and includes a one-year extension exercisable at the option of the borrower, subject to certain conditions.
$155.0 Million Unsecured Term Loan
As of March 31, 2016, HTALP had a $155.0 million unsecured term loan outstanding that is guaranteed by HTA. The loan matures on July 19, 2019, and the interest rate thereon is equal to LIBOR, plus a margin ranging from 1.55% to 2.40% per annum based on our credit rating. The margin associated with our borrowings as of March 31, 2016 was 1.70% per annum. We have interest rate swaps in place that fix the interest rate at 2.99% per annum, based on our current credit rating. The maximum principal amount under this unsecured term loan may be increased by us, subject to such additional financing being provided by our existing lender.
$300.0 Million Unsecured Senior Notes due 2021
As of March 31, 2016, HTALP had $300.0 million of unsecured senior notes outstanding that are guaranteed by HTA and mature on July 15, 2021. The unsecured senior notes are registered under the Securities Act of 1933, as amended (the “Securities Act”), bear interest at 3.38% per annum and are payable semi-annually. The unsecured senior notes were offered at 99.21% of the principal amount thereof, with an effective yield to maturity of 3.50% per annum.
$300.0 Million Unsecured Senior Notes due 2023
As of March 31, 2016, HTALP had $300.0 million of unsecured senior notes outstanding that are guaranteed by HTA and mature on April 15, 2023. The unsecured senior notes are registered under the Securities Act, bear interest at 3.70% per annum and are payable semi-annually. The unsecured senior notes were offered at 99.19% of the principal amount thereof, with an effective yield to maturity of 3.80% per annum.
Fixed and Variable Rate Mortgages
As of March 31, 2016, HTALP and its subsidiaries had fixed and variable rate mortgages with interest rates ranging from 1.89% to 6.49% per annum and a weighted average interest rate of 5.39% per annum. Including the impact of the interest rate swap associated with our variable rate mortgage, the weighted average interest rate was 5.67% per annum.
Future Debt Maturities
The following table summarizes the debt maturities and scheduled principal repayments of our indebtedness as of March 31, 2016 (in thousands):
Year
 
Amount
2016
 
$
51,013

2017
 
116,626

2018
 
14,428

2019
 
464,281

2020
 
344,904

Thereafter
 
685,004

Total
 
$
1,676,256


The above scheduled debt maturities do not include the extension available to us under the Unsecured Credit Agreement as discussed above.
Deferred Financing Costs
As of March 31, 2016, the future amortization of deferred financing costs is as follows (in thousands):
Year
 
Amount
2016
 
$
1,344

2017
 
1,640

2018
 
1,547

2019
 
1,442

2020
 
893

Thereafter
 
1,097

Total
 
$
7,963


We are required by the terms of our applicable debt agreements to meet various affirmative and negative covenants that we believe are customary for these types of facilities, such as limitations on the incurrence of debt by us and our subsidiaries that own unencumbered assets, limitations on the nature of HTALP’s business, and limitations on distributions by HTALP and its subsidiaries that own unencumbered assets. Our debt agreements also impose various financial covenants on us, such as a maximum ratio of total indebtedness to total asset value, a minimum ratio of EBITDA to fixed charges, a minimum tangible net worth covenant, a maximum ratio of unsecured indebtedness to unencumbered asset value, rent coverage ratios and a minimum ratio of unencumbered net operating income to unsecured interest expense. As of March 31, 2016, we believe that we were in compliance with all such financial covenants and reporting requirements. In addition, certain of our debt agreements include events of default provisions that we believe are customary for these types of facilities, including restricting HTA from making dividend distributions to its stockholders in the event HTA is in default thereunder, except to the extent necessary for HTA to maintain its REIT status.
v3.4.0.3
Derivative Financial Instruments
3 Months Ended
Mar. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments
Derivative Financial Instruments
The following table lists the derivative financial instrument assets and (liabilities) held by us as of March 31, 2016 (in thousands):
Notional Amount
 
Index
 
Rate
 
Fair Value
 
Instrument
 
Maturity
$
100,000

 
LIBOR
 
0.86
%
 
$
(76
)
 
Swap
 
6/15/2016
50,000

 
LIBOR
 
1.39

 
(860
)
 
Swap
 
7/17/2019
105,000

 
LIBOR
 
1.24

 
(1,270
)
 
Swap
 
7/17/2019
25,892

 
LIBOR + 1.45%
 
4.98

 
(2,529
)
 
Swap
 
5/1/2020
The following table lists the derivative financial instrument assets and (liabilities) held by us as of December 31, 2015 (in thousands):
Notional Amount
 
Index
 
Rate
 
Fair Value
 
Instrument
 
Maturity
$
100,000

 
LIBOR
 
0.86
%
 
$
(142
)
 
Swap
 
6/15/2016
50,000

 
LIBOR
 
1.39

 
(71
)
 
Swap
 
7/17/2019
105,000

 
LIBOR
 
1.24

 
427

 
Swap
 
7/17/2019
26,092

 
LIBOR + 1.45%
 
4.98

 
(2,157
)
 
Swap
 
5/1/2020

As of March 31, 2016 and December 31, 2015, the gross fair value of our derivative financial instruments was as follows (in thousands):
 
 
Asset Derivatives
 
Liability Derivatives
  
 
 
 
Fair Value
 
 
 
Fair Value
Derivatives Not Designated as Hedging Instruments:
 
Balance Sheet
Location
 
March 31, 2016
 
December 31, 2015
 
Balance Sheet
Location
 
March 31, 2016
 
December 31, 2015
Interest rate swaps
 
Receivables and other assets
 
$

 
$
427

 
Derivative financial instruments
 
$
4,735

 
$
2,370


There were no derivatives offset in our accompanying condensed consolidated balance sheets as of March 31, 2016 and December 31, 2015. As of March 31, 2016 and December 31, 2015, we had derivatives subject to enforceable master netting arrangements which allowed for net cash settlement with the respective counterparties (in thousands):
 
March 31, 2016
 
December 31, 2015
 
Gross Amounts
 
Amounts Subject to Enforceable Master Netting Arrangements
 
Net Amounts
 
Gross Amounts
 
Amounts Subject to Enforceable Master Netting Arrangements
 
Net Amounts
Asset derivatives
$

 
$

 
$

 
$
427

 
$
(427
)
 
$

Liability derivatives
4,735

 

 
4,735

 
2,370

 
(427
)
 
1,943


We have agreements with each of our interest rate swap derivative counterparties which provide that if we default on certain of our unsecured indebtedness, our counterparties could declare us in default on our interest rate swap derivative obligations resulting in an acceleration of the indebtedness. In addition, we are exposed to credit risk in the event of non-performance by our derivative counterparties. We believe we mitigate the credit risk by entering into agreements with credit-worthy counterparties. We record counterparty credit risk valuation adjustments on interest rate swap derivative assets in order to properly reflect the credit quality of the counterparty. In addition, our fair value of interest rate swap derivative liabilities is adjusted to reflect the impact of our credit quality. As of March 31, 2016, there have been no termination events or events of default related to our interest rate swaps.
v3.4.0.3
Stockholders' Equity and Partners' Capital
3 Months Ended
Mar. 31, 2016
Equity [Abstract]  
Stockholders' Equity and Partners' Capital
Stockholders’ Equity and Partners’ Capital
HTALP’s partnership agreement provides that it will distribute cash flow from operations and net sale proceeds to its partners in accordance with their overall ownership interests at such times and in such amounts as the general partner determines. Dividend distributions are made such that a holder of one partnership unit in HTALP will receive distributions from HTALP in an amount equal to the dividend distributions paid to the holder of one share of HTA’s common stock. In addition, for each share of common stock issued or redeemed by HTA, HTALP issues or redeems a corresponding number of partnership units.
Common Stock Offerings
In January 2016, HTA entered into a new equity distribution agreement with respect to its at-the-market (“ATM”) offering program of common stock with an aggregate sales price of up to $300.0 million. During the three months ended March 31, 2016, HTA issued and sold 3,418,571 shares of common stock, at an average price of $27.25 per share and as of March 31, 2016, $206.8 million remained available for issuance under the ATM.
In April 2016, HTA completed an underwritten public offering of 5,980,000 shares of common stock at a price of $28.75 per share.
Common Stock Dividends
See our accompanying condensed consolidated statements of operations for the dividends declared during the three months ended March 31, 2016 and 2015. On April 25, 2016, HTA declared a quarterly cash dividend of $0.295 per share to be paid on July 8, 2016 to stockholders of record for its common stock on July 1, 2016.
Incentive Plan
HTA’s Amended and Restated 2006 Incentive Plan (the “Plan”) permits the grant of incentive awards to our employees, officers, non-employee directors and consultants as selected by our Board of Directors. The Plan authorizes the granting of awards in any of the following forms: options; stock appreciation rights; restricted stock; restricted or deferred stock units; performance awards; dividend equivalents; other stock-based awards, including units in HTALP; and cash-based awards. Subject to adjustment as provided in the Plan, the aggregate number of awards reserved and available for issuance under the Plan is 5,000,000. As of March 31, 2016, there were 2,123,422 awards available for grant under the Plan.
LTIP Units
Awards under the LTIP consist of Series C units in HTALP and were subject to the achievement of certain performance and market conditions in order to vest. Once vested, the Series C units were converted into common units of HTALP, which may be converted into shares of HTA’s common stock. The LTIP awards were fully expensed in 2013, except for 225,000 units that were forfeited in 2015.
Restricted Common Stock
For the three months ended March 31, 2016 and 2015, we recognized compensation expense of $1.8 million and $1.9 million, respectively, which were recorded in general and administrative expenses in the accompanying condensed consolidated statements of operations.
As of March 31, 2016, there was $6.7 million of unrecognized compensation expense net of estimated forfeitures, which will be recognized over a remaining weighted average period of 1.8 years.
The following is a summary of our restricted common stock activity during the three months ended March 31, 2016 and 2015:
 
March 31, 2016
 
March 31, 2015
 
Restricted Common Stock
 
Weighted
Average Grant
Date Fair Value
 
Restricted Common Stock
 
Weighted
Average Grant
Date Fair Value
Beginning balance
487,850

 
$
23.13

 
463,050

 
$
20.90

Granted
194,151

 
27.17

 
172,115

 
26.98

Vested
(162,140
)
 
22.65

 
(113,029
)
 
21.99

Forfeited
(3,244
)
 
24.23

 
(8,000
)
 
22.08

Ending Balance
516,617

 
$
24.79

 
514,136

 
$
22.60

v3.4.0.3
Fair Value of Financial Instruments
3 Months Ended
Mar. 31, 2016
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments
Fair Value of Financial Instruments
Financial Instruments Reported at Fair Value - Recurring
The table below presents our assets and liabilities measured at fair value on a recurring basis as of March 31, 2016, aggregated by the applicable level in the fair value hierarchy (in thousands):
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
Derivative financial instruments
 
$

 
$

 
$

 
$

Liabilities:
 
 
 
 
 
 
 
 
Derivative financial instruments
 
$

 
$
4,735

 
$

 
$
4,735

The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2015, aggregated by the applicable level in the fair value hierarchy (in thousands):
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
Derivative financial instruments
 
$


$
427


$

 
$
427

Liabilities:
 
 
 
 
 
 
 
 
Derivative financial instruments
 
$

 
$
2,370

 
$

 
$
2,370


Financial Instruments Reported at Fair Value - Non-Recurring
As of March 31, 2016, there were no assets measured at fair value on a non-recurring basis. The table below presents our assets measured at fair value on a non-recurring basis as of December 31, 2015, aggregated by the applicable level in the fair value hierarchy (in thousands):
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
MOB (1)
 
$

 
$
547

 
$

 
$
547

 
 
 
 
 
 
 
 
 
(1) During the year ended December 31, 2015, we recognized a $0.9 million impairment charge to the carrying value of an MOB. The estimated fair value as of December 31, 2015 was based upon a pending sales agreement on this MOB.

There have been no transfers of assets or liabilities between levels. We will record any such transfers at the end of the reporting period in which a change of event occurs that results in a transfer. Although we have determined that the majority of the inputs used to value our interest rate swap derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with these instruments utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. However, we have assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our interest rate swap derivative positions and have determined that the credit valuation adjustments are not significant to their overall valuation. As a result, we have determined that our interest rate swap derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy. 
Financial Instruments Disclosed at Fair Value
We consider the carrying values of cash and cash equivalents, tenant and other receivables, restricted cash and escrow deposits and accounts payable, and accrued liabilities, to approximate fair value for these financial instruments because of the short period of time between origination of the instruments and their expected realization. All of these financial instruments are considered Level 2.
The fair value of debt is estimated using borrowing rates available to us with similar terms and maturities, which is considered a Level 2 input. As of March 31, 2016, the fair value of the debt was $1,710.1 million compared to the carrying value of $1,667.3 million. As of December 31, 2015, the fair value of the debt was $1,619.7 million compared to the carrying value of $1,590.7 million.
v3.4.0.3
Per Share Data of HTA
3 Months Ended
Mar. 31, 2016
HTA, Inc.  
Earnings Per Share  
Per Share Data of HTA
Per Share Data of HTA
HTA includes unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents as “participating securities” pursuant to the two-class method. The resulting classes are our common stock and restricted stock. For the three months ended March 31, 2016 and 2015, all of HTA’s earnings were distributed and the calculated earnings per share amount would be the same for all classes.
The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per share of HTA for the three months ended March 31, 2016 and 2015 (in thousands, except per share data):
 
Three Months Ended March 31,
 
2016
 
2015
Numerator:
 
 
 
Net income
$
10,036

 
$
6,942

Net income attributable to noncontrolling interests
(176
)
 
(138
)
Net income attributable to common stockholders
$
9,860

 
$
6,804

Denominator:
 
 
 
Weighted average shares outstanding - basic
129,336

 
125,175

Dilutive shares
1,904

 
1,930

Weighted average shares outstanding - diluted
131,240

 
127,105

Earnings per common share - basic
 
 
 
Net income attributable to common stockholders
$
0.08

 
$
0.05

Earnings per common share - diluted
 
 
 
Net income attributable to common stockholders
$
0.08

 
$
0.05

v3.4.0.3
Per Unit Data of HTALP
3 Months Ended
Mar. 31, 2016
Healthcare Trust of America Holdings, LP (HTALP)  
Earnings Per Share  
Per Unit Data of HTALP
Per Unit Data of HTALP
The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per unit of HTALP for the three months ended March 31, 2016 and 2015 (in thousands, except per unit data):
 
Three Months Ended March 31,
 
2016
 
2015
Numerator:
 
 
 
Net income
$
10,036

 
$
6,942

Net income attributable to noncontrolling interests
(31
)
 
(33
)
Net income attributable to common unitholders
$
10,005

 
$
6,909

Denominator: 
 
 
 
Weighted average units outstanding - basic
131,242

 
126,330

Dilutive units

 

Weighted average units outstanding - diluted
131,242

 
126,330

Earnings per common unit - basic:
 
 
 
Net income attributable to common unitholders
$
0.08

 
$
0.05

Earnings per common unit - diluted:
 
 
 
Net income attributable to common unitholders
$
0.08

 
$
0.05

v3.4.0.3
Supplemental Cash Flow Information
3 Months Ended
Mar. 31, 2016
Supplemental Cash Flow Elements [Abstract]  
Supplemental Cash Flow Information
Supplemental Cash Flow Information
The following is the supplemental cash flow information for the three months ended March 31, 2016 and 2015 (in thousands):
 
Three Months Ended March 31,
 
2016
 
2015
Interest paid
$
13,062

 
$
13,238

Income taxes paid
88

 
99

 
 
 
 
Supplemental Disclosure of Noncash Activities:
 
 
 
Investing Activities:
 
 
 
Accrued capital expenditures
$
5,688

 
$
1,464

Financing Activities:
 
 
 
Dividend distributions declared, but not paid
$
38,784

 
$
36,309

v3.4.0.3
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2016
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
Our accompanying condensed consolidated financial statements include our accounts and those of our subsidiaries and any consolidated variable interest entities (“VIEs”). All inter-company balances and transactions have been eliminated in the accompanying condensed consolidated financial statements.
Interim Unaudited Financial Data
Interim Unaudited Financial Data
Our accompanying condensed consolidated financial statements have been prepared by us in accordance with GAAP in conjunction with the rules and regulations of the SEC. Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, our accompanying condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. Our accompanying condensed consolidated financial statements reflect all adjustments, which are, in our opinion, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Interim results of operations are not necessarily indicative of the results to be expected for the full year; such results may be less favorable for the full year. Our accompanying condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our 2015 Annual Report on Form 10-K. There have been no significant changes to the Company’s significant accounting policies during the three months ended March 31, 2016, except as noted below regarding the adoption of U.S. Financial Accounting Standards Board (the “FASB”) Accounting Standards Update (“ASU”) 2015-02, Amendments to the Consolidation Analysis and ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments.
Principles of Consolidation
Principles of Consolidation
As of January 1, 2016, the Company adopted FASB ASU 2015-02, Amendments to the Consolidation Analysis, as described below in “Recently Issued or Adopted Accounting Pronouncements”, which simplifies consolidation accounting by reducing the number of consolidation models and changing various aspects of current GAAP, including certain consolidation criteria for VIEs. The consolidated financial statements include the accounts of HTA and its subsidiaries and consolidated joint venture arrangements. The portions of the consolidated joint venture arrangements not owned by HTA are presented as non-controlling interests in HTA’s consolidated balance sheets and statements of operations, consolidated statements of equity, and consolidated statements of changes in partners’ capital. In addition, as described in Note 1 - Organization and Description of Business, certain third parties have been issued limited partner units in HTALP (“OP Units”). Holders of OP Units are considered to be non-controlling interest holders in HTALP and their ownership interests are reflected as equity in the consolidated balance sheets. Further, a portion of the earnings and losses of HTALP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of common shares issued and the carrying value of the OP Units converted is recorded as a component of equity. As of March 31, 2016 and December 31, 2015, there were approximately 1.8 million and 1.9 million, respectively, of OP Units issued and outstanding.
VIEs are entities where investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support or where equity investors, as a group, lack one of the following: (i) the power to direct the activities that most significantly impact the entity’s economic performance; (ii) the obligation to absorb the expected losses of the entity; and (iii) the right to receive the expected returns of the entity. We consolidate our investment in VIEs when we determine that we are the primary beneficiary. A primary beneficiary is one that has both: (i) the power to direct the activities of the VIE that most significantly impacts the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The Company will evaluate on an ongoing basis the need to consolidate entities based on the standards set forth in GAAP as described above.
Investments in Real Estate
Investments in Real Estate
Depreciation expense of buildings and improvements for the three months ended March 31, 2016 and 2015, was $25.7 million and $23.3 million, respectively.
Recently Issued or Adopted Accounting Pronouncements
Recently Issued or Adopted Accounting Pronouncements
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive new revenue recognition model requiring a company to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration (i.e., payment) to which the company expects to be entitled in exchange for those goods or services. In adopting ASU 2014-09, companies may use either a full retrospective or a modified retrospective approach. In July 2015, the FASB deferred the effective date of ASU 2014-09 to the first interim period within annual reporting periods beginning after December 15, 2017 along with the ability to early adopt as of the original effective date. We do not anticipate early adoption and we are evaluating the impact of adopting ASU 2014-09 on our consolidated financial statements.
In February 2015, the FASB issued ASU 2015-02, Amendments to the Consolidation Analysis. ASU 2015-02 affects reporting entities that are required to evaluate whether they should consolidate certain legal entities. The amendments in ASU 2015-02 affect the following areas: (i) limited partnerships and similar legal entities; (ii) evaluating fees paid to a decision maker or a service provider as a variable interest; (iii) the effect of fee arrangements on the primary beneficiary determination; (iv) the effect of related parties on the primary beneficiary determination; and (v) certain investment funds. ASU 2015-02 is effective for fiscal years and for interim periods within those fiscal years, beginning after December 15, 2015 with early adoption permitted. We adopted ASU 2015-02 as of January 1, 2016. The adoption had no material impact on our interests in joint venture arrangements. Accordingly, there was no material impact on previous or current reporting periods’ consolidated financial statements.
In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs. ASU 2015-03 changes the presentation of debt issuance costs by requiring these costs related to a recognized debt liability to be presented in the consolidated balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. In August 2015, the FASB issued ASU 2015-15 to include the presentation and subsequent measurement of debt issuance costs associated with line-of-credit arrangements. ASU 2015-03 and 2015-15 are effective for the fiscal years beginning after December 15, 2015, and requires retrospective application with early adoption permitted. We adopted ASU 2015-03 and 2015-15 as of December 31, 2015. As a result of the adoption, all deferred financing costs, excluding costs related to the unsecured revolving credit facility, were reclassed to debt. Unsecured revolving credit facility costs remain classified as an asset on our consolidated balance sheets and will continue to be amortized over the remaining term. The guidance requires retrospective adoption for all prior periods presented.
In September 2015, the FASB issued ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments. ASU 2015-16 eliminates the requirement that an acquirer in a business combination has to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amount of the adjustment, including the effect on earnings of any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. ASU 2015-16 is effective for fiscal years beginning after December 15, 2015. We adopted ASU 2015-16 as of January 1, 2016. As a result of the adoption there was no impact in the previous or current reporting periods’ consolidated financial statements.
In February 2016, the FASB issued ASU 2016-02, Leases. ASU 2016-02 will supersede the existing guidance for lease accounting and states that companies will be required to recognize lease assets and lease liabilities on the balance sheet and disclose key information about leasing arrangements. ASU 2016-02 requires qualitative and quantitative disclosures to supplement the amounts recorded in the financial statements so that users can understand the nature of the entity’s leasing activities, including significant judgments and changes in judgments. Within ASU 2016-02 lessor accounting remained fairly unchanged. In adopting ASU 2016-02, companies will be required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. ASU 2016-02 is effective for the fiscal years beginning after December 15, 2018 with early adoption permitted. We do not anticipate early adoption and are evaluating the impact of adopting ASU 2016-02 on our consolidated financial statements.
v3.4.0.3
Investments in Real Estate (Tables)
3 Months Ended
Mar. 31, 2016
Investments [Abstract]  
Schedule of Purchase Price Allocation
The following investments were determined to be individually not significant, but significant on a collective basis. The actual revenues and earnings since the investment dates as well as the supplementary proforma information assuming these investments occurred as of the beginning of the prior periods, were not material to us. The allocations for these investments are set forth below in the aggregate for the three months ended March 31, 2016 and 2015 (in thousands):
 
Three Months Ended March 31,
 
2016
 
2015
Land
$
17,315

 
$
748

Building and improvements
128,945

 
30,086

Below market leasehold interests
1,099

 
2,350

Above market leases
840

 
398

In place leases
15,919

 
2,181

Below market leases
(5,382
)
 
(463
)
Above market leasehold interests
(50
)
 

Net assets acquired
158,686

 
35,300

Other, net
3,321

 

Aggregate purchase price
$
162,007

 
$
35,300

Schedule of Weighted Average Lives of Acquired Intangible Assets and Liabilities
The acquired intangible assets and liabilities referenced above had weighted average lives of the following for the three months ended March 31, 2016 and 2015 (in years):
 
Three Months Ended March 31,
 
2016
 
2015
Acquired intangible assets
10.5
 
16.9
Acquired intangible liabilities
8.9
 
9.9
v3.4.0.3
Intangible Assets and Liabilities (Tables)
3 Months Ended
Mar. 31, 2016
Identified Intangibles, Net [Abstract]  
Schedule of Intangible Assets and Liabilities
Intangible assets and liabilities consisted of the following as of March 31, 2016 and December 31, 2015 (in thousands, except weighted average remaining amortization):
 
March 31, 2016
 
December 31, 2015
 
Balance
 
Weighted Average Remaining
Amortization in Years
 
Balance
 
Weighted Average Remaining
Amortization in Years
Assets:
 
 
 
 
 
 
 
In place leases
$
265,666

 
10.5
 
$
249,824

 
11.0
Tenant relationships
180,845

 
10.4
 
180,925

 
10.4
Above market leases
25,203

 
6.0
 
24,974

 
6.0
Below market leasehold interests
35,706

 
63.2
 
34,606

 
63.0
 
507,420

 
 
 
490,329

 
 
Accumulated amortization
(230,271
)
 
 
 
(219,334
)
 
 
Total
$
277,149

 
16.5
 
$
270,995

 
16.6
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
Below market leases
$
27,622

 
22.5
 
$
22,240

 
27.2
Above market leasehold interests
11,632

 
53.6
 
11,582

 
53.7
 
39,254

 
 
 
33,822

 
 
Accumulated amortization
(7,716
)
 
 
 
(7,211
)
 
 
Total
$
31,538

 
33.2
 
$
26,611

 
38.0
Summary of Net Intangible Amortization
The following is a summary of the net intangible amortization for the three months ended March 31, 2016 and 2015 (in thousands):
 
Three Months Ended March 31,
 
2016
 
2015
Amortization recorded against rental income related to above or below market leases
$
337

 
$
475

Rental expense related to above or below market leasehold interests
96

 
105

Amortization expense related to in place leases and tenant relationships
10,767

 
11,956

v3.4.0.3
Receivables and Other Assets (Tables)
3 Months Ended
Mar. 31, 2016
Receivables and Other Assets [Abstract]  
Schedule of Receivables and Other Assets
Receivables and other assets consisted of the following as of March 31, 2016 and December 31, 2015 (in thousands):
 
March 31, 2016
 
December 31, 2015
Tenant receivables, net
$
7,902

 
$
5,820

Other receivables, net
10,069

 
11,882

Deferred financing costs, net
5,192

 
5,524

Deferred leasing costs, net
18,402

 
17,923

Straight-line rent receivables, net
67,907

 
65,543

Prepaid expenses, deposits, equipment and other, net
33,540

 
34,584

Derivative financial instruments - interest rate swaps

 
427

Total
$
143,012

 
$
141,703

Summary of Amortization of Deferred Leasing Costs and Deferred Financing Costs
The following is a summary of the amortization of deferred leasing costs and financing costs for the three months ended March 31, 2016 and 2015 (in thousands):
 
Three Months Ended March 31,
 
2016
 
2015
Amortization expense related to deferred leasing costs
$
1,052

 
$
986

Interest expense related to deferred financing costs (1)
331

 
327

 
 
 
 
(1) For the three months ended March 31, 2015, amounts have been adjusted to reflect the retrospective presentation of the early adoption of ASU 2015-03 and 2015-15 as of December 31, 2015.
v3.4.0.3
Debt (Tables)
3 Months Ended
Mar. 31, 2016
Debt Disclosure [Abstract]  
Schedule of Debt
Debt consisted of the following as of March 31, 2016 and December 31, 2015 (in thousands):
 
March 31, 2016
 
December 31, 2015
Unsecured revolving credit facility
$
296,000

 
$
218,000

Unsecured term loans
455,000

 
455,000

Unsecured senior notes
600,000

 
600,000

Fixed rate mortgages
296,392

 
298,030

Variable rate mortgages
28,864

 
28,988

 
1,676,256

 
1,600,018

Deferred financing costs, net
(7,963
)
 
(8,411
)
Discount, net
(973
)
 
(911
)
Total
$
1,667,320

 
$
1,590,696

Summary of Debt Maturities and Scheduled Principal Debt Repayments
The following table summarizes the debt maturities and scheduled principal repayments of our indebtedness as of March 31, 2016 (in thousands):
Year
 
Amount
2016
 
$
51,013

2017
 
116,626

2018
 
14,428

2019
 
464,281

2020
 
344,904

Thereafter
 
685,004

Total
 
$
1,676,256

Schedule of Amortization of Deferred Financing Costs
As of March 31, 2016, the future amortization of deferred financing costs is as follows (in thousands):
Year
 
Amount
2016
 
$
1,344

2017
 
1,640

2018
 
1,547

2019
 
1,442

2020
 
893

Thereafter
 
1,097

Total
 
$
7,963

v3.4.0.3
Derivative Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instrument Assets and (Liabilities) Held
The following table lists the derivative financial instrument assets and (liabilities) held by us as of March 31, 2016 (in thousands):
Notional Amount
 
Index
 
Rate
 
Fair Value
 
Instrument
 
Maturity
$
100,000

 
LIBOR
 
0.86
%
 
$
(76
)
 
Swap
 
6/15/2016
50,000

 
LIBOR
 
1.39

 
(860
)
 
Swap
 
7/17/2019
105,000

 
LIBOR
 
1.24

 
(1,270
)
 
Swap
 
7/17/2019
25,892

 
LIBOR + 1.45%
 
4.98

 
(2,529
)
 
Swap
 
5/1/2020
The following table lists the derivative financial instrument assets and (liabilities) held by us as of December 31, 2015 (in thousands):
Notional Amount
 
Index
 
Rate
 
Fair Value
 
Instrument
 
Maturity
$
100,000

 
LIBOR
 
0.86
%
 
$
(142
)
 
Swap
 
6/15/2016
50,000

 
LIBOR
 
1.39

 
(71
)
 
Swap
 
7/17/2019
105,000

 
LIBOR
 
1.24

 
427

 
Swap
 
7/17/2019
26,092

 
LIBOR + 1.45%
 
4.98

 
(2,157
)
 
Swap
 
5/1/2020
Gross Fair Value of Derivative Financial Instruments
As of March 31, 2016 and December 31, 2015, the gross fair value of our derivative financial instruments was as follows (in thousands):
 
 
Asset Derivatives
 
Liability Derivatives
  
 
 
 
Fair Value
 
 
 
Fair Value
Derivatives Not Designated as Hedging Instruments:
 
Balance Sheet
Location
 
March 31, 2016
 
December 31, 2015
 
Balance Sheet
Location
 
March 31, 2016
 
December 31, 2015
Interest rate swaps
 
Receivables and other assets
 
$

 
$
427

 
Derivative financial instruments
 
$
4,735

 
$
2,370

Schedule of Derivatives Subject to Master Netting Arrangements
As of March 31, 2016 and December 31, 2015, we had derivatives subject to enforceable master netting arrangements which allowed for net cash settlement with the respective counterparties (in thousands):
 
March 31, 2016
 
December 31, 2015
 
Gross Amounts
 
Amounts Subject to Enforceable Master Netting Arrangements
 
Net Amounts
 
Gross Amounts
 
Amounts Subject to Enforceable Master Netting Arrangements
 
Net Amounts
Asset derivatives
$

 
$

 
$

 
$
427

 
$
(427
)
 
$

Liability derivatives
4,735

 

 
4,735

 
2,370

 
(427
)
 
1,943

v3.4.0.3
Stockholders' Equity and Partners' Capital (Tables)
3 Months Ended
Mar. 31, 2016
Equity [Abstract]  
Schedule of Restricted Common Stock Activity
The following is a summary of our restricted common stock activity during the three months ended March 31, 2016 and 2015:
 
March 31, 2016
 
March 31, 2015
 
Restricted Common Stock
 
Weighted
Average Grant
Date Fair Value
 
Restricted Common Stock
 
Weighted
Average Grant
Date Fair Value
Beginning balance
487,850

 
$
23.13

 
463,050

 
$
20.90

Granted
194,151

 
27.17

 
172,115

 
26.98

Vested
(162,140
)
 
22.65

 
(113,029
)
 
21.99

Forfeited
(3,244
)
 
24.23

 
(8,000
)
 
22.08

Ending Balance
516,617

 
$
24.79

 
514,136

 
$
22.60

v3.4.0.3
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2016
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The table below presents our assets and liabilities measured at fair value on a recurring basis as of March 31, 2016, aggregated by the applicable level in the fair value hierarchy (in thousands):
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
Derivative financial instruments
 
$

 
$

 
$

 
$

Liabilities:
 
 
 
 
 
 
 
 
Derivative financial instruments
 
$

 
$
4,735

 
$

 
$
4,735

The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2015, aggregated by the applicable level in the fair value hierarchy (in thousands):
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
Derivative financial instruments
 
$


$
427


$

 
$
427

Liabilities:
 
 
 
 
 
 
 
 
Derivative financial instruments
 
$

 
$
2,370

 
$

 
$
2,370

Schedule of Fair Value, Assets Measured on Non-Recurring Basis
The table below presents our assets measured at fair value on a non-recurring basis as of December 31, 2015, aggregated by the applicable level in the fair value hierarchy (in thousands):
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
MOB (1)
 
$

 
$
547

 
$

 
$
547

 
 
 
 
 
 
 
 
 
(1) During the year ended December 31, 2015, we recognized a $0.9 million impairment charge to the carrying value of an MOB. The estimated fair value as of December 31, 2015 was based upon a pending sales agreement on this MOB.
v3.4.0.3
Per Share Data of HTA (Tables)
3 Months Ended
Mar. 31, 2016
HTA, Inc.  
Earnings Per Share  
Schedule of Earnings Per Share, Basic and Diluted
The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per share of HTA for the three months ended March 31, 2016 and 2015 (in thousands, except per share data):
 
Three Months Ended March 31,
 
2016
 
2015
Numerator:
 
 
 
Net income
$
10,036

 
$
6,942

Net income attributable to noncontrolling interests
(176
)
 
(138
)
Net income attributable to common stockholders
$
9,860

 
$
6,804

Denominator:
 
 
 
Weighted average shares outstanding - basic
129,336

 
125,175

Dilutive shares
1,904

 
1,930

Weighted average shares outstanding - diluted
131,240

 
127,105

Earnings per common share - basic
 
 
 
Net income attributable to common stockholders
$
0.08

 
$
0.05

Earnings per common share - diluted
 
 
 
Net income attributable to common stockholders
$
0.08

 
$
0.05

v3.4.0.3
Per Unit Data of HTALP (Tables)
3 Months Ended
Mar. 31, 2016
Healthcare Trust of America Holdings, LP (HTALP)  
Earnings Per Share  
Schedule of Earnings Per Unit, Basic and Diluted
The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per unit of HTALP for the three months ended March 31, 2016 and 2015 (in thousands, except per unit data):
 
Three Months Ended March 31,
 
2016
 
2015
Numerator:
 
 
 
Net income
$
10,036

 
$
6,942

Net income attributable to noncontrolling interests
(31
)
 
(33
)
Net income attributable to common unitholders
$
10,005

 
$
6,909

Denominator: 
 
 
 
Weighted average units outstanding - basic
131,242

 
126,330

Dilutive units

 

Weighted average units outstanding - diluted
131,242

 
126,330

Earnings per common unit - basic:
 
 
 
Net income attributable to common unitholders
$
0.08

 
$
0.05

Earnings per common unit - diluted:
 
 
 
Net income attributable to common unitholders
$
0.08

 
$
0.05

v3.4.0.3
Supplemental Cash Flow Information (Tables)
3 Months Ended
Mar. 31, 2016
Supplemental Cash Flow Elements [Abstract]  
Schedule of Supplemental Cash Flow Information
The following is the supplemental cash flow information for the three months ended March 31, 2016 and 2015 (in thousands):
 
Three Months Ended March 31,
 
2016
 
2015
Interest paid
$
13,062

 
$
13,238

Income taxes paid
88

 
99

 
 
 
 
Supplemental Disclosure of Noncash Activities:
 
 
 
Investing Activities:
 
 
 
Accrued capital expenditures
$
5,688

 
$
1,464

Financing Activities:
 
 
 
Dividend distributions declared, but not paid
$
38,784

 
$
36,309

v3.4.0.3
Organization and Description of Business (Details)
$ in Billions
3 Months Ended
Mar. 31, 2016
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
General partnership interest percentage 98.60%
Purchased property inception to current date $ 3.7
v3.4.0.3
Summary of Significant Accounting Policies (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Dec. 31, 2015
Building Improvements      
Partners' Capital Notes [Abstract]      
Depreciation expense $ 25.7 $ 23.3  
Healthcare Trust of America Holdings, LP (HTALP)      
Partners' Capital Notes [Abstract]      
Limited partner's capital, units outstanding 1,833,849   1,929,942
Limited partner's capital, units issued 1,833,849   1,929,942
Healthcare Trust of America Holdings, LP (HTALP) | Noncontrolling Interest      
Partners' Capital Notes [Abstract]      
Limited partner's capital, units outstanding 1,800,000   1,900,000
Limited partner's capital, units issued 1,800,000   1,900,000
v3.4.0.3
Investments in Real Estate - Acquisitions (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Apr. 27, 2016
Mar. 31, 2016
Mar. 31, 2015
Investments [Abstract]      
Closing costs   $ 600  
Business Acquisition [Line Items]      
Land   17,315 $ 748
Building and improvements   128,945 30,086
Below market leasehold interests   1,099 2,350
Above market leases   840 398
In place leases   15,919 2,181
Below market leases   (5,382) (463)
Above market leasehold interests   (50) 0
Net assets acquired   158,686 35,300
Other, net   3,321 0
Aggregate purchase price   $ 162,007 $ 35,300
Subsequent Event      
Business Acquisition [Line Items]      
Aggregate purchase price $ 204,800    
v3.4.0.3
Investments in Real Estate - Weighted Average Lives (Details)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Investments [Abstract]    
Acquired intangible assets 10 years 6 months 16 years 10 months 24 days
Acquired intangible liabilities 8 years 10 months 24 days 9 years 10 months 24 days
v3.4.0.3
Intangible Assets and Liabilities - Summary of Intangible Assets and Liabilities (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2016
Dec. 31, 2015
Assets:    
Gross $ 507,420 $ 490,329
Accumulated amortization (230,271) (219,334)
Total $ 277,149 $ 270,995
Weighted Average Remaining Amortization in Years 16 years 6 months 16 years 7 months 6 days
Liabilities:    
Gross $ 39,254 $ 33,822
Accumulated amortization (7,716) (7,211)
Total $ 31,538 $ 26,611
Weighted Average Remaining Amortization in Years 33 years 2 months 12 days 38 years
Below market leases    
Liabilities:    
Gross $ 27,622 $ 22,240
Weighted Average Remaining Amortization in Years 22 years 6 months 27 years 2 months 12 days
Above market leasehold interests    
Liabilities:    
Gross $ 11,632 $ 11,582
Weighted Average Remaining Amortization in Years 53 years 7 months 6 days 53 years 8 months 12 days
In place leases    
Assets:    
Gross $ 265,666 $ 249,824
Weighted Average Remaining Amortization in Years 10 years 6 months 11 years
Tenant relationships    
Assets:    
Gross $ 180,845 $ 180,925
Weighted Average Remaining Amortization in Years 10 years 4 months 24 days 10 years 4 months 24 days
Above market leases    
Assets:    
Gross $ 25,203 $ 24,974
Weighted Average Remaining Amortization in Years 6 years 6 years
Below market leasehold interests    
Assets:    
Gross $ 35,706 $ 34,606
Weighted Average Remaining Amortization in Years 63 years 2 months 12 days 63 years
v3.4.0.3
Intangible Assets and Liabilities - Summary of Intangible Amortization (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Amortization recorded against rental income related to above or below market leases    
Schedule of Finite-Lived Intangible Assets and Liabilities [Line Items]    
Amortization of intangible assets and liabilities $ 337 $ 475
Rental expense related to above or below market leasehold interests    
Schedule of Finite-Lived Intangible Assets and Liabilities [Line Items]    
Amortization of intangible assets and liabilities 96 105
Amortization expense related to in place leases and tenant relationships    
Schedule of Finite-Lived Intangible Assets and Liabilities [Line Items]    
Amortization of intangible assets and liabilities $ 10,767 $ 11,956
v3.4.0.3
Receivables and Other Assets - Schedule of Receivables and Other Assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Receivables and Other Assets [Abstract]    
Tenant receivables, net $ 7,902 $ 5,820
Other receivables, net 10,069 11,882
Deferred financing costs, net 5,192 5,524
Deferred leasing costs, net 18,402 17,923
Straight-line rent receivables, net 67,907 65,543
Prepaid expenses, deposits, equipment and other, net 33,540 34,584
Derivative financial instruments, asset 0 427
Total $ 143,012 $ 141,703
v3.4.0.3
Receivables and Other Assets - Amortization (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Receivables and Other Assets [Abstract]    
Amortization expense related to deferred leasing costs $ 1,052 $ 986
Interest expense related to deferred financing costs $ 331 $ 327
v3.4.0.3
Debt - Schedule of Debt (Details) - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Debt Instrument    
Total debt, gross $ 1,676,256 $ 1,600,018
Deferred financing costs, net (7,963) (8,411)
Discount, net (973) (911)
Total 1,667,320 1,590,696
Unsecured term loans    
Debt Instrument    
Total debt, gross 455,000 455,000
Unsecured senior notes    
Debt Instrument    
Total debt, gross 600,000 600,000
Mortgages | Fixed rate mortgages    
Debt Instrument    
Total debt, gross 296,392 298,030
Mortgages | Variable rate mortgages    
Debt Instrument    
Total debt, gross 28,864 28,988
Unsecured revolving credit facility    
Debt Instrument    
Line of credit facility, amount outstanding $ 296,000 $ 218,000
v3.4.0.3
Debt - Textuals (Details) - USD ($)
3 Months Ended
Mar. 31, 2016
Dec. 31, 2015
Feb. 11, 2015
Dec. 31, 2014
Debt Instrument        
Outstanding amount $ 1,676,256,000 $ 1,600,018,000    
Unsecured term loans        
Debt Instrument        
Outstanding amount $ 455,000,000 455,000,000    
Unsecured term loans | $300.0 Million Unsecured Term Loan        
Debt Instrument        
Basis spread on variable rate 1.15%      
Outstanding amount $ 300,000,000      
Unsecured credit agreement, extension option period 1 year      
Weighted average interest rate with interest rate swap impact 1.73%      
Unsecured term loans | $155.0 Million Unsecured Term Loan        
Debt Instrument        
Basis spread on variable rate 1.70%      
Debt instrument, face amount $ 155,000,000      
Weighted average interest rate with interest rate swap impact 2.99%      
Unsecured senior notes        
Debt Instrument        
Outstanding amount $ 600,000,000 $ 600,000,000    
Unsecured senior notes | $300.0 Million Unsecured Senior Notes due 2021        
Debt Instrument        
Debt instrument, face amount $ 300,000,000      
Debt instrument, stated interest rate 3.38%      
Debt instrument, percentage of principal amount received 99.21%      
Debt instrument, effective interest rate 3.50%      
Unsecured senior notes | $300.0 Million Unsecured Senior Notes due 2023        
Debt Instrument        
Debt instrument, face amount $ 300,000,000      
Debt instrument, stated interest rate 3.70%      
Debt instrument, percentage of principal amount received 99.19%      
Debt instrument, effective interest rate 3.80%      
Mortgages        
Debt Instrument        
Weighted average interest rate with interest rate swap impact 5.67%      
Effective percentage rate range, minimum 1.89%      
Effective percentage rate range, maximum 6.49%      
Weighted average interest rate 5.39%      
Minimum | Unsecured term loans | $300.0 Million Unsecured Term Loan        
Debt Instrument        
Basis spread on variable rate 0.90%      
Minimum | Unsecured term loans | $155.0 Million Unsecured Term Loan        
Debt Instrument        
Basis spread on variable rate 1.55%      
Maximum | Unsecured term loans | $300.0 Million Unsecured Term Loan        
Debt Instrument        
Basis spread on variable rate 1.80%      
Maximum | Unsecured term loans | $155.0 Million Unsecured Term Loan        
Debt Instrument        
Basis spread on variable rate 2.40%      
Unsecured revolving credit facility        
Debt Instrument        
Line of credit facility, borrowing capacity     $ 850,000,000 $ 800,000,000
Basis spread on variable rate 1.05%      
Line of credit facility, commitment fee percentage 0.20%      
Unsecured revolving credit facility | Minimum        
Debt Instrument        
Basis spread on variable rate 0.875%      
Line of credit facility, commitment fee percentage 0.125%      
Unsecured revolving credit facility | Maximum        
Debt Instrument        
Basis spread on variable rate 1.55%      
Line of credit facility, commitment fee percentage 0.30%      
v3.4.0.3
Debt - Principal Maturity Schedule (Details) - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Debt Disclosure [Abstract]    
2016 $ 51,013  
2017 116,626  
2018 14,428  
2019 464,281  
2020 344,904  
Thereafter 685,004  
Total $ 1,676,256 $ 1,600,018
v3.4.0.3
Debt - Amortization of Deferred Financing Costs (Details) - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Debt Disclosure [Abstract]    
2016 $ 1,344  
2017 1,640  
2018 1,547  
2019 1,442  
2020 893  
Thereafter 1,097  
Total $ 7,963 $ 8,411
v3.4.0.3
Derivative Financial Instruments - Table of Derivative Financial Instruments (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2016
Dec. 31, 2015
Derivative    
Fair Value, Liability $ (4,735) $ (2,370)
Fair Value, Asset 0 427
Interest rate swaps | 0.86%    
Derivative    
Notional Amount $ 100,000 $ 100,000
Index LIBOR LIBOR
Rate 0.86% 0.86%
Fair Value, Liability $ (76) $ (142)
Interest rate swaps | 1.39%    
Derivative    
Notional Amount $ 50,000 $ 50,000
Index LIBOR LIBOR
Rate 1.39% 1.39%
Fair Value, Liability $ (860) $ (71)
Interest rate swaps | 1.24%    
Derivative    
Notional Amount $ 105,000 $ 105,000
Index LIBOR LIBOR
Rate 1.24% 1.24%
Fair Value, Liability $ (1,270)  
Fair Value, Asset   $ 427
Interest rate swaps | 4.98%    
Derivative    
Notional Amount $ 25,892 $ 26,092
Index LIBOR + 1.45% LIBOR + 1.45%
Rate 4.98% 4.98%
Fair Value, Liability $ (2,529) $ (2,157)
Basis spread on variable rate 1.45% 1.45%
v3.4.0.3
Derivative Financial Instruments - Derivative Instruments Fair Value Table (Details) - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Derivatives, Fair Value    
Derivative financial instruments, asset $ 0 $ 427
Derivative financial instruments, liability 4,735 2,370
Not Designated as Hedging Instrument | Interest rate swaps | Receivables and other assets    
Derivatives, Fair Value    
Derivative financial instruments, asset 0 427
Not Designated as Hedging Instrument | Interest rate swaps | Derivative financial instruments    
Derivatives, Fair Value    
Derivative financial instruments, liability $ 4,735 $ 2,370
v3.4.0.3
Derivative Financial Instruments - Derivative Offsetting (Details) - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Asset derivatives    
Gross Amounts $ 0 $ 427
Amounts Subject to Enforceable Master Netting Arrangements 0 (427)
Net Amounts 0 0
Liability derivatives    
Gross Amounts 4,735 2,370
Amounts Subject to Enforceable Master Netting Arrangements 0 (427)
Net Amounts $ 4,735 $ 1,943
v3.4.0.3
Stockholders' Equity and Partners' Capital - Textuals (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Apr. 25, 2016
$ / shares
Apr. 27, 2016
$ / shares
shares
Jan. 31, 2016
USD ($)
Mar. 31, 2016
USD ($)
$ / shares
shares
Mar. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2015
shares
Common Stock Dividends            
Dividends declared (in usd per share) | $ / shares       $ 0.295 $ 0.290  
LTIP Units            
Incentive Plan            
Number of forfeited units/shares           225,000
Restricted Common Stock            
Incentive Plan            
Number of forfeited units/shares       3,244 8,000  
Nonvested awards, total compensation cost not yet recognized | $       $ 6,700,000    
Period for recognition       1 year 9 months 18 days    
Restricted Common Stock | General and Administrative Expense            
Incentive Plan            
Compensation expense | $       $ 1,800,000 $ 1,900,000  
2006 Incentive Plan            
Incentive Plan            
Number of shares authorized       5,000,000    
Number of shares available for grant       2,123,422    
Subsequent Event            
Common Stock Offerings            
Number of shares issued   5,980,000        
Share price (in usd per share) | $ / shares   $ 28.75        
Common Stock Dividends            
Dividends declared (in usd per share) | $ / shares $ 0.295          
ATM            
Common Stock Offerings            
Number of shares issued       3,418,571    
Sale of stock, average price per share (in usd per share) | $ / shares       $ 27.25    
Remaining amount of shares available for issuance | $       $ 206,800,000    
ATM | Maximum            
Common Stock Offerings            
Maximum amount of common stock authorized | $     $ 300,000,000      
Healthcare Trust of America Holdings, LP (HTALP)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Dividend distribution ratio       1    
Common Stock Dividends            
Dividends declared (in usd per share) | $ / shares       $ 0.295 $ 0.290  
v3.4.0.3
Stockholders' Equity and Partners' Capital - Restricted Common Stock Activity (Details) - Restricted Common Stock - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Dec. 31, 2015
Restricted Common Stock      
Balance as of beginning of period (shares) 487,850 463,050 463,050
Granted (shares) 194,151 172,115  
Vested (shares) (162,140) (113,029)  
Forfeited (shares) (3,244) (8,000)  
Balance as of end of period (shares) 516,617 514,136 487,850
Weighted Average Grant Date Fair Value      
Balance as of beginning of period (usd per share) $ 23.13 $ 20.90 $ 20.90
Granted (usd per share) 27.17 26.98  
Vested (usd per share) 22.65 21.99  
Forfeited (usd per share) 24.23 22.08  
Balance as of end of period (usd per share) $ 24.79 $ 22.60 $ 23.13
v3.4.0.3
Fair Value of Financial Instruments - Assets and Liabilities at Fair Value (Details) - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Assets:    
Derivative financial instruments, asset $ 0 $ 427
Liabilities:    
Derivative financial instruments, liability 4,735 2,370
Fair Value, Measurements, Recurring    
Assets:    
Derivative financial instruments, asset 0 427
Liabilities:    
Derivative financial instruments, liability 4,735 2,370
Fair Value, Measurements, Recurring | Level 1    
Assets:    
Derivative financial instruments, asset 0 0
Liabilities:    
Derivative financial instruments, liability 0 0
Fair Value, Measurements, Recurring | Level 2    
Assets:    
Derivative financial instruments, asset 0 427
Liabilities:    
Derivative financial instruments, liability 4,735 2,370
Fair Value, Measurements, Recurring | Level 3    
Assets:    
Derivative financial instruments, asset 0 0
Liabilities:    
Derivative financial instruments, liability $ 0 $ 0
v3.4.0.3
Fair Value of Financial Instruments - Assets on Nonrecurring Basis (Details) - USD ($)
12 Months Ended
Dec. 31, 2015
Mar. 31, 2016
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]    
Assets: MOB $ 547,000 $ 0
Impairment on property being marketed for sale 900,000  
Level 1    
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]    
Assets: MOB 0  
Level 2    
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]    
Assets: MOB 547,000  
Level 3    
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]    
Assets: MOB $ 0  
v3.4.0.3
Fair Value of Financial Instruments - Textuals (Details) - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Fair Value Disclosures [Abstract]    
Debt, fair value $ 1,710,100 $ 1,619,700
Debt, carrying value $ 1,667,320 $ 1,590,696
v3.4.0.3
Per Share Data of HTA (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Numerator:    
Net income $ 10,036 $ 6,942
Net income attributable to noncontrolling interests [1] (176) (138)
Net income attributable to common stockholders/unitholders $ 9,860 $ 6,804
Denominator:    
Weighted average shares outstanding - basic 129,336 125,175
Weighted average number of shares/units outstanding — diluted 131,240 127,105
Earnings per common share - basic    
Net income attributable to common stockholders (in usd per share) $ 0.08 $ 0.05
Earnings per common share - diluted    
Net income attributable to common stockholders (in usd per share) $ 0.08 $ 0.05
HTA, Inc.    
Numerator:    
Net income $ 10,036 $ 6,942
Net income attributable to noncontrolling interests (176) (138)
Net income attributable to common stockholders/unitholders $ 9,860 $ 6,804
Denominator:    
Weighted average shares outstanding - basic 129,336 125,175
Dilutive shares 1,904 1,930
Weighted average number of shares/units outstanding — diluted 131,240 127,105
Earnings per common share - basic    
Net income attributable to common stockholders (in usd per share) $ 0.08 $ 0.05
Earnings per common share - diluted    
Net income attributable to common stockholders (in usd per share) $ 0.08 $ 0.05
[1] Includes amounts attributable to redeemable noncontrolling interests.
v3.4.0.3
Per Unit Data of HTALP (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Numerator:    
Net income $ 10,036 $ 6,942
Net income attributable to noncontrolling interests [1] (176) (138)
Net income attributable to common stockholders/unitholders $ 9,860 $ 6,804
Denominator:    
Weighted average units outstanding - basic 129,336 125,175
Weighted average number of shares/units outstanding — diluted 131,240 127,105
Earnings per common unit - basic:    
Net income attributable to common unitholders (in usd per share) $ 0.08 $ 0.05
Earnings per common unit - diluted:    
Net income attributable to common unitholders (in usd per share) $ 0.08 $ 0.05
Healthcare Trust of America Holdings, LP (HTALP)    
Numerator:    
Net income $ 10,036 $ 6,942
Net income attributable to noncontrolling interests (31) (33)
Net income attributable to common stockholders/unitholders $ 10,005 $ 6,909
Denominator:    
Weighted average units outstanding - basic 131,242 126,330
Dilutive units 0 0
Weighted average number of shares/units outstanding — diluted 131,242 126,330
Earnings per common unit - basic:    
Net income attributable to common unitholders (in usd per share) $ 0.08 $ 0.05
Earnings per common unit - diluted:    
Net income attributable to common unitholders (in usd per share) $ 0.08 $ 0.05
[1] Includes amounts attributable to redeemable noncontrolling interests.
v3.4.0.3
Supplemental Cash Flow Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Supplemental Disclosure of Cash Flow Information:    
Interest paid $ 13,062 $ 13,238
Income taxes paid 88 99
Investing Activities:    
Accrued capital expenditures 5,688 1,464
Financing Activities:    
Dividend distributions declared, but not paid $ 38,784 $ 36,309
begin 644 Financial_Report.xlsx
M4$L#!!0    ( -R FT@71Q9N\@$  +8@   3    6T-O;G1E;G1?5'EP97-=
M+GAM;,W:S4[C,! '\%>IG[_Y"G.=G88X[+J4_+?&(MM3U;'VGD:SRWV@Y%Y6VOO!M#H9-[+M
MV!UDG;O5RK34N?;!YBUURJ7I4XY7LSL=THVV.07;#6P*[#]Y7>+L8PI&'TAW
ML2=*=JAC>AHH'JN_C[Q4OJ*5?AC2NPH_W[LZT#"MB;WQSZ6N=SE+S+\MJQR-
M;ZIPN/%OG1E;AN;']6\[ROD_7LO!3=S:X2KH1W-08'NR,95C;;49CXWJT87-
M#^5):%^A-!8Z??_3T*=@9-/AA$B\JP\!TH<$Z4.!]-& ]'$&TL=G
MD#Z^@/3Q%:0/OD!I!$54CD(J1S&5HZ#*453E**QR%%QW8OG*\M"_V/Z'D4X$G1H>)%]2-F Q+M*;V"
M^GH A3&^.R6:E((C-Z."N[_8_ )02P,$%     @ W(";2%WP<_ON 0  ;"  
M !H   !X;"]?K
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M<$=9U0L(3G&?E[SQFO:C?M0@<
MG2*#@V?1+FPG?A^VCKS?;T&H2,B5,"A'$]"Q8KG]EJF3,UNO5E1M<9G,V%(P3#L*C8SB6*XQ6T[.
MK=B -D56-6&"/ +EY$H7)ZN &RQHMN! 1EIC'=BSW3&Z8)Q5F'B$&-B&(J=$
M/Y@,U([N)$Q@82H6%&YDV ;(-1,H!H:GO16X9'7I#HJ1\6LF>8(=Y@NY^KTN
M5%L32LR
MBK=#H5^#UL=49^2:RS^'HJNO@K!34P7DZYPNZDLA#&M+ 2U5JL&> DG?ZLLB
M=->Q5Q:ANXZ]L@C==>R4A=\=MS[\'*]0NNZD>UM,][R^N+KNI'O$U49F?:*VMA H8R[N/,\4&ZQO?8
M'EM9.!8]50R%G&.([ZFQK\S2J(\S6DE\YN[$8T^6@E*5'$^!]MP7NI_3:\!I
MT AZ;@7X.>Y&X&T>/;<"_)R?]3E]=R>H:%)>[51UJ1VI?I?JG^C@T^/XPU,X
M./T)%_T%4$L#!!0    ( -R FT@57U,C/@$  &D#   1    9&]C4')O<',O
M8V]R92YX;6S-DTU/PS ,AO\*ZKU+NTU%JKH> '%B$A)#(&XA\;:PYD.)IZ[_
MGLSK6KXNNW&K:[^/7\=))5PIK(=';QUX5!"N#KHQH11ND6P174AJ*&J;=M).Z.Z.'#.7I3J]7N5%F17E?/9VG.R;O]&P[H?XMX[/!FF[J+"!"W=+
M&DG+I4\"20C"*X?*FHMPA/DB)EC8OW^ P,M!O9 NVPZZUGH9:KI?8W1\.7%E
M&^N[4^I'].U5U9]02P,$%     @ W(";2)E&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>	+]O6N[!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW A(5M>5 TR  
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:[email protected]$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ 
M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04    
M" #<@)M(X,VIBV8"  !F#   #0   'AL+W-T>6QE]508,L>0+,R8C_?2S,0&"EB;I;N3%A^/C
MW_G[ L?Q"[6E^&F-L0(5H[P(X%JI_*/C%/$:,U1,1(ZY[DF%9$CI1YDY12XQ
M2@HSB%%GZKH+AR'"8>CSDBV9*D L2JX".&]=P(Z_%PD.X//E^^^E4'?O@&TO
M/EQPB_/@_^"GH 
MOCD"?L ;3 ^L=+_OEZM]:^!.LZVAGPK>[>X46D?H%R]@@ZB.]TQX+*B00.GC
MHU74'HX8MA'WB))($N-,$2-T:]U3XZA/7!/'"!>RSFTS#/-,W"Z3S*( NLWO
M]'111Z\;,SU"Z?[TM"/T=]P;4
MCB,30VQI0^
MF??[6[K'KE)@8\P>NQ 8%3M3+T1C=L>@7E2G3[/L/G;V)BZHTC:!'HWRG&X_
M49)QAJU8ZUJ*YND8WCN #WVTHX*UD.1%QYN#$&L'EA!LL%0D[GM^2)2O<*6:
M$^Q4Z2&%;YWRW]3TYU>M4Z./X+]>GO^:O+\W]6L(!WI.V(K'DD58+NNO\_G"
M9M=C56;*\6BE+<8K;<0;>C-6:;/;L2HSUZ3?D^8TY;17L_*:5>M-3.IND)=]RH4Z4O_7A8-2W"*2JJ^DHU0=6< ._O!R/<6
M;=2J102PL[_@A)3,7AJ[?Q;A3U!+ P04    " #<@)M(!BJ-@8@$  ">$0  
M#P   'AL+W=O*K1!-92DKR4#Y]2LYH7VS"$]S9#)R
M4HN@K/$KM?;%EN9_A>;73HK&KZ0,K=[ 6J%,\?&#/UDJ+>^E\Q%,Q'K]MVCE
MM'C6!='"A_-&!=E,"QZ+]DGN7'#=^E.G="I4XZH8)=AK5V\(JL@2^5\F*?N]D^VRJA6O:1VQY)?V:?/UJD7:X+0\]I9
MK?NWTHW^I5B#_W$EMC&H>N?!(!:WZ4M,B\DX A^55PNE5?@^+?IS+5-/1O_K
M2C_\/\^(Z0?G]1,381IR;D*DD$NS^7AQ:%(;XL.735^Q.U'QQ%TVY6:H$'1F
M32.-EPV)9]YJU<11:<@GH86I)0$0!1#=%\0 Q #$?ADT#_$0NPP@#B"^+Z@"
M4 6@:E_0!$ 3 $WV!1T"Z!! AV]!U^Y!&/72?^M>@9GTM5/KOFR7 #H"T-%;
MT+QK6^&^QW?(7#T8%=.'B%:=UK7MHE4 .@;0\5O0I7F,<9Z4]$09A^][SMWI40?*-B<;#U
MMY753YD^M1O&H8H=+C,2'P3
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M, IE9R@[R\@^F 8.<)W'4':6D7T0Q8X0A;:SC.U]1CD@\[@':3K=Q^$FRLXSGF\A-T[%5+".#GP1H7,IQ?1-1!1Z
MSC.>;U&GK8T;@6WD]-U;2N=V4>@YSRY!!M(GQZ4U1\_YOJL3SA&UL[K>-ZES
M])RCYWS?I,[1\XSGPRA,ZAP]YQG/!^<'CIYS])QG/!]&'2,*/><9SP=1
M%6;U"FVO,K:_,VME J="VZN,[>]-6UL6HM#V*F/[X+15H>T5VEZQ[>[YYX:Y
MD4ME9)-^)_B^FK@?K],_AGC8K/UYE1:(J?S%-K'N]'.@(,M.Z[-X[=I<6=%O
MH3?DU[\*'_\#4$L#!!0    ( -R FTC3@'=$Q (  *L+   8    >&PO=V]R
M:W-H965T&ULC5;;;J,P$/T5Q <4/-Q"19":K%:[#RM5?=A]
M=A,G006Q($Q&;QW;2^6X4'*XV,4
MBZHJ?9-OT
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M965T&ULC9I;;^,V$(7_BN'W7?-.*7 ,K%44[4.!Q3ZTSTJL
MQ,;:EBLIZ^V_+R4.M;F,A_,26\I'ZDBB#H='7E_;[GN_;YIA\?-T//?WR_TP
M7.Y6J_YQWYSJ_G-[:<[A/T]M=ZJ'L-D]K_I+U]2[J='IN%)"N-6I/IR7F_6T
M[VNW6;+^4R[?AV>-X/XX[59KV:V^T.I^;<
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M8_ORK<3SA/AX$A'12@HE;V,58$)[X?)J#*K&0!_885Q4DQ!=.&]N&P^&GC;HB8@QSDH"JP#3PILRK\:A:AS<"$(-((5P2CA"#G!.6R=5
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MFGRRD)CL;)9 [FQFWODVS$7&LI,%@[NLLF!Q9[4BGRP DTL6
M &,F"Q9W5BOSR0(P^60A@=QDP>+N:E4^64@,E2Q\9&XKP5W5ZGRRD!@Z69@I
M3K)@\634&G:R8&^\;((5/>7*P"CCR%DB85XY1NUC<3^UT0(=54D#,ZY5=4$]
MGPD,:U57-7'[YW
M\=U\W!C:2_JIP?Q[A\W_4$L#!!0    ( -R FTATC^_5F0(  /L*   8    
M>&PO=V]R:W-H965T&ULE9;1;ILP%(9?!?$ !1N"(2)(+=6T
M74RJ>K%=.XF3H +.;"?IWGZV#V1)95R:BP#._Q]_=@Z_7%ZX>),'QE3PWK6]
M7(4'I8[+*)*; ^NH?.!'UNM?=EQT5.E'L8_D43"ZM::NC7 <9U%'FSZL2COV
M(JJ2GU3;].Q%!/+4=53\?6(MOZQ"%(X#K\W^H,Q 5)71U;=M.M;+AO>!8+M5
M^(B6-PB;^X# [_F_,T\_-BNPM@PL)9ME"E!]>7,:M:VII*>^<]0
M]/^K\==4LIJWOYNM.FC:. RV;$=/K7KEE^]L6,/"%-SP5MKO
M8'.2BG>C)0PZ^@[7IK?7"_Q"BL'F-N#!@*\&E'H-R6!(/A@B(+/K>J:*5J7@
MET >J?FWT5++A2FB*P=Z,5+ODZTI[$Y5Y;G*(O97DL B0Q \QFA;5#M$D2>HD28%D
MX9HD Q*0Z'<*/M/*>DHYR;1P,BV *?,P@<3'\E$QR9 Y&3)@(!Z&[%.&CXI)
M!N)D(,"0?^[/G5V:S^[2PCE_ ?["TZ7%G"YUB"9)4.Q$LI1B$N,L3XH97-C-!1E%L(\+S^?"
M7^9R1Q^"S,)X1H74V=8(8H;,Z&OD#A@$X4"<^3ON#6A0GB1YZGP%QIT9A 4N
MBG3.JMR!@R LB"^)!\T,INR+3.X 0I! Q)?$@V96#Y$O]U#NYH)D([YT'C2S
MN'(O5W1S3#G2/?M)Q;[I9;#F2I]X[,%DQ[EBNE3\L B#@SZ)7A]:ME/FENA[
M 6%#\.!XUK^?=ZA]02P,$%     @ W(";2%XG',R,!0  A2   !@   !X
M;"]W;W)KV^]X?JFI(
M?C7UJ;]?'8;A?+=>]T^'JBG[V_9R[L]=5>[GHJ9>*R'L
MNBF/I]5V,V_[VFTW[>M0'T_5UR[I7YNF[/Y[J.KVJG;'YOJU!_;4])5S_>K+_*NL#,R$_\BY?Z^%;>_FSPCF8:<"GMN[GO\G3:S^TC2]9)4WYR[T>3_/KQ7V3"2RC
M"Q06J*4@#1< %L!2L BC"S06Z+<"/2^-F\J\$$4YE-M-UUZ2_EQ.IX>\&_%N
M&F0<.1EGWX\+.X_9S4N[W?SUHLK57*X^
MWD'AB#2/[P&N]P!N#C#79R)>KZ_KW<8OVM7+:XFG&4G=)!PB1:J,^!@K')9G
MVJBX&$.*,4Z,HO9BG1B'6/,Q4B"2Q5584H5U*B"@POHE 1E28G%)C&(LR;GK(ZB]3A7
MRO*0'N]C1Y$4IT>L8
MOPN2=CKI3"H/61TR-U:'/,93QG".-^UX$HTJ9'G(W*@T)+I8,"$9GB=36H]S
MO5R']#CF!C0$SS_$E+&<]:%-5#KSRT,NBLR-U#)\@7H.,L&Y(F@KE)6D%=+AC-:*,X9:N@9&90#C"%H@U26,R/+FI']S(SHIE"E*(=SF&E+
M4QD.$?(T#ZDNYXSD]&2*]C2%7B1"IN8AD$H'VH'"[JP,2C(W@WBF1'Y)CA$2Q]M"T[/@+=BD$:#Y#(
MQ!*DQW@1$FC?@BP>(I&)I$A/L6(DT)8%>3Q&(A.)D9YBQ4A-NY46\1B)3"Q&
M>HP7(S7M5EK&8R0RL1CI,5Z,U'2GI54\1B(3BY$>X\5(3;=:&M@Q4G]P]T['
M8R0RD1CI*5:,U+3]:1./D,Q$IE8C/08+T9JVDMU&H^1
MR$1CY,+Q8J2FW51G\1B)3-#:D>'$2$T[J<[C,5+[!C$<(Q'CQ4A#6ZD19(R\
MOA4M\-0A.R%_,]I#C/!A:!LUDA$0WR"ZH\>&"S&;"T83:N@6TOC RO M0_>0
MQO>'H3R%4"1/O5&,D\_0]_.,#ZR<@_3!HPO#F9%ASU(H(2(42XCO
ML+@>NQC7R2F9-X1+:'^Q].VPJUMFUMO+[^%H_>[!:U-U+_,3[#YY:E]/@WOF
MN&Q=GI(_J.G![6_;=_*ND,3V<5YW.RN(;T91XS?N^?C;KK>;<_E2_5UV+\=3
MGSRVP] V\Q/?Y[8=JG$NXM:LDD-5[I&PO=V]R:W-H965T
M&ULC9A+<^(X$,>_"L7=@UZ6I12A:@E@[V&KIN8P>W:"$ZBQ
M,6L[8?;;KQ\M$;)2HTO SJ\?ZI;T%UI>ZN97>RB*;O:[*D_MX_S0=>>'Q:)]
M.115WGZKS\6I_\]KW51YUS\V;XOVW!3Y?C2JR@4C1"ZJ_'B:KY;CN^_-:EF_
M=^7Q5'QO9NU[5>7-O^NBK"^/_MP_SLF00U$6+]W@(N\_/HJGHBP'
M3WWD?\#I->9@^/F[\;X;A]NG_YRWQ5-=_GW<=X<^6S*?[8O7_+WL?M27K( Q
MQ(/#E[ILQ[^SE_>VJRMC,I]5^>_I\W@:/R_3?Q0!,["D]SSK.]CVDV/TV8S38[7\6%&BEXN/P=$-PT9F#0PE
M?N9I8J3R(QOCAOJ9K6&8G]D9AON9U##"SV2&B2VSZ,OFK!V[K9V8:L? @;P-
M(
MRJC1QP"1H&Z5H$8"D#@;"\6,\*"%0=U"0>WNCM7QNAN3!-F--U=OV!JB5BQ8
M'&,3EQJUD'$LL*EK$Z2]2T1>,Q-:J4\3U%\SX:X9* 9#(CU9*"%,*K>&F69^
M0L-$G[J%B,;&$=9,@ 21.E98,ZTW1'"V0#'>UY0@!=D!&.F82&QZI"8N3[3 
M%D%F0BZXHC.T3JC.@?FUORJ XX2!E(TZ R,K=,,2-3V%G*0(HX-RFH
M(E#8AG=UA!QT4E$4>P\E%XI9*?*
M@(IN,/_8W5+$C'A@YU> (JZ)PLX!EE.Q0+J6NCE_ZNZ?64S>3ST#*(I%R&)U
MZP9+[A][email protected]_W1E72J+U":$R$U*$7'2X58J!2KFO N"$9"$B97^*16]%
M;M"@)>F6& ;JP9$=?6T@T?]PP"X]-M8;0>Y9MD QP1CER(%K!V"D$\VQ2Y34
M)BC$_ZZU;FY';&C-OR[EQ:?;OW/^5OR5-V_'4SM[KKNNKL;[OM>Z[HK>#?D6
MSV>'(M_;A[)X[8:O2?^]F>YYIX>N/IMK:WMWOOH/4$L#!!0    ( -R FTA*
M^S@&[@,  )@2   8    >&PO=V]R:W-H965T&ULC9C!;MLX
M$(9?1?#=%4F1E!@X!K:V%^UA@:*'W;,2T[%02?1*2MR^?25Q1HV#$:U+;#G?
M#/\9DC]I;ZZN^=&>K>VBGU59MX^K<]=='N*X?3[;*F\_N8NM^_^<7%/E7?_8
MO,3MI;'Y<0RJRE@PIN,J+^K5=C-^]JW9;MQK5Q:U_=9$[6M5Y'E=_\8>#2 =D)/XM[+5]]SX:Q#\Y
M]V-X^'I\7+%!@RWMDR/N7-[NS93EDZD?^'Y+^&7,(?/\>L_\]EMO+?\I;
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M6*94LT$X;
M.$?7)4?"E@(D4B;NG"J(FJ'U2UHJ:5D2#XU02Q%BVJC ";1',$F--L$UZD&1
MBD7;[\/9 (<+5\M/%T[;/@>[EF15."L>2OJ%LJS5M*]S-/: *^T ,ESHX-JE
ML'E!] ' \00(':X(&;ZL=MK>N5EPOB*4,=+>L72"FK_?T<8MV((S%J!UNFR#
M"=I*!5IIZ)@%:,W[NU:@=!*;%S1SN07;4Z%9!\CH.U=;CZUON7E%M#4*L#(5
MF(T=0*0:; ]<6+D)>-0!J/4--B^9MDV!CABZKP"T3@S+0A>6BD%-R
MR_Z".XN@K5R E:O 1MLCE#"M
MQ9VU#6B6+/M>(6C7%^#Z*N!I.X1D?P&D=P%V$T$I$WI-84,]**36'U=Y_.XK
M_B5_L?_DS4M1M]&3ZSI7C5_J3\YUMD_#/O6UG6U^G!Y*>^J&M^E0M/_AQ#]T
M[H*_ TT_1FU_ U!+ P04    " #<@)M(*69N+AH&  "<)   &    'AL+W=O
MSDQ9;H;Y=G+SSKK;;_O:Q.=?]A_:IN8Q_N6^[K_4:+WPZ/CP.TX7M?K==
MRMT=S\VE/[:75=?<7Z]O]%45XH3,Q-_'YK7_[O-J$O^Y;;],7_Z\NUZK24-S
M:FZ'J8IZ_/725,WI--4TWOE?J/3;/:>"WW_&VG^?FSO*_USW3=6>_CG>#8^C
M6K5>W37W]?-I^-2^_M% &_Q4X6U[ZN>?J]OG?FC/6&2].M=?T^_C9?[]FOY2
M*"A&%S!0P"P%EOO0!2P4L-\*N+FE2=GYM!2Y5X.8*ROA6XV5&8FI%0K12-KQ/58D*I3-Y
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M6?#3R'D\0)O(+2 KI&P43&9+>[,%VXW<7@0A4P3-O9.!*Y07O)(M; K%82-;0K6XO;,$X-0%:Q"V?$E-."99VEG=F",Q?<:P(A6QBV@Q#S
[email protected]#';9*A&\)#:'_P4*MH%;62B"NR4R&<5V"GQ%\(*6] MPEVU
M8#ML:>>RI2"P "B76" FBRP<[5M."4(+A/C4 BE1;.%HWW(8T7$V 1";%V!%
MDNC"T9;EC""\ "B37B EBB\.]ACG
M\_$%,-GX8N%D\86CUX NY..+A>'L!B%1?.%H]W.XK6;[)XKB"\"$\86C_<_A
MMEHRY+3_.=P*LSV,6^%>]D./FV'NA0-0-KY8.%E\X6E#]+@IYM:E +%JPJ_$%YXV1(^;8LX0
M ]\2[5>P>PBTI09<
M,'(C!5 NO@!,,$B!MM, =EIP@Q3POS9\?+%@HO@BT(8:P% +;J@ RL87"R>+
M+P*](0ZX(>;>@0!EX@ND1/%%H+TY8%#)[4H0RL47P,GBBT!;7 S8V9#HW\_7CTV]=WRY=3<#]/'.'[NTN&9]&5HG_ L
MT'(@:?\_4$L#!!0    ( -R FTCIP>"+H0$  +$#   8    >&PO=V]R:W-H
M965T&ULA5/;;J,P$/T5RQ]0$Y*V4420FE:KW8>5JC[L/CLP
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M8*E1M/G$'2\[email protected]/0]GM]IYN DB7IEX;]:/'35-'+PL3N5J>U>P4Q"ZP"3B
M8<(L".;5K[;(Z35Z'NGY]_3U)7V='*XGA_??"VPN!39)8//5B ESF#';3TW8
MV9XJ,&V\.I94.&B7MG2I+K?S(8]G\@$OBYZW\)N;5FA+CNC\R<8#:! =^/;9
MS2TEG7\_2R*A<2&\][%)5RHE#OOY@2ROM/P/4$L#!!0    ( -R FT@;EV=5
MI $  +$#   8    >&PO=V]R:W-H965T&ULA5/+;MLP$/P5
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MDT]X50Z\@U_<=$);0(OHP+?/;FXIZ?W[61()K0OA=Q^;=*52XG X
M/9#EE58?4$L#!!0    ( -R FTA%:0 "HP$  +$#   9    >&PO=V]R:W-H
M965T6CG-"\V![ D3U#<
MWN  VO]IT2CN?&HZ9@<#O(DD)5F>95^8XD+3JHRU)U.5.#HI-#P98D>EN/E[
M (G3GF[H4G@67>]"@54E6WF-4*"M0$T,M'MZO]D=BH"(@-\")GL6D^#]B/@2
MDI_-GF;! DBH75#@?CG! T@9A'SCUUGSO64@GL>+^F.
M;$9) RT?I7O&Z0?,(]P&P1JEC5]2C]:A6BB4*/Z65J'C.J4_^=U,NT[(9T*^
M$KYFT7AJ%&U^YXY7I<&)V(&'L]OL/-P$$:],O#?KQXZ:)@Y>E:=J\RTOV2D(
M76 2\3!C5@3SZE=;Y/0:/8_T_'/Z]I*^30ZWL\/MYP+%I4"1!(K_C9@PAP53
M?&C"SO94@>GBU;&DQE&[M*5K=;V=]WD\DW=X50Z\@U_<=$);0(OH
MP+?/;FXIZ?W[61,)K0OAG8]-NE(I<3@L#V1]I=4_4$L#!!0    ( -R FTAZ
M\'5\I $  +$#   9    >&PO=V]R:W-H965T6C&-&\V@[ D7
M9;=,<:%I6<3:LRD+')P4&IX-L8-2W/P]@,1Q3U=T+KR(MG.AP,J"+;Q:*-!6
MH"8&FCU]6.T.FX"(@-\"1GL6D^#]B/@:DI_UGF;! DBH7%#@?CG!(T@9A'SC
MMTGSHV4@GL>S^E.;$9)#0T?I'O!\0=,(VR#8(72QB^I
M!NM0S11*%']/J]!Q'=.?]?U$NT[()T*^$+YET7AJ%&U^YXZ7A<&1V)Z'LUOM
M/-P$$:],O#?KQXZ:)@Y>%J=R=;\MV"D(76 2\3!A%@3SZE=;Y/0:/8_T_&OZ
M^I*^3@[7D\/;KP4VEP*;)+#YWX@)'4LJ7#0+FWI4EUN
MYT,>S^0#7A8];^$7-ZW0EAS1^9.-!] @.O#MLYLM)9U_/TLBH7$AO/.Q252X^_OIXKC)$*PO%DF?;<]@".?2FJ[I;USPX8Q
M6_>@N+W" ;3_TZ)1W'G7=,P.!G@324JR/,MNF.)"TZJ,L5=3E3@Z*32\&F)'
MI;CYLP.)TY:NZ#'P)KK>A0"K2K;P&J% 6X&:&&BW]'ZUV14!$0&_!$SVQ":A
M]CWB>W!>FBW-0@D@H79!@?OC  \@91#RB3]FS:^4@7AJ']6?8K>^^CVW\(#R
MMVA<[XO-*&F@Y:-T;S@]P]S"=1"L4=KX)?5H':HCA1+%/],I=#RG]*?(9MIE
M0CX3\H5P&PDL)8IE/G+'J][email protected] P^Q6&P\W0<0K$U^;]6U'31,;K\I#M;J[
M+=DA")UA$G$W8Q8$\^H74^3T$CV/]/Q[^OJ9?,&KS.!):%\P?WC9II9+C<#@^D.655G\!4$L#!!0    (
M -R FT@5-VFZH@$  *\#   9    >&PO=V]R:W-H965TZ:EE42$Y"HD9:5_'SYDV2Z,
MMA=Q=S4S.\M'.:%YMSV (Y]*:KNEO7/#AC%;]Z"XO<$!M/_3HE'<^=1TS X&
M>!-)2K(\R^Z8XD+3JHRU5U.5.#HI-+P:8D>EN/F] XG3EJ[HL? FNMZ% JM*
MMO :H4!;@9H8:+?T<;79%0$1 3\%3/8L)L'['O$])"_-EF;! DBH75#@?CG 
M$T@9A'SCCUGSU#(0S^.C^K_YQ:>4/X2C>N]V8R2!EH^2O>&TW>81[@-
M@C5*&[^D'JU#=:10HOAG6H6.ZY3^Y/E8>J6)7L$'0N((FW2Y 3@GGQJQUR>HV>
M1WK^;_KZDKY.!M>)GOU'_^)2H$@"Q5\F3)!=,??XTR0[VU$%IHL7QY(:1^W2
MAB[5Y6X^YO%$3O"J''@'/[CIA+9DC\Z?:]S^%M&!;Y_=W%+2^]>S)!):%\)[
M'YMTH5+B<#@^C^6-5E]02P,$%     @ W(";2 =9G#.C 0  L0,  !D   !X
M;"]W;W)K&ULA5/+;MLP$/P5@A\0RK*
MN6'/F*U[4-S>X0#:_VG1*.Y\:CIF!P.\B20E69YE]TQQH6E5QMJSJ4HQHOZMSBM=W_B
M%IY0_A:-Z[W9C)(&6CY*]X+3=YA'V 7!&J6-7U*/UJ%:*)0H_I96H>,ZI3_W
M#S/M-B&?"?E*>,BB\=0HVOS*':]*@Q.Q P]GM]E[N DB7IEX;]:/'35-'+PJ
MSU6>;4MV#D)7F$0\)LQF13"O?K-%3F_1\]3B<_KVFKY-#K>SP^)S@>):H$@"
MQ?]&3)CC@ME]:,(N]E2!Z>+5L:3&4;NTI6MUO9V/>3R3=WA5#KR#G]QT0EMR
M0N=/-AY B^C M\_N=I3T_OVLB836A?"+CTVZ4BEQ."P/9'VEU3]02P,$%   
M  @ W(";2&2; \"C 0  L0,  !D   !X;"]W;W)K&ULA5/+;MLP$/P5@A\0RK+R@"$+B!,4[:% D$-[IJ651(3D*B1EI7]?/B3%
M+HSF(NZN9F9G^2@G-&^V!W#D0TEM][1W;M@Q9NL>%+%'_%J?U[H_;4=) RT?I7G'Z#O,(
MMT&P1FGCE]2C=:@6"B6*?Z15Z+A.Z4^QG6G7"?E,R%?"0Q:-IT;1YC-WO"H-
M3L0./)S=9N?A)HAX9>*]63]VU#1Q\*H\57EV5[)3$+K ).(A838K@GGUJRUR
M>HV>IQ9?T[>7]&URN)T=WG\M4%P*%$F@^-^("7-8, __-&%G>ZK =/'J6%+C
MJ%W:TK6ZWL['/)[))[PJ!][!3VXZH2TYHO,G&P^@173@VVQR9=J90X')8'LK[2ZB]02P,$%     @ W(";2,4@S&.D 0  L0,  !D 
M  !X;"]W;W)K&ULA5/;3N,P$/T5RQ^ D[2PNU4:
MB8(0/*R$>-A]=I-)8F%[@NTT[-^O+VEH404O\%+=7.(#V?UHTBCN?FH[9P0!O(DE)5F39#5-<:%J5L?9LJA)'
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M8)T$UE^-F#"[&9-_'I*=[*D"T\6K8TF-HW9I2Y?JS)!):%\(?/C;I2J7$X7!\(,LKK?X#4$L#
M!!0    ( -R FTB?S8,(JP$  /(#   9    >&PO=V]R:W-H965TY#,WND!E#]IM9',
M^=!TQ X&6!-)4A":9=^(9%SAJHRY%U.5>G2"*W@QR(Y2,O/O $)/>YSC)?'*
MN]Z%!*E*LO(:+D%9KA4RT.[Q?;X[% $1 ;\Y3/9LCX+WH]9O(7AJ]C@+%D! 
M[8("\\L)'D"((.0+_YTU/TH&XOE^4?\9N_7NC\S"@Q9_>.-Z;S;#J(&6C<*]
MZND7S"U$A[46-GY1/5JGY4+!2++WM'(5URF=4#K3KA/H3* KX4<6C:="T>8C
M&7DO5G?=M0TL?&J/%4TIR4Y!:$+3"(>$B9?$<2K
M7RU!\34Z325NTS>7]&URN)D=;FX+;"\%[email protected];PL45QT47_VCA#DLF.)3
M$7)V*1),%V?/HEJ/RJ4[6;/K>-_'*2 ?\*H<6 ?/S'1<6734SH]&O,%6:P>^
M?'978-3[![@& EH7MM_]WJ293('3P_+"UF=>_0=02P,$%     @ W(";2"E=
M@ NK 0  \0,  !D   !X;"]W;W)K&ULC5/;;IPP
M$/T5RQ\0 \LF[8I%RB:JVH=*41[:9R\,8,5FB&V6]._K"Y#=:-7T!8_M<\Z<
M8<;%A/K%= "6O"G9FSWMK!UVC)FJ \7-#0[0NYL&M>+6;77+S*"!UX&D),N2
MY)8I+GI:%N'L29<%CE:*'IXT,:-27/\Y@,1I3U.Z'#R+MK/^@)4%6WFU4- ;
[email protected]?;H[;#TB 'X)F,Q93+SW(^*+W_RH]S3Q%D!"9;T"=\L)'D!*+^02
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M 'AL+W=OF9' [R-)"59D65?F.)"T[J*M2=35S@Y
M*30\&6(GI;CYNP>)\X[F]%1X%OW@0H'5%5MYK5"@K4!-#'0[>I]O]V5 1,!O
M ;,]BTGP?D!\"S8 $D-"XH<+\NB^=XR$,_CD_ICG-:[
M/W +#RC_B-8-WFQ&20L=GZ1[QOD'+"/V=*VNM_.^B&?R#J^KD??PBYM>
M:$L.Z/S)Q@/H$!WX]MG-+26#?S]K(J%S(?SJ8Y.N5$H&ULA93;CILP%$5_Q>(#!L(E,!%!FDQ5M0^51O/0/CMPN&AL3&T3IG]?
MWR#)"(47L,W>>YT#V/G$^(=H 23ZI*071Z^5M&Q'G&HC][+[G#*M,((?G&?G35;)5Q08>JJ#&
M(Y'O;/H!KH5$!Y:,"'-%Y2@DH[/%0Q1_VGO7F_MDGR2QLZT;0F<(%T,6F,(M
MR)3Y#4MK
MN2I\E;Z*"+TU>V@1V_;HWA[9"B-+?PZV ^+[@-@&Q*[%<*U%JSG-FF@;DJQ"
M$A<0/X#,FF0;LE^%[%W _@%DUJ3;D'05DKKW_>AUI0Z2;4.R54CF IX?0)PF
M^OKA_9O_G )OS'86J&1C+^UOOJPN)\9+:/;)55[D V[@%^9-UPMT9E+M-K,I
M:L8D*'SPE'BH56?:,B%02SU,U9C;;6XGD@WSH;6&PO=V]R:W-H965TVFI!NI-&:4&M"W5+3*^!UH$D
M.$F3Y)8(RB0NBY![T66A!LN9A!>-S" $U7\.P-6XQQL\)UY9VUF?(&5!%E[-
M!$C#E$0:FCV^V^P.N4<$P"\&H[G8(U_[4:DW'SS7>YSX$H!#9;T"=D$R']1"#1*)3Y0"TM"ZU&9'KJ9[?9
M.;CV(DX9N=J,:SMHZM!X69S*--L4Y.2%KC"1>(B8,X(X]56+%*_1TVCQ-3V[
MIF>QPBRZ_\B^%MA>"VRCP'9J,5UK,6(.,^8_3/)5DWP2V/[#9,;DGTS(Q> $
MZ#;<3X,J-4@;Y[9DER=PEX;!G^%ET=,6?E+=,FG045EW?<*4&Z4L./OD)L>H
M5?4$L#!!0    ( -R FT@_)AZ7L@$ 
M !8$   9    >&PO=V]R:W-H965THB5[WE3,*K1J87@NJO W U[/$*3QMOK&FMWR!%3F9>Q01(PY1$&NH]?ECM
M#AN/"( _# 9S-D<^^U&I=[_X5>UQXB, A])Z!>J&$SP"YU[(&7^,FC^6GG@^
MG]2?0[4N_9$:>%3\+ZMLZ\(F&%50TY[;-S6\P%A"2%@J;L(7E;VQ2DP4C 3]
MC".381SB2;8=:[?:.;CV(DX9N6S&
ME1TT=2B\R$]%NM[FY.2%+C"1>(B8U8P@3GW1(L5+]#1:7*>O+^GKF' =W>^W
MUP6R2X$L"F1CB;=+)4;,8<+<73?9+)IL1H'[_YB,F"SYQX2<-4Z ;L+]-*A4
MO;2Q;_/N_ 0>TM#X'WB1=[2!WU0W3!IT5-9=G]#E6BD+SCZYV6#4NDQL75G73*YQ_!<4W4$L#!!0    ( -R FTCQFZT:L $  !8$   9
M    >&PO=V]R:W-H965TT),U8&@YD'U(-U)H[2@UBUU2TRO@=:!)#A)D^0+$91)7!9A[U67A1HL
M9Q)>-3*#$%3_.0)7XP%O\+SQQMK.^@U2%F3AU4R -$Q)I*$YX*?-_IA[1 #\
M8C":JSGRV4]*O?O%C_J $Q\!.%36*U WG.$9./="SOACTKQ8>N+U?%;_%JIU
MZ4_4P+/BOUEM.QQ&GC%PVX\H.FCH4
M7A;G,LTV!3E[H1M,)!XCYH(@3GW5(L5K]#1:W*=O;^G;F' ;W7>[^P+9K4 6
M!;*IQ'2MQ(@YSICM?9-\U22?!++_F,R8_!\3$I#XR_PLNAI"S^I;IDTZ*2LNSZARXU2%IQ]\I!CU+E'NBPX--9/']U^"=_J 6V/Z/2&Z
M;$%0?2=[Z.R;6BI!C=VJANA> :T\27"21%%&!&4=+G)_]JR*7 Z&LPZ>%=*#
M$%3]/0*7XP''>#YX84UKW $I?7,;S)=A-M
MG9!,A&0AW$<^\6#DT_Q.#2UR)4>D>^K^7;RW<.5$K#*RN6E;MM=4OO B/Q?)
M-LO)V0E=80+Q&##Q@B!6?=4BP6OT)%C)'WM(%?5#6LT^@DC>U1WTJUE :L?7278M3:FV#9
M<*B-"WP0 
M !D   !X;"]W;W)K&ULA53-;J,P$'X5RP]0$P(T
MC0A2T]5J][!2U4-[=F  JS9F;1.Z;U__ $U6J+G@L?W]S(@9YZ-4[[H%,.A#
M\$X?<&M,OR=$ERT(JN]D#YV]J:42U-BM:HCN%=#*DP0G<11E1%#6X2+W9\^J
[email protected]@62$]"$'5OR-P.1[P!L\'+ZQIC3L@14X67L4$=)K)#BFH#_AQLS]F
M#N$!KPQ&?1$CE_M)RG>W^5T=<.12  ZE<0K4+F=X LZ=D#7^.VE^63KB93RK
M__35VNQ/5,.3Y&^L,JU--L*[email protected]+S(\1=,):1.L)1<^R\J!VVDF"D8"?H1
M5M;Y=0PWV6ZBK1/BB1 OA%WD$P]&/LT?U- B5W)$NJ?NWVWV%JZY.F^ 102P,$%     @ W(";2.#1
MA=^E 0  L0,  !D   !X;"]W;W)K&ULA5/+;MLP
M$/P5@A\02K*=%(8L($X1M(<"00[MF996$A&2JY"4E?Y]^9 4NS"0B[B[FIF=
MY:.N6'/F*U[4-S>X0#:_VG1*.Y\:CIF!P.\B20E69%E
M]TQQH6E5QMJ+J4H#\AOH7D9W.@6;  $FH7%+A?SO $4@8AW_A]
MUOQL&8B7\:+^'*?U[D_;4=) RT?I7G'Z ?,(NR!8H[3Q2^K1
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M@',OY(S_39J?EIYX.9_5?X1J7?H3-?"D^%]6
MV\Z%33"JH:$#MZ]J_ E3"2%AI;@)7U0-QBHQ4S 2]#V.3(9QC"?W,VV=D$V$
M;"$\)"%X- HQGZFE9:'5B$Q/?>_2O8-K+^*4D
MZ H3B<>(21<$<>JK%AE>HV?1XC9]-$Z#;<#\-JM0@;>S;LKL\@<$WU2V3!IV4==&ULA5/;;J,P$/T5RQ]0 PEM-R)(35?5[L-*51]VGQT8P*K-
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MULXH8@XSYB'YKPB[&(H"W8:[9TB%8V_C3);L&PO=V]R:W-H965TYSB.?'*VL[Z
M!"D+LO!J)D :IB32T.SQ?;H[;#TB /XP&,W%'GGO1Z7>?/"KWN/$6P .E?4*
MU"TG> #.O9 K_#YIGDMZXN5^5G\*W3KW1VK@0?&_K+:=,YM@5$-#!VY?U?@,
M4PO!8:6X"5]4#<8J,5,P$O0CKDR&=8Q_\I\3;9V0381L(?Q(@O%8*-A\I):6
MA58C,CWULTMW#JZ]B%-&SIMQ;0=-'1HOBU.9W:4%.7FA*TPD'B+FC"!.?;5$
MAM?H62SQ-7US3<^CPTVD?X.?7_,WD9]'?II_+;!=-;"=CBA;.Z*(.?>WQ)P:*S?WKF]CEJ8!  "Q P  &0   'AL+W=O&<,V=\
M*2;4KZ8#L.1=R=X<:&?ML&?,5!TH;NYP@-[]:5 K;EVJ6V8&#;P.)"59EB3W
M3''1T[((M6==%CA:*7IXUL2,2G'][P@2IP--Z5)X$6UG?8&5!5MYM5#0&X$]
MT= $0!_!$SF(B;>^PGQU2>_Z@--O 604%FOP-URAD>0T@NYQF^S
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M:4JO&Z]=TUJ_P8JJG7IS]S ,XH_
M765;%S:AI(*:#\*^XO@#IA)"PA*%"4]2#L:BO%(HD?P]CIT*XQC?[).)MDS(
M)D(V$[(8/!J%F-^XY46N<22FY[YWZ<'!M1=QRL1E,Z[LH*E#X45^*;+=+F<7
M+W2'B<13Q*0S@CGU18N,+M&SR6+_6&!]+[".&=?1?[][++"Y%]A$@O6Y%';3.PFZ"4?4D!('96/KYMWY
M%CQEH?0._N&XZ9<@9K3M!H=$UH@5GGZRVE+3NGLX+ ;7UTYV;ZWAT
MX\)B?[V(\]^@^ ]02P,$%     @ W(";2)M+ZN-3 @  *@@  !D   !X;"]W
M;W)K&ULE5;;KJ(P%/T5P@<(;4' ((F73&8>)CDY
M#S//5:N0 Y1IJYSY^^E-U),JC ^VW:RUNO8N=IOWE'WPDA#A?39URY=^*42W
M" *^+TF#^8QVI)5/CI0U6,@E.P6\8P0?-*FI QB&\Z#!5>L7N8Z]L2*G9U%7
M+7EC'C\W#69_UZ2F_=('_C7P7IU*H0)!D0<#[U UI.45;3U&CDM_!19;@!1$
M(WY5I.=W
M@S_-6+5Z[,V3)+$T-P%: AP(PSYN K($="-$+PF1)41?"(%)11=BBP4N%,B4AE3V;/96&U)M.E+?)+ 5.8!QQ%8@?
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M:E8SF>0"  !/"P  &0   'AL+W=O+=
M5X\6>=GJS/BS.% J@]>A'\4J/$AYO(TBL3G0H14W[$A']63'^-!*->3[2!PY
M;;N_U!
MZHFHKJ(Y;ML-=!0=&P-.=ZOP#MTVB&B)4?SNZ%F\NP\T_!-CSWKP<[L*8\U 
M>[J1VJ)5EQ>ZIGVOG=3*?\'T;4T=^/Y^F-]@[9.B@#!W0 (!R1PP
MK^,.P!" EP:D$)"^!:0F-78K)A%-*]NZXNPZ57*N391SH'8O5&*-
M)S>IK:N7.B%%%;UHHPM-8C3WDX9\K5E;#9H5D2)P8B2A:XD$EB@]2X#F:T5C
M%45YG0)?4F";#&PW4>+K!NFE@9V\2RUB&5]"CD93V&U831['UQ?)G)09++(@
MV;F3,@<#%V1N(:T$%1AE7V^EL:HB)==)"B=)80RP,UU 8B5('8W4B6)ES>04
MD_PZ#''"$$A+XJ&Q&A27GN0U8(2S!:^X=**4@((]*%9#4D_R&JO!Y8(7A&(G
MB9G6**D'!40H*Y$O+Y,7(@N.+D)N'BA&I>$A^1
M%6&<(!]/NC@[F9ME*IO.$PJU&40H5SV2,XM0^$"W-#ON,HSRJ68ML/A0/^%3
M@(KEWP+DKGJ(7,_+_22*4_*)-GK7=@R4[TW_)H(-.XW2?N[GV;E'O$MTV_)A
M?JU[1]/.O-G4U;'=TU\MWW>C")Z85$V1Z5UVC$FJT.*;+ P.JKN=!SW=27U;
MJ'MN^ST[D.PXM:]S#UW_!U!+ P04    " #<@)M(M]7SL]4!  #*!   &0  
M 'AL+W=O)X.0'ZH&T.B3LU;M
M<:UUMR-$Y35PJIY$!ZW9*87D5)NEK(CJ)-#"D3@C81!L"*=-B]/$Q=YDFHA>
MLZ:%-XE4SSF5_X[ Q+#'*SP%WINJUC9 TH3,O*+AT*I&M$A"N<>'U2Z++<(!
M?C4EKB]7Q2_^FJ
M->Y/5$$FV)^FT+4Q&V!40$E[IM_%\ O&$IS#7##EOBCOE19\HF#$Z:(D>.GKX?8+,([;/
MCS-$MQE\\!!Y@\_18X'UK<#:"ZS'4U@TZ3''"1-]C\DFS/JQD7C12#P*Q'>,
M3)C-'2,39OO%"+FZ(QQDY7I'H5STK?;_;X[.[7EPM_A+_&C:UG?9129-.EK!
M*Y55TRIT$MK<8'?12B$T&%O!4XQ1;1Z6><&@U':Z-7/I>\TOM.BFEV-^OM+_
M4$L#!!0    ( -R FTBWI*P?L ,  %,2   9    >&PO=V]R:W-H965T5Q^[;=<&%87T_WHCUK;Z&=3M_US?+3V])0D_?:H
MF[+_;$ZZ'?[9FZXI[7#9'9+^U.ER-S5JZ@084TE35FV\7DWWOG7KE3G;NFKU
MMR[JSTU3=O^]ZMIAQO?J\/1CC>2]2J9V^VJ1K=]9=JHT_OG^(4_;80:
MD8GXN]*7_L-Y-(I_,^;'>/'G[CEFHP9=ZZT=0Y3#X5UO=%V/D8:>__5!?_4Y
M-OQX'J)_F88[R'\K>[TQ]3_5SAX'M2R.=GI?GFO[W5R^:C^&= RX-74__4;;
MJG8X7]T_.?#.\ ?@&,#< M=A ^ ;BID'BE$WC^J.TY7K5
MF4O4G\K1;?XTX-T89(@<#8/IAWF:8G;33*U7[VO!\E7R/@:Z8F!B7AW#[Q.;
M$*68F610@,J &.L"I@"PT(4GLL<]B.L>W,T7X21R]CB O X@70#I ]S,0SLQ
MF1N&8U*626#WL8W#9,$$$&8L1>6D7@Y@_2@GQS&?0##(4-F.VP2.%T+(QX(4
M*DBY+.$+ W]5WL2,RV)A?@+&BB)]+"=#Y61^?@264XYY#8R\SVP"0Q"2HXF7
M.[,)>5>@ RD(>>>9 E*Y,*V>$CG 8S&(AS)18M"EB:$^H,X'4&&,&B -T^;*\LFB'"D@:\QH"O
M"P7AX0B 6@1A+1,\ GPM@R!XY"%0J5)H[?4F!4X6.5!&A>^)0%)<\A!;@#8!
MHCR: "\SX,L,"$((A;ND?L,E?#E#1G')03QGN4R77)JYX=%.D)3CDG**2QZ"
MIXY"%(X39UKTP*F"PRPK0(?-<@
M*+N& $&ZX!$"W1>#5QH1=@V$Q2CP78.0O^$1OIX%9=L0H#1C2^4N8%(QPF-6
MX-L&0=DV! B6=G8S=+NS2SZ\PS>Z.TS?-OIH:\ZM=:_P\]WY^\D+3-\ ?N'K
MU:D\Z+_*[E"U??1FK#7-],*_-\;JH7_V.8VCHRYW\T6M]W8\S8;SSGWS&PO=V]R
M:W-H965T]"IF6LFV5V7^__0#421U]L>WEG'//O<)MT7/Q+FL A3X8;>4JJ)7JEF$H
M=S4P(E]X!ZU^!
MY(DQ(OYM@/)^%>!@#+PUQUJ90%@6X<3;-PQ:V? 6"3BL@C5>5MA"+.)W [V\
MVB-C?LOYNSG\W*^"R'@ "CME)(A>SE !I49)9_X[B%YR&N+U?E3_;LO5]K=$
M0L7IGV:O:NTV"M >#N1$U1OO?\!00VH$=YQ*^XMV)ZDX&RD!8N3#K4UKU]X]
MF4<#S4^(!T(\$:8\?D(R$)(+868K=(]D1\R_C9<:+HR(5D:Z
M&*G[9#6%[519G,LDGA?AV0C=8&*+V3@,GA"A5O>FB ,?/;;T^'Z"RB'RQ>,,
MR6V&F2LB&8IX0F!V*^""ZYD32*+' JG703H(X-LJ6XO)71]&3'X?4SG,+$\?
M&\F\1K(A2?Q8(/>V(G^^%7.O@_E7KZS
MG*+3V%W'9G1\BF_,.+8CY2)3%ATYPB\BCDTKT98K/9CL_#APKD [BU[2 -7Z
MPI@.% [*;'.]%VZ$NH/BW7@C3-=2^1]02P,$%     @ W(";2*3J)T!" @  
MBP<  !D   !X;"]W;W)K&ULC97+;J,P&$9?!?$ 
MQ3;WB" U5*-V,5+5Q,ZF9AF'2'*#;4&6@.$/@
MODKD5(FL2N(:)3$JAH'RO8HO"^3.F52*[.P_!O#)/*!65B]RE)Q'#T@
MDSEE,B,3@069;'K EZAJ2HJS![8I=\KD-@(NR!AF2<00T2,G @1.#]VMGG[G
M,/:5GJ H!'#IK9XYF(+OVQ1<')L#/I*?F!V;GGM;*N0)K _* Z6"R!SP%/M>
M+;^,\TU+#D(U4]EFYEMA;@0=ID_?_/TM_P%02P,$%     @ W(";2+U8M(#?
M 0  RP0  !D   !X;"]W;W)K&ULC53;;J,P$/T5
MBP\H8*!L(H*4L*IV'U:J^K#[[,!P46U,;1.Z?[^^$))4--T7;(_/.7/&>)Q-
M7+S*%D"A=T9[N?-:I8:M[\NR!4;D Q^@USLU%XPHO12-+P>%WCGPTC6M,@$_S_R%5W4,>MGQ
M'@FH=]X^W!:)05C [PXF>35'QON1\U>S^%GMO,!8  JE,@I$#RK5*O-!AZJH"8C52]\^@%S"=9AR:FT7U2.
M4G%VIGB(D73;F;:.@'/!+P0ECSKA&@F1!=";"MUSFQ=WXDB>2;X
MA.1 S,\.MQHNC(A61KH8J<_):@I[4GEVRJ,89_[)"-U@L,4<'"9<$+Y67TV!
MO34ZMO0["0J'2#=?9XAN,[C@/G(&-_\A$-\*Q$X@GD\ANC796TSJRG"8,$CP
MYZ#"@3;?'K]VDJPZ268G\1TG,R8*[QB9,3C]8,2_NB0,1&.;1Z*2C[UR/W")
M+OVYQ^:2?8@?=-^Z-KO(Y-E &OA%1-/U$AVYTE?8WK2:*C5+\NR
MH% K,TWU7+AF&ULE99=;YLP&(7_"N*^Q3;8
M0$606J9INYA4]6*[=A(G006]W!\8H.K$Q>O8
MBM[Z;I"+>*?4_B%)Y&K'>BKO^9X-^LZ&BYXJW17;1.X%HVM;U'<) H D/6V'
MN*[LV+.H*WY073NP9Q')0]]3\>>)=?RTB&$\#KRTVYTR TE=)>>Z==NS0;9\
MB 3;+.)'^- @BUCB9\M.\D,[,N:7G+^:SO?U(@;& ^O82AD)JB]'UK"N,TKZ
MR;^]Z/LS3>'']JC^U4Y7VU]2R1K>_6K7:J?=@CA:LPT]=.J%G[XQ/P=L!%>\
MD_8W6AVDXOU8$D<]?7/7=K#7D[N#2U\6+D"^ )T+8#99D/J"])^"Q#FS\_I"
M%:TKP4^1W%/S;\,'C0LCHI4C/1FI<[*:PB955\Y9N0 
M +"X;2@+&LJIQI/%1F$M\W@H!GLTRDFS#CFKLRGO(S0
M'"LD:(6X<"&8L.(90O(437"-YW )2#ECY>1!0[G/IKPM4 37;C%_[99!!^74
MVO61.";#6"_*B42"V%4[$ 3]V&%M",^1@,%,()P?"D1A%VA&+!XR6W4RES!W
MW5+X)0/]6P;/6/TP"P>3?2*8\&:&>$XP#D+ZU5*BJ6!&K@#IG&#"FQH2'PR:
M(9&'@\D_$4P1=E',"<9!J"A(-I7+B)7%C$\ #&]LZ'KFRD?RW<>1@\?]&2CZ^+8
M<*Z8U@'W.(YV^HAY[G1LHTPSUVWA#EVNH_A^/$.>#[+U7U!+ P04    " #<
M@)M(*V(RR&H$  #5&0  &0   'AL+W=O8VDD40%& 61EWWXY]	:7#C
M"TM"?Q^F9[[I$6RNKO[9G*QM@]]E437WX:EMSW=1U.Q.MLR:3^YLJ^Z;@ZO+
MK.T^UL>H.=_U=N,N;9%7]GL=-)>RS.K_OMC"
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M^*2(.N]H"!%BYF(P%_,!'D 1STL>!>1IYC5/7A-_G*E\FZD"S'J.$F-D(;QMB\],%+.Q5/;J6S:6DT+0WC2C]V8-#"
M&'IA8C2#F%"84:.T9L,?IC1C7>:4LTDE:%())$4H2XJ6):67A3,TA>%RY\(P
M;%TKX,^+" ARCL?AA GP(L:H=>4"CP8D&A1Z/RHODH0X$H\#P!JU%,>+-"$.
MCC4'K@UEHC6Z5+A>L58,GH6AK!4O(FR"'&>5 ZQF<:V,(DYGD.,0\H0RAUY$
M0)6G>!R 51-2%0R=0\'HICS
M<;R(,DLXL@)HC E[C, [IUC1.B7>.B4CK!4OHJ\5B8,K.6&M3**$$ ?G4 K"
M6IE$A.U0XJU32L):\:*$4C><: FP)H2SB\1;IUS1.B5.H/1=<:G)>%%"(%WB
M!$J *UF\J?2)<.6%Z4$IA0.'L*L$H)3"B%CU:M&"W>_92FC!9$*8$)
MA;.G *N4<,Y7,3[:>,5H<6)40ADMB%("F0HG1@$,*>'7AL:/F7K%,5/CW4IS
MPFB]**7$P8G1_I8+86XU?FK4*TZ-&N\Q&F!(W^U2MR>!1Q E^L-#]9.7T@\-
M>N:^"P4Q+TH)VZ?&$=,>L70ISBA2I/'@[4W#C1=&V+AT@D]WLF*Z<<1T2JEJ
M"JD2-BZ#-R7#"%4%D6($ @P.J^'@@K#K&(%6U0AZ50W>E(PD5-6+*.W X+ :
M1:FJ@I*\WT6CFWO=_;)4:J6&;M4)ZA[Q=G!![4"8H0H;%G3)57I]UY45(T[-"WO=",[H/AQG3RGJ^W2*;S@9\,'?3,'
M+O>=E&]N\?VP3I!+@0N^-\Z!V>'"MUP(9V3!OZ/G/Z0+O)V/[E]]M3;['=-\
M*\6OYF!JFRQ*P($?V5F85SE\X[&$W!GNI=#^%^S/VLAV#$E R][#V'1^',*3
M L6PZ0 < _ U("6S 5D,R#X$P)"9K^L+,ZPJE1R [IEK=KJRLPD:_'_%-BJ*JP3:!":SP/=9A,UG'.)1^M@@
M&PTZ;T"#038:?*@CB(I01Q#E*4JSQQPRR2$CIYCB!-$FB-*44DP?@_))4#Z"
M%C.@($H)P8O''#K)H2-G.<,)(D(MYQ,=*B9!101A- ,*HHR0)2*/08O[LT0"
M:!%/]%R'@H8NQ&ULC97=;ML@&(9O!?D""MC$/Y5CJ4DU;0>3JAYLQR0AL55L
M/"!Q=_<#/CM+*C?I2?CQ\[[O!\:D')1^,[40%KVWLC/+J+:V?\38;&O1M&Y)WNE6V[=4!^PZ;7@NR!J)8X)27'+FRZJRC#WHJM2':UL.O&BD3FV+==_
M5T*J81G1:)IX;0ZU]1.X*O%9MVM:T9E&=4B+_3)ZHH_KPA,!^-6(P5STD:]]
MH]2;'_S8+2/B2Q!2;*UWX*XYB;60TANYX#^CY_](+[SL3^[?PFI=]1MNQ%K)
MW\W.UJY8$J&=V/.CM*]J^"[&)2R\X59)$W[1]FBL:B=)A%K^#FW3A7: )SD9
M9?.">!3$9P%E-P7)*$@^"#!4%M;US"VO2JT&9'KN7S9]=+CV)LX9N<48MT_!
M4X>=JLI3Q4A>XI,WNF+BP*R B3\GUB.1G1'L"IBM(KZN B:?8M 3>M\@F0RZ
M8)""03(9I-=5 I3!.@"B"6/W8]AL#)MBLKD8@%8 T921^S&+V9C%%)/?B &(
M+M@7=CV=C4FGF.)&#$"4L?A^3#8;DXTQ,;D1 U!>)/=3\NLCQ" E'P_RK3<#
M#"7%%[:LF$TIP('.+F4\9L!D19I\#JT!RAG]>.3QQ5?<\X/XR?6AZ0S:*.LN
MA/#=[I6RPIF0AT6$:G=/GP=2[*WO9JZOX>J"@57]=!&?_PVJ?U!+ P04    
M" #<@)M(;A:A^5H#  "A$   &0   'AL+W=OQX
MD14?#,C/KEYI5VN)],3;UV[/F'#>ZZKI5NY>B,.]YW7K/:N+[HX?6-/_LN5M
M78C^L=UYW:%EQ48:U94'A$1>792-FZ6R[:G-4GX45=FPI];ICG5=M/\>6<5/
M*Y>Z8\-SN=N+H<'+4F^RVY0U:[J2-T[+MBOW@=[GOD0D\;MDI^[LWAG$OW#^
M.CS\W*Q<,FA@%5N+P4717]Y8SJIJ\-3W_%<[_>AS,#R_'[U_E\/MY;\4'^>D'TV,(!X=K7G7RVUD?.\'KT<1UZN)=7V^#H@@')/"J&SA.Y(OPS+UZO )4!+M8%2 =@
MZ$(3\>T>_,L>5..#KP9*R6T'P:6#0#D(M(-/\]!()E;#4,PBB/UPGLHU!7YL
M(29$Q81:#&#=1$J,8L@\D6LO-I,:H3(B+<._[2!&HQ+;1V6)*EAJ!X$A*HJA
M9/@8PH)BLW(25$ZBY818)BOF<62B>2:_9F:%4((JD+1T"*.#$$:(1J A1K U8!68U&N*%Y-Z!?*"<7K"0TL4E=#X8W41;%Y
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MOXN+V=%0 *9JA4!*C'=V(JQ9NY,GY)8>BAW[
M5;2[LNF<%R[Z&ULC55=;]L@%/TKR#^@X*\XB1Q+K:MI>YA4]6%[)C&.
MK8)Q@<3=OQ]?29,--WDQ<'W.X=Q[,2XG+MYD1X@"'XP.D4'V? ""M)OH,5[7,3(0B_C5DTE>S($Q
MO^7\S2Q^-)L(&0^$DITR$E@/1U(32HV2WOG=BW[N:8B7\Y/Z-YNNMK_%DM2<
M_NX;U6FW* (-:?&!JE<^?2<^A]P([CB5]@EV!ZDX.U$BP/"'&_O!CI-[LT2>
M%B8DGI"<"7'V)2'UA/0? G3.;%[/6.&J%'P"%DBO!3(G
MD%J!-(NO30X64[@T' ;-(^KTOV+,VLB"-C(OL IMLG V/*9(\WE0[4!)6J#;
M5O*@E=QMD]XAL CV9'%_3XJ@@^*KGOAB%/,]\94H[N_),FACZ0L1WQ98!0NQ
MNK\0,0I:L.'9<^&/YPDTP'WW*N
MB%9!#WD$.GW#GQ>4M,I,"ST7[LYS"\7'TQ5^_H]4?P%02P,$%     @ W(";
M2%LM/3(" @  F08  !D   !X;"]W;W)K&ULE97+
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M,IW75R10D3,Z CX@56QO(^5,F4AG()/A2G(@S\')Z4T97&UYH7
MHUE0E%:13!(H 68I_&L*,_GL6XK@L4%P;1 :@\ :A->0O=8D)@VC<>\K2NNR
M)H]P%B.T&-'<(K'!".]C&$5I%%]6<42S')'EB!PYV5,@#29\;-:4"2Q/W*7) (^^):4!P+50W
MD7UFCDXS$'0X7P33;53\ U!+ P04    " #<@)M(FJY$[H #  #3$   &0  
M 'AL+W=OSNW.U/T_&]M4>=<_-D]QNVM,OAZ-JC(&QE1[=5&9
MNBUL'35F>?36FVX?_D+?FUI:_BG6W[:-ELVAM-OE+V?VP
M^R\&GQI.UMYDUE4Y7_!@ ,E9 X$&
MXF @V%F#! V2HP=^UD"B@3QZT&<-%!JH4 .-!OH8TIA#[*H[]N8N[_+EHK'[
MJ-WEPXCE5SV\&4AZYJAO2-OW>N1LQFXO%Z_+1*2+^'[email protected]' B+GQF&P:C+!)*LAD2"]#*!(B-02)!1>2K7
M,XDY7PX$'$0"$."+%C9'U8:$"XRL+G@]!LSD0,L,4$&*'$\NXUL$
MR2P-JR[[email protected]*GCQ1].1"D"<%+3/A94:.7&=ZAR#!
M6.B4*2;VI0*W60$,"9TR*DT%;"<%+2'A)71NWD90P+ 5M,J$"I]5!*TRH4.V
M\3IL'W^$_1=/_.;HMLN?S+>\>2KJ-GJP77\*' ]K&VL[T[.P>7^^W)I\?7@H
MS:8;;G5_W[@SMWOH[,Y_0CA\QUC^ U!+ P04    " #<@)M(A!V[N-P"  "Q
M"@  &0   'AL+W=OYAI:J'W3--G 05<(J=IOOMUR](4SEN+L$V_QG_/)X,4Y[9^,H/
ME(K@H^\&O@P/0AP7<JUI[$JV4ET[4"?QH"?^KX9_ZUHQ\[+$(;3PG.[/PBU$%=E/-MMVYX.
MO&5#,-+=,GR$BS4D2J(5?UIZYI_&@8)_8>Q537YMER%0#+2C&Z%<-/+Q3FO:
M=D!%U(^*B?2X",Y@$C0CPX5I4#<,=EY4Z8W,)XMED930+3%&8>FDE&($X]*9:[$O8F
M=>'\9Q66^HZD@,!Y;KVL7#A1
M,^<]0&BQH2U=&E4Y'<@(3<2LDBY%\G64A2EB1?)ZF!4W!,E[$:R
MA?=K]I^->=T@\V+#3(,P'=5Z=N[!'I!J#+^LKN*A-+W5Q4Y7'9D]_-^.^
M'7CPPH1L.W1WL&-,4$D&HB0,#K)_G"<=W0DUS.1X-!V5F0AVG!K$N4NM_@-0
M2P,$%     @ W(";2-""]I&- @  YPL  !D   !X;"]W;W)K&ULE9;?CJ(P%,9?A?   RT@:)!DALEF]V*3R5SL7E>M0@8HVU:9
M??OM/UQU"M8;@?J=C^^T_N+)!T(_6(4Q]S[;IF-KO^*\7P4!VU:X1>R)]+@3
MW^P);1$7C_00L)YBM%-%;1/ ,%P$+:H[O\C5VALMX8S7I/(KW:_\9K$J82(E2_*KQP"[N/1E^
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M*)D6E5H$H]0ARL(:96%^&/"^06K=B]3]3#-K@FSN3,UF9--G:G8BS(@I'9V,'"#BUX@%I@QQ:X< ON@PL>
M(!?8T07N[$([N]"%7>C$+GR$76AG%X[L)@X6$W^U#[ +[>Q"%W;A?7:_2*:#
MV-F%[NQ".[MPEETS., 9=LWD\$6B@P07(UF/#O@GHH>Z8]Z&<#'=J2%L3PC'
MPB)\2GRO$E/W^:'!>RYO4W%/]1RJ'SCIQ['Z/-L7_P!02P,$%     @ W(";
M2-:1*&@Q @  4@<  !D   !X;"]W;W)K&ULE55=
MCZ(P%/TK37_ M 4$-$CB.-GL/FPRF8?=YZI5R!3*M%5F__WV U$W=61?I"WG
MG'O/E7M;]$*^JXHQ#3X;WJHEK+3N%@BI;<4:JIY$QUKS9B]D0[79R@-2G61T
MYT@-1Q'&*6IHW<*R<&>OLBS$4?.Z9:\2J&/34/GGF7'1+R&!YX.W^E!I>X#*
M HV\7=VP5M6B!9+MEW!%%FN26(A#_*I9KZ[6P":_$>+=;G[LEA#;'!AG6VTE
MJ'F_;^38X'6I@0#81H))#T2T(\$.(+
MP94.^J:5E(T0/54?MODX6!2RMBE($QHTR=G*9TE2J+4YGD:8%.5N@&
M$SG,L\?$>#YBD-$/!HE@2"!R E%V/\9Z@#R.$-]&\(>K>+"1/19(;@42+Y ,
M OEMCJW#9-Z&Q\R2#&-\'[;V,/PXDUDPD]F0R3P4(O69>,P!XWF7Y5\,)I/K>4\['$^];,B.&C2'4]T24C0)B$3
M? Z@?[ZM^Z&BL%WBVRB>H!#N(_(?C43"G42FM!()-PFZ&F$-DPZ56 CM!FD;M[MA=#,1,=/,P@J<\&-&\[V
MVBXSLY9^Y/N-%MWY!ANOT?(O4$L#!!0    ( -R FT@Y -HKOP$  $@$   9
M    >&PO=V]R:W-H965TF.F#<9ZWX-@^D%.,-J93BK!C$W5 >M) 6L]27"<$E)@P88QJ2M?>U9U
M)8^&#R,\*Z2/0C#U^PFXG+<)3=E*\N^=9N$^(L (>]<0K,#B=H@',G9!?^%37_+NF(E_%9
M_8OOUKK?,0V-Y#^'UO36+$E0"QT[OJ?Q.U=6ISM>DPB8I8-*/$4U$E L$6P,W7:37+D+Q
M,0U\2OXMD%T+Y$$@BVW0:Y.CQY2AC8"A)264D(]Q3<05=%V2_S"4WS241T/I
M'4-Y7*@HL_2>H8A;K4FQ+MX9PA>'/K$#?&?J,(P:[:2Q]\E :M#'E8)
MZNVS7A(.G7%A:6,5;GI(C)S.[W;Y>=1_ %!+ P04    " #<@)M(H9!^SE<#
M  !,#P  &0   'AL+W=OQ=L\QD1I-U$57NHM.JA/;.)DZ %G&)GL_WW]1PE@WHS?&R9/GN+,
M^E=^H%1X[VW3\:5_$.*X" *^.="VX@_L2#OY9L?ZMA+RL=\'_-C3:JN#VB; 
M89@$;55W?EGHM>>^+-A)-'5'GWN/G]JVZO\^T8:=ES[RAX6?]?X@U$)0%L$8
MMZU;VO&:=5Y/=TO_$2W6.%,0C?A5TS._NO<4^1?&7M7#]^W2#Q4'VM"-4"DJ
M>7FC*]HT*I/<^8]->ME3!5[?#]F_:KF2_DO%Z8HUO^NM.$BVH>]MZ:XZ->(G
M.W^C5D.L$FY8P_6OMSEQP=HAQ/?:ZMU0+2D&R!K0>0"2;)YN 9).A*!.%2ZR@9 *T-J D"QT^80KV0&I[
M()Y/D(%:,IM@HF(K@T$X)W 7V,(.L!BE#G1RD$YNZ8 ]:>D8#"((1V!Q+1T+
MPRD*'>B@$*RO7E:$')H%(5 2&LP&[-S,FHT!A0]A=A^UOJ!<%&%8D;&=^*I[
M[Z<@L"+BHH@X*2*?403;&#+V@Q%Q2!'#18G=O13!IH"2>3=%HW-,VJF%N?DI
M2F$Z*>BH-W\DBYGQRQ'E8I@(=AF4.5BF!:_*I\ *$!11Q< F.8#G;P<@N:-?,!
MY^CF&#XQX<&X'#H9PV:#(P?OLZ 9[[N@7!3!QH5C=S?'L''AQ$51XJ0H^8RB
MT;@Z2T0M3(? [H(S\&AX_JCZO=UQ[T7)N1$I >7
M'6."2BWA0^Q[!SG:C@\-W0EUF\K[W@Q[YD&PXS"[C@-T^0]02P,$%     @ 
MW(";2$A>!'5< P  1 \  !D   !X;"]W;W)K&UL
ME5=-;P-@FYSX'71W8@C;]2;G6CK0JK'
M=A]TQY876QU45P$0$@=U439^OM!C#VV^$"=9E0U_:+WN5-=%^^^>5^*\]*D_
M##R6^X/L!X)\$8QQV[+F35>*QFOY;NG?T=LUI#U$(WZ7_-R]N?=Z\D]"//,4WLD]1J,L+7_&JZC.IF?_:I)6B"'!%8.G$#BD8KHBY*&).BMA7%.$V1HW]@(/YT BO2>1NI13W!!K/
MFRD=C6/232W,S4YI@M-)4$.]VD<6\XW1B5TT@I@#%]QB:.K@EQ<0OJJ&VJ2V
M-L3A;Y-F^-<>3,9AR0%!)<%@"U.V:4':J&"BQ ,.8L:( R7<9F"PF2GKM* I
MV_P ^9P(X$3 P<,M:+XV\+7:X"!^K[CW?A*-7\4&5>Z;E=*V\_ZK:/=ETWE/0JI.2#1[!]72C@\5W\G^-E'WK6GRS(,4QZ%G
M'1OG_#]02P,$%     @ W(";2)F0>],@ @  9@8  !D   !X;"]W;W)K&ULC57;CILP%/P5BP]8P%P3$:2$5=4^5%KM0_OL! ?0
MVIBUG;#]^_H6DK3D\A)?F)DSX^!#,3+^(5J,)?BBI!^5A=E[XV7!#I)T/7[C0!PH1?S/
M!A,VKKS0.VV\=TTK]89?%O[$JSN*>]&Q'G"\7WGK<%DM-,( ?G5X%!=SH+UO
M&?O0BQ_UR@NT!4SP3FH%I(8CKC A6D@5_G2:YY*:>#D_J7\S:97[+1*X8N1W
M5\M6F0T\4.,].A#YSL;OV$5(M.".$6%^P>X@)*,GB@(SH38)+7.3*Y7)%%9<#8",2#]9X=+!>=:1"D#%4:H'!T:.KQ=H+*(;/&X0G1=P6ZN
M(Q?B"8'X6B"V K$5"(-KD[W!9#:&Q811D,+;J.J$@E'^V$PR:R9Q9L*Y,JDU
M8S%Y?AM26SY,[*
M$P*+V2P+)Y#<>4$L)LJS/+[S@CA4&OWWMOH7]Y=BWIB^)L".'7II[]:T.[7.
M-=3W_Y_]C6JIM@.>9&UL[7W9!SSU<@'.EH90S$) "N
M5>Z*4&XN=>?6*:4=#L<\0"0DH8HD: "44@X_^"/F92*Z?\Y?,F>Y*^[%0F56
MV>.I"+N2(N]Z[KGGGOW\IJKJX+#+_W3(7A2'7?UOOYI&LU\%G[>;7?5OO[JM
MZ_TWSYY5J]MLFU:C8I_MX)?KHMRF-?Q9WCRK]F66KJO;+*NWFV?Q>#Q[MDWS
MW:^^^TV5?_>;^KN7Q>JPS79UD.[6P:M=G=59_
M]YMGV(?[)<';8E??5M!GG:V;O[Y-RU&01&$0CZ-9\\>S/?P83_T_>I;PQS?Y
[email protected];_:^6YA^SF[RJRQ3V\2[=9LU6W[\Z>W/Y_8NSCZ^"RX^?+BZ#]Z^#
ML[>O/IZ_. N#\WE_MG;X
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M7G^Z>!F1I\\>/L,L@ QC6&0QR!Y\0;ZIO
MW+/:.23B^2$G,!#AR;?[LKC+J+?3.4LK'!Y.ZB:_VKBDJ&4587!3%I73&C#F
ML#UL"#[K#*CC*FHF\.2\AV B A2!5@+V\C@[M8!WH:@ND_WSB@7V>I0XJ67$ P#
M..9]FJ^#4KYT#+2.I9PK<)FM.B#7,182GYRQA9$"7D[ _ SVYS3&E_V;:I^N
MLG_[%:RZRLJ[[%??!2X2K#-X\G%YNV*' Y;%9H/720+(6<4KP,+ZX=F'M*QW
M65G]*U#6?0XK=T[T0YE=9T#$UT'%Y/+)>#2.X"S+ +#XD'T+M& Q?)W?Y4"XUQ72X.SS*JMH-?!F
M[O"%\&,: >D6'A$XQ;_]]?\0>:F=];P;B!8\IG\,![.9/C$B[14BM>SS3;[%
MMR:0#7&MHFD()[I(DG Q6?)QAG]-6D:O%N[6^]6O1O#+ _'X)K#
M'B[:E(<]7/1=MCMX6*N/L"1B@.!U=&2G<\D(:7:FX)43M?=U8<)2BNF<^_YY
MC[!I6T;;.1!KM][F.Q+ D:*YW"!0DHH>Q],R(\[;9?R.8,3%BR66Z\(%MQY<
M9=<%"%^%X'WINQ/1Q[FK"I:B@0,"U4"L/Z@+X"Z[F57GKA3XN -7< N,)8H0
MP76:2V(">-2%"97.@EPL&?O2RAH'*E1'>&R?C\"ZPGKY?@K0&
MR>GJ4!,3#),,Y8/_&#E:I(Y13<94\%S/D,Z(S\XE$IP;/0RR+](+Z@1$Y"JM
M\I6#7X]?0' ")];]$O6N:9UO#G!2SJI^G^4WMWB$Z1U<=4 .LS.OPB*WS@#/
M<;.T0K.+L\"7//^0AI)=7F>K38I/?7-/ ^!Q3GB/K_&6I=0FR,M^XI0>ABYZ"R= ;,L05L:043Z@C'*^DPQ!AXSRTI117BD9Y56GC'+1D%%>
M#9%1).EPT"B[R79FTUICR%TPM,)=6DOW=?#T"0DI1.)]",/CW%O9M[
M^E=YEG_\"(L/7A?E?5JN'<)"BL93N/-XB;!%@$KJ*ET1?T$4W=S+([J[C_7^
M  ((KI[U3[#AS88?5C@UDYITS7S$,/V7U-7)KCL.LY-7:G3M:WX4Y@SHW=?C
M'%A6:G@$J-OZ^%0^V[T\@1;"9'"#G:=[U%"//S^/>:?K_)SF@ZCJ"^)<*B ?
M@:/<>A2M/5;Y+UEACZ#UI4-+ 6O T%+L9S7$E<)=^&//%AQZ&NEA[2>:O8,]
MDHBZ)_1U**B?83 0W4?&;FQ94@B07WM-,GO_%:GL_4/!V& 8XX=7K!5C@R[EJ10)D3!
M%L='\R)P)>O@ZF'8!*9&(K34$>T'9M(J6 &J$KB'4"NX)[,FT;CM]Q=?2227
M#R0,9.R=+'VTF4V'>>_=4 CV'2N;3'N@?J[MJKC:4IM'Y]2#0 <8=/!KL
MAG$U;%I6'?-IZ^8/>*2P(-\F^C8NCJA[X\^+$E9&4GJ!-[M"&V:&!LN[8G.'
MG>$-A6T")JSPJ!Q1ZD/Z("[DH[JWS0^LX#;8%/#B=DVHI],FX401_!;,FS:W0=UJEY
MJK2H 9HB1^]9WJ0[\REYB50I5TS"\T.5[S+7;\7L%QK/L1SF SH+[&H%G]?J
M93!>ZS^>7:&6?E4[?/;0904@E\![B&S#PX:=&OUEZQ"9E72_WX!8!+ -D<:<[<1#A*H\^%_P\=7Y);L3 5-PFSDH MN0B[N_S5>WLIU^SHP%CH(SGSTW
MY'GO=RB/!,O%:/9KLY=/$&_NWM2\5\BH\+I M -Y( >NHRZP4?89J!T]\L7U
M=;Z2* =# B^0PE?P;-?HDL*+P8V4&?IV-C:BEW2BY\76;R[//T@F$N@)@X:V
MC;\">G5"$,$ EY/:7A\V&UPPC%[A@ADOMOM-5F=DZ@9LS8G%>, 3%F/PAM.'
MT[HXA7^";;J#%T(YHXK;U#CH'+$S.&RO2B0&UC[I^)$)6B$W@"WYE'DVP@NX
M M7AJLK7>5JB.P-J\^B;.MW5<%)VV*F8*0.I]AM<)4 S5RZ2B$*
MD1;\7JX"R:$'^)6&'8$X1;@<-C4#P_J#*WG=8/!L"MBI#?!]K ZP05["!@Z\3-<9\[XAM*P)D7:%TX 7RQB0(_PS
M.?P&O3\!I9L]$ ?@P4%7520HNP"H";HZB#L$D['7(8@J?_OK?[U]_[SZVU__
MF] ?1_VTRY5XPRT^C2Y&U(*Y>AB0G J#3996[-D&/ ^U_.V;,VPX"GY/7\+C
MGF\!R38/YFI2-(66,#_=6NG]J.G/;7YS&_SID-)-P=7AB==BO&Q=;)&HUS#F
MIE@QR>2%K]+M'N9 Z(=(1F& &R0*]WD-;.\N9:4_](/?2GCRQ5\H-MWLT!TA
MN-6*J>JA0E_K$2K44F$Q0'(-IP1W&RY80>_;&@2P\H'-?'[email protected]_
M:R &995?Y\1)XM*#;?Z9GXD4Q2+X4A$,XGLR!A%;BU%\NR_*'T?!^T,I  I;
MN/J!/6>(?!=P(3\#@?US9IK(A*R$VX=%5*L/7Q5WY;% 2!-%FL 
MQ\ITZ&20"]X,EXGF(;&X,J]^/$U)]B1V%PC-CBA: 0LT373(TJV0ZD%#.K"<
MU6'$:4';E102",K Z/ EK6\1S>4&$>C? -5^"@QV]B.3$K3=-'8!2Y6P(Y*D
MZ6A(>"K1#-H!HM46H2WH@&YNZV]A'IBHQGN%I[0^K0@OC./@YQ"1$JX+',6/
M*#\RB 5B>K"(#YM:&7!<9]OBIDSW0)\%O/FYX#4!?++/.&L8"ONODAB00@Y."#_G"Z*F0G5I,B30!L@97![W3FB >"
M-JXRQ*Q*/)?WZ#RQR;,[IF,X4@CB8TXN8Z:(QZ1N4Q5,X7!M>! _9@\*.VC]
M1#;T:Z).G@7#%$3R4U3?  ZM@KHDL!'.W"*#>(_$#1[\&L[OSWS2J.D @5\Z
M6WJPFI0: O/W0)Z0J]2,?ZV(F*!)%@EK4&240X,,'X^<_74%,9)H*6^YOAR:
M\1/"-C(:! ARYB5Z;=P314CYC@"YN;D!$HVK5/(/X <+3D^2T3P 5-[D1/CY
M_C!=\+%)@PR_@
M_X!(Y)=V\,IJGNOE>-M^S,(6B>09$&D&VSBI^4P&/@,[F
M?$OA1L'-D1Z@1-F5RG1EJDRUHJY2XM@(X+NZ/::'E !HT=M]NGL@]YV"1* R
M$T+ WA %"2]Q7>:K<'];4'/%FL.!(U5CV0)IUPVI60B5Q6M$C!B LG7V0?!CRWXK'%FZRO&^B(U=9MK-?
M5I(363U';OZE/ D+1D<="_JM$. LH?K]%XPI1+Y,+>R@3Q,>#7E(EG#"7-*#
M/?@=_$;\E9+J,HQPR@4D?W?^JF(V]&PC_,).Q8KE"RFF-:QH!F0S%%9W-)/@
MB1\/17+GR+>[email protected]:9U^&4#UFOG468UV8 D1!BW7Q X0547\XO=Q]\-A
M1YOF'^B^'&0D#9#=P\868RY>O1@%+\3;E1M!B=C^NBAJO'O$8FZ*"G70, BR
M^+AJ?'-W.V F^C:@MUV4+$6C*$-,(1(HN%*P#/\Z1T3M2J0^FX?PB] >N#@2
M026F&H)PV\:-W0+L"B"^PBA:W!#I"BK XED0C Z:P6@Y7"5%@"F+KRC80[P1I3XY*TC%)F="9R@ =WK"P^LNBT.&WQ'
MD75<>V\A8:T@$<.?0$9 9+0RV+C VK4\?#0A!V=\_3YFR*XA?_H:GZAH?/H?
M])25F7$)=X7%%:R$S0S5(S#9"]X\J8'ZF(?UH90J-F#1LBS8M"*6+I==6$U&!V+I -@5Y5\+Q 1XD3[ IOPNNS
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M)@X[I4_T:V6%]E0_MGG8SUGV&+C#L9BMMV_=$
MC#5T>!;N0H]WR+Q$<"T'6W]"A1SU;5ZR38,4Z8J.BN XOZ^+,C,@N7G_@12N
M@E_]7BC., )'_"#T#\#KPR]*'=-V)(%4O:E)M+E$J^?U ;( 1-P$G[50C0N^
MM^-0@?X>2GQX4-TI<$^BG@S=9!U$4;%25BZH)+9*"-]L1>[>BU([\SYTV*"Q
M)< GI#P@W<'*/NT+NKBDX^%E*7 VH@E"DB[6^?4US(F[N\KJ>SQ">OXMCQ/+
M\=^,?V3EOTEC#WMF;$JQ&(7!8DUL1T5]\6$?\@(-&\HU(!WY?+".N29">H]6ID+8
M(07)5DLC+=86-6(�L*3ROHC5OC\BB4NH!@I+\ )N5:F:T&5UM\ANF.*A2
MN:J*\HJ'D RLOCYZ9%,-3+PO*J^%"UB6"_6:&H$U](TA2&]I7&^A5)0& "0 
M=-H TQWJ']<9^K)@#AK:_WVF5"W2)'&5[3(\=O@,^.O[6IJOA$(4+G91WPZ&
MNU@^K*KG"*IA9R! V'$.$O2E'\B\L]I=V4HR^R:3+#@J"?U+@R.[ARL99$@X
MZ"#(N%OL;@IV$J^$@7Z7,;DT#TW=0Y-$!I7B:]$2*
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MS?4E,SR.DOQ;@V-@#,(SA_%M>5 \(K[W6S(!=#XXW%US-!GO+$6BX8/16?$BUX?=NH$%0&GU)2!;-&=:0UU=)=2S95/1**\L4R>S1]A[6Z=\3QN7
M:H\[J&'#; :6KX^)'SZ%C$ J..B9V7_HD='1?38]-S*05J%"5%^@ ;9Y\
MHG62MYFCG:8X N5C2][3K"Z2KVQ-ICO^P0C-3TTG(!I$1@,\B)=.ZT-Z)6.^
M?8*'7:.FBI;'SF:FI,CO,A/WM&[,&QKV/>%?@K^CD85>SFG5+>DX<@?DI1."=
M\*/RO?X>[1Z), TG'Q$OA)SY758V?'.1]C,9O#GD;*5L.T=Y8&26VJ"S2PZ?
M)$U7-Y-NQ 5:V>F$^B[%3Z>?-^;0IN1*[)^V2)>+N17I#DEI0 "3E,OH2J^)
M78P+J3>F11C7]%3&L1GA8!8(45@ZWP$I06\6.1TPV@=*4")%C9X1#8..^%7Y
M%A-'92H(,HNV9<8XIH;=Y!QV6F>(?"B:*934 H/?$[=&^E6E/,N-1TPB0WYM
M*MC)F31=2_LRVV/)WX<;:1]+9J/-@^MF,'HIDY^FH,SKYP6;$O5-&4HWM^"53@>H \P(MDEHHX<.HKCD"67S]!IIQ4!&&!]]86;K$RQHXXTFQUQR6,C(6<^R[E^AZE%YC?J>
M,]JN(ECLK,SF:!SY3^BR(+\P_2)@[:BOW$@*D"DT-]&:'T*?&;E@Z(!X7%;L
M$JA+"U5PO 2-5][*@5Z!7[-7X)5"(,9-]/ @E948"++L3=
M)>0P(\"$!6.3HPV"5L0IO0RZUW9"-GXX-.1H#F+_3WA
MJX8VL:MENX-CAW;R]6!58]C0;U?T,/0YFD:S>#16^D>"-ER: W%S3\:CF?J)
MK$.5)XL2"QQ6IF3I8%S:;UGJ)HA3Z=V.<4-KL[,RLZ5U%"8L:#'J 9B9>RQ6XN"T/LVY]19G*7AK
MW+B2GXD(B4UME&>YO-N-&2D 0"G@E9<$':3"ND=HRT]8A<&)!)Y^ ZO!KF8E
M@F97ZO:&-.I!- \3^.M),)\L@M;\XT$4+\+E9!HDXW"\F 7/:?7LT<[4E:+&
MM&XB"L?+91"'R70P@J?!W_[ZOX-W)(PS:[ 2ST@T780SV% "PX['
MP7NV8&.*A"1,XHCZG;71!( >YL0=S^&3&.!2G$=&:IG,)LDY:#S$R$:I;J8A"U*"46"[email protected];\=A"SV-=^SUI
M,26RG.G[\:8C ?T:>5CB]L[-U/UXL[LXAIYIC,':+JK4OJW=:S@\Q;5-JI6;
MHW/?M5K$S+$"5[8QB3N!S&NCLE2>B2$_JB'/S+0ML)X_$.?YZ(X,T6\<0OXD
MB&?3<#:;,96 /R?+P'@>X1,41\LP22;PD3,\PB[G\S":+)$JTJ;GL(LE$-\V
M;!_.XCB(8^X=AS&\D_$4>HH?XB@RM@3(-4T6, "L D\UG,'/R6(T;G*0J+,PXHG82:&VW@US
MQI^/U;$P5WM;W:08-4?U+W34HFD&()##*J^\9Y4D^.Y/YM- Y*26_A##AF@<
MWQ(O2F.IG@'SQC4CZN^]3.-P/ILC)BRG3@JK9KD4SCM\YLWWT]6VG>CZ2W9T
MCM55P^6GH+]#Z*FB4VIIS!P"NQPNQW@?IG"M!-_H-H-#&,^6> @+N(YM&7VX
M[32,EG!EPRG02-52ZFF,=M$BG,#,P+#R'E.2AGCI23Q7A"6:
M).$XBNE3!%0Y&4!0+ I"]B@?I-CB:T/Y[T5O/)>X9=%/4&J:(CR6()$T\Z][
M!VCN\21Z"F<%Y!G C)^':D2FH=(\:J]E%=-/*E;M)V0KVII&5ZDN>[ B-(ZV
MH[GIL*[JX*5B9SO8/6Z)__D[$8TAMC9X2)_W!8/P#"1 UI?KGSXJ.(M&KR6%ID9)_J$F8'0V>+,9C0W4)NWRRF(XM92;27GYRE8T&MZGT#AT'08HQ
M0Y]O*/FTX4^"3VV#E&=,Y*]EZ!NVDWY7 %[,@L0.]&2@P3LMG9M6A126D/(T
M7%L'PH972KE2#ELC.X!MK1P"9!$VJ XN-#4*QB'KZW*5<)QN,GE
M[XRP;;2<,!2X[)D67/P**'!QZ-D; Y>-#6W*Z.@W5%0
M:$VJ5A-RTH:;+C:4W$5#'8W!(%9;NY*R&(ED$H'RE1,82"
M.$Y1K2RS5Q';FY6K7.0#8[Y192C$-9/[1!D#HS0KSQ:6@!R3XG4M*@\JS1F$T)WXC.3-6@:CR8_
M+S[/;3KQ>Z'(]N&NTDL0X*[SSY[MPP_Q:+E\%(ZV/M*2U.95"Q[;#S/GP[!P
MCN+_'_]&CR0M=!'T@CGT=\2AKX&PP3L:]2-K@[9"XX.?Z7<0%DT9#L:*E%)L
MH9"H2OX$L)@F!;#&9]]YK").3A+Z51,YAU$Q?L8T+5HF"4?6;5F\E/RPW11Y
M8'2N3K4?,Z)%,DH6S;>+PHY%J=PJV^:G'%FQ<;@9:\G$BA84O4F>7SA&WD=*@.3=M!XR+/-FG.FU9Q@&09)1E/[3AQU]LG?^^S9+5LE44Y22Y;AW+2(W
MK=@BEU7S%5@LZ168C29+![JN#S
MN0W_ V$J*6_>\D')1&5:=,1].8@LK/
M!^T.0T98[)NM.3&K[WB;"B T?*&.#U&.&CP)IE$XCA(.XXJB63B+9^RO%4W"
M2;Q@MF RFX3Q(F)I*IE,PN5XPBE7V-MKMD 5S\14B C%"PG49$K0>VKNN)&I
MB)TM)3?6E+KU;>X0ZS$V-*]6!_(D%[&A2O'S6KV2%)31)<-<\ZFVJFZ;2LR<
MSH$/O!H"_2@$: [email protected]!'HP^EDSI"/PLDD9K@OEHD)<_13T1IIUEN)9+5F
M&B?2H4IM"*7F48FX^2!2"35.OXH^I2JYR/5U3@Y)=S*QT@W_@2H,-"\(Q\1F
MCDF*V93YE]CN7S_LV8=!9U$,!?]2<6B9S-2U$]>86:I5IF(W.!\8A_(W<3(#)/NK6\K+;+95!E'4AMZ3UDJN+O0M1S^/S26YL)$K8TZZ
MH27CQ\)9LC4*KJE9-9>GTHNP31.M&@P#I26*BPSW[ F3ZW1T*;F*H[^NY\ X
MK$?ZL1M1$\V$S%)^%+>TB2"2.*+G(;\ 0(12=+(G)K\BK/RBRZB=J$M1: 4_
M(R=&K_@V_1'_EB7N&_HN;*G41F%OA,
ML6)V&C<:-^1WIL?7")8.#MJ!(6&U8NS4>+6;!K^'KDSDZ9%P@]S5[%DV?T;Q3LVD$
M3%UPLIB-9;OYLVC^C-^\\=1J&$^"DRB,YYZF\31<+&/1\G]"V\GTU\%DM%P$
M)W$XC9>RQ_19](P>T9\+Y/W&N)\"ZM$D'@1V\@'JASJ:O)L GP';T0;P:#IW
M 'YL_A^1D=].6,04L<=TCWQY!_=%OAJ& T"EO)H>K&\-X!L?S19PY5:G9\H3\FMX0L?T!%Z6#CM8B)TAEI=98OLB1GI\A7=B"V?F%M#M5';_20;EVV8"6F*;^5_$/"!;^,]3
M\:6^E&9GQCURPZ%/C(.B8Q0N)XG2\1I,DP@Y I@JB=E1#AADI7$Z?,S2'YG5
MZM><08HY&$S-9G-M?FXW%.[&UNB<6DD4#!6)CHV!^U>K$SU5(MZ2F5Z.Q%UE
M&YD.1RE&](K<8B 45O49Y0].S23TV)CJS.+C"BHP?&KDGY+*Y59 DOI=LJ0P
M%8A5^8TP*E@3P4 4U292YQ7.47+C4Q(['GRSL(>D^\Z0XKSG/Y1TEW??GNZQ9Z,28"%FD1.@%! E._6735'0?:5,WQZBCLV@&^Y$LC$D*:@#'P
MM!EP0XDHZU, V*GPWJ:LT)=OR9VK$+,C6MZ4Z=:!A1NXA%ACOG.XR,0^KU <02157.A'D8]_212R;AYL:S9@=I
M/\8_Z*IQE+N@QF7*7%2N.F%137X5R$8/.%0\9%0)4A2*#(GEDC_HHI(JF32\
MP:F@^%4F,B +KHQSQZ-"0O9BLR6M-#V ]*$M4;0V@9YB442F%2=C!7!N0<1E
MOYCJ6XFR>R/')F49A9^D-I'P#5I9WQ2E-J;P&$0IOS43G(JU?*LQPJA:^ZT0
M::FS*-;-[4V-9B-=->=H0RRS>HQ,H41C=[$E&7"J4$R2?<2_=@GX3
M[N9YDF6?7B3M+65QUQBZ"30C
MP-;X&=U2V8!O+8;F-Q)2[W1*;&Y0-$O$"J>:1A]-@?TLQ*6$BX QS8O)/!^D
M'8$0 TXG4;ILA'X,DE6)D
MS@K>PJ*KMU5Y,AC."UCIN8=I0PR3JJT2!<.'+0?[3S?_O^.85\RB-!YR?S,_YF:!7879_>
M/&<+3>8G1=%1E(?:+U->2*!*2Y)/&C'#&I94OGWN>X<)?N4$V"A2D2 FUN5
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MEITHV9,D<*)@A&W/M+VTQ%GI6D'I1KCL+*OYI&<3)QL$)NLTQT(I&X
M\2H<*!6"BDP23O!-SV6B)RI[%;GDJA@' 4RFNWEEKB152$:4IC/FTEZH\BXG
M^3@*Y]%X%*FWD/.!9NOV)_ )Q;4;=6ODW&VN.]W3SZ*E(:(/FGZZ'!M='"/B
M!UC"!>F#J0 QZV^:CK15!V0 G@YA:E"-G'2EL[^OL@%'S(/:]$QN7-H65M DN^-&>+4B3JD=> 
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M7E9F/^VF9"::_OERBRG_9#+; ^(FX7@6\XP87"7>G(C&]$XE<[7N,;S!Y)LHNHI,Q&H#4;>R@7WFRQH'B\R6QB
M1 B:0[0X2TD/!DXD3BEL>7_)(IPO)O@!L'^\=,]467\N#!G7+/@H2]"?R$]/
MFX,\)WT>#&%6GQJ4T-#;DV+3AACJ.BN#2_>3@Q;-BDKY\3NUP5%+90WNU'O3
MA?'0@PFKN7*1:13KJ,VIK.HHC$AB6E1*I2L^)JU:4Y5LE#7_L3MV<[V=BSIM
MGW;I84UV)2W\XSLZZ&CZ!OFR4]* V&-(L0@3/7C=$*G0*B-#)7DM__BU8M1\$)5P#,2VU-%NZ+&,'DKR;,*6B4>GFM1]FQ ;QO=
M^J@&%4I?A@P$R_"OLU%D;JC'E'=!C?CE5"D;6C=N[!9@3U#&74L'LA9D^Z)C
ME_[!N#I#SR9U#H 'H0S9*/;YCMV3K\F  #O8D$3O+OJUFB%[*"H!F6D5R
M^3PU"B". GE)6D81VD.YP!QK*@.]7PG?>:GZ
MYKZB!JQ4':D")UBN%:T-W[)R5S873B18* 9V?%>4RMW&ZO6%!R8*>Y+S0;KV
MWD+"6D$B^@=4I74*4<2KS'0UO;4\?$X#RM>/[5^H# :A?PN"T5IHY6
M5364A5!I\R3UF\V,\CI[^GT87IBK6
M>&KH+W2$C<)@H8D-JIX8U>1Z5"G=T*[_K6J2P&D\IIHV')^DA!5#
M6J;.UU,;*$NE.->'E3P-[?IG=Z':V$;]*=9OBN0*%1>@-JQ$^!"8;HM&3C%C
M4-@R%7&A@T=FB+5=\9WCM===V;',O"[N\T-CI/G2!83=,*"^S4M=IEC39>%4WRC;W'3C
M1/+U7CB#,E/]O?:;EC\TC2/\7K8=26 D -"^HL)PYXMD(9_":^&WG%8RS*&W
M/FV%:7?*FE)]IQ+W).HI11(YRA2DY5:J)-(A#.72B B>
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MC,FE>6CJ'IHD,J@4GVREMR91UWK]1':N@8J1UII.+S,C],3P*934+PSU"
M\QFR+3N>&E9IUDJ43GF:+3:*
MV:>!U-]9)7%E5RH;L<_%=92N9GBZ-T7!YG*16YV?5KD^TFBIXLODLF;$:@MV
M1M00RD?9*)2&^ZJ* 6
MUWE9U0W]B_2Y$VHZIU!S;SG8.;!?!<9.2&6B3/J GG&Z!(=1XE)X &T:BQY>
M.%8F.1A:.Y9@(-/['EUTNJMB^S%R[LCLA@GY" ,UP!7U59E4S3K#BJ##$TH(
M56,-JBZ5;"S'YF%P#6G%+VI#]N#R3B2("2\H
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MF9&-L$14LU!)6C?F#57](YG6@'Y?BU(\ NJ'&WCH^\ .N*N5W"[R2(R-E6VUH\KL2PNJ3T-ATB)J7[E\P"87B<,>T^F70C+C(X13JAODOQTQD:C#FTH5TZB:GDIX);VKJ38-4.OU2,F
MD2&_-C7[. F^K<)0KC*32)T& ((-L8*--@^NF\'HI4Q^FH)RM)\?Z* B]E,N
M7O!<\E5?]14WN?=9Z^69$??^ADJ8CLPOF0I4!Y@7:)%4?XEZ&^J:(S"I_JEY
M3,HTH5S%I3BHP\\U3Z^15@QDQ(/2%V: F&!!&V\T^S!1]$GP8_9@NRET746P.*^83A+^)_2]D%^8#AY4L$2Z Q(
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M',=4H+B O$2 ;$($='>KY19SCQ2&RFGC)NZ WW=HDIHL-H$7FKQ)],PV2!
M&:I/)C-T=>^M#'\RQ10"*D;313B##24P[%A4LA9%G\,DCJC?
MF3J=O;Q;G%,-H#>+P_$80\UY@*Z+Z60S>2-2'0-_+%9SKHO%G^DGV4A1X+O#
M:B]FJ7E_@H*CI;>1
MN<\%M%F.''?I7O .(K!''])Y[[G\!*6:E7.;<[Q:AC1KT@Q)'2U3USB8_%$-
M:17_AO7\@9[I1W>4Z1V:9.))$,^FX6PV8Z3 '#K+L@=48#Z>!;-D%&.Y
M^!E_'@?3\3RL<4H(;I+ONI:!2%LR0.I@G,
M!)^G"_H\!QH>QM-)D"0 _;AC6_-P'E&\WSR,K;K7@%S39 $#C&(ZU7 &/R>+
MD4M*=:P#$G+S%AHS]3 YC919;(^N+5IC+OOG>XTM]->.-3ML92/0/FC;M*LI7W1H[#
M^0PKAH7+ZI3M0""
M#TN@+U:, Z(SZ<_0=.I)SL&AAYCM2167FR3A.*+ L4D$)#OIH#9GC,>=[&IIE ,T@0HND75_;\N+;2I.F 4VJ/AZLL(&C;2)N
M%:BK>A#1PX;>SG\G(C;$B@*O_G)&F1+A4\0Y$W4_5 M,X6SHOI$&BFB5#\?0N
M5*W,#ZK^)[7[J(J =C-+__]5&NVZ6:VO0#>I_^Z?IS+HT:7IV@A63T=3JCYY
M8U9(^S[;K(?@["_U[WZI?_=/5/^NB?)<;,M.UGMLJED)9BI_2?7Z2ZK77U*]VDE:;"GE,@/QS
M9@<=\?4M)AZ4$/]T\3(X>>*@V&_MDN!6/B8CBU&SVW(!0OROG2=&^-6B!1%3
M:E'>&R2E(I&)#,U!/_ OR8&KMG\:B&TQ(-ZV $+Y0Y\;OM#.XATEUSNR0[>G
M8O8E&G%*3F3IIKY=X;-^61ZXCNH9O ^P.TJOA80H#/ =IL?K:? 70F&#^LM+
M9UM*P?$?9Z:SM)<'U 7;I9?6_^, R;I7I3'8=VY^LI1RIFLQ6O=
MO3\J=/D5QL4?A2XM/NT*<9Q%M7IW.Y@T%B$^,_&2. UFH@&T%&]-/ $*\>""
MO=M;O-E\,73/NF\DJ"*^ET06GW\FWV>Y89^_6
M ^[%@+F$_\P+?N!ZN5TLVP$TO W%T3>_C^.>E<3S@3-,DV%+5NT6/0-&D7_)
M/A?XUBLVZ<'?F7^.V5"XRH9?\5Y8SN5'WX:?P-NZ4R4*6%]GIT@;!\3X=+YK
M33>DWI@?U]7YBQW!.]?T!0[A1[F GP9#G;T?@1\MOM?>Q[>W5:>#8&MCU_W:
MM;KV^E^[*9N/=\#N\-[RV@U"1L0C#_-K7NC!3L?>R@M'>AU[O6UMY&3OW:/W
MQ)E\%& ='"7; ?I4ANR]%)M;0^J26$[S,/F.8LI=\.%;H[&J$H1:DG7#'6REI
M>N*0$$.OQ4L;#P:2\G5\(6^Q%9OH)4CH)#-B\O'HM'ES@2^PQN,
MHJDCINM)9*8B:<1!U6>-&1OQ55)!]GGA,)K,KK2RBE+I9\=PD'N/I^8J1^"[
M2Y\G'4NWH1A-I\=!$49W]1>$,IH&AHAO6I
M4_GQ'?PL)W(/>UP)%^-N*'_TB/F><3UG[IT
M\2V#[VON)_*B4.\\1^\G'DW<>5H?3UV>>)4"Z?6\N]%H[,*G=3PTB>0B1V66
M=:B-QZ.XZZ*W!Q?])7CKORCCT6+NKG0\BN*N=Z]S(O\E&H^2E@?CU(C,48[I
MBG%\A-2BPC=:IAL:P_(H9K4G& 08*F(V!OBJ?]'T#FMFN",I?]>N1F<^Z<7G
MQ/T7"AIPCK81D^".M,X^.Q<$0P$.EYTX:D0^(;
M .[^T^B*./BJ$_5M\,L.[?WU=27*2SO@-?[;OO
MOI0>CWQ7\3/8W=XGQCH;(ZL"6N
MV6FF<]RA4Q _*4$_^"X=JK;WNT [;#L,WE^>B-HU+0Y'S
M013_L'&YM'>J-MBU\JHGOYAG_GE:(@?.8HOZ+U$J
M#.N3H"_"0U:;+J6P3T>]R/G]T _$*-7@5P$$2V4T6'B-!FW1#W\)I.L!HOS9
M&@4AM+,3\%[YC>DOS U)Y9YG _%XC+D'AAV%\ E,#_5M@0'2CJSK-KV#"Z@*
M/=Y@M$4G)K[':DYHZ.\=F1.,.H3BEFN@8:ZR(S'U[/*M,UK*[)NL-R7$/QY>
MNYT>.=%',QN52'GK!9?*H>TY-UAM.P,NI28]OAT#I,[/-S*!\)3]F"TL,@@\
MNHB;[3YPY'MPAI>JTYKC]0,*J)[(%Q']O@@JZ_%L:WS:<6HR6H>=OZW$B2+)
MYPEW=/V&1(Q1V^\ROJCE9R.JJ*6%O30$;O^BAD54/0((]D5HA45W,PF2[E8&
M9+H;=@*H9XX!T5:G;6;-M#;Y[./9-U-(,U*(5Z&.QGI$%[CT(CKC2SK'7]+9
M434>!6:.J2GMD)I!1HOC0MX\DW0:JG50B\/KZ.@3*J0A//ZN,AR9S9VQY T=MUUV!*GKF>V^C@O?:[_?<&3?BDJ"-"'%RVY)@5M"RZ$4/B
MPP)?Y,1/B ;#'?*';-_RG3_^ $Q7]\?!O^%>WPK_@T^F&N) ?S1UZ' A]T[A
MK-GR7?>(@;;CNMO XY+NT-X.#W6'G/H&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " #<@)M(G3O\A3X#  #3#0  $           
M    @ $W!0  9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( -R FT@57U,C
M/@$  &D#   1              "  :,(  !D;V-0&UL4$L! A0#%     @ W(";2.#-J8MF @  9@P 
M  T              ( !41   'AL+W-T>6QE$0  #P              @ 'B$@  >&PO=V]R:V)O;VLN
M>&UL4$L! A0#%     @ W(";2-. =T3$ @  JPL  !@              ( !
MEQ<  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ 
MW(";2%XG',R,!0  A2   !@              ( !-B,  'AL+W=O&PO=V]R
M:W-H965T&UL4$L! A0#%     @ W(";2"EF;BX:!@  G"0 
M !@              ( !]C$  'AL+W=O"+H0$  +$#   8              "  48X  !X
M;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0#%     @ W(";2$5I  *C 0  L0,  !D              ( !
M]SL  'AL+W=OO!U?*0!  "Q P  &0              @ '1/0  >&PO=V]R:W-H965T&UL4$L! A0#%   
M  @ W(";2!4W:;JB 0  KP,  !D              ( !B$$  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ W(";2,C1=>6D 0  L0,  !D     
M         ( !M$P  'AL+W=O&PO=V]R
M:W-H965T&UL
M4$L! A0#%     @ W(";2#\F'I>R 0  %@0  !D              ( !B5( 
M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ 
MW(";2+0[@S'! 0  >P0  !D              ( !4E@  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ W(";2$EV"9ZY 0  &00  !D         
M     ( !M6,  'AL+W=O&PO=V]R:W-H
M965T&UL4$L!
M A0#%     @ W(";2+?5\[/5 0  R@0  !D              ( !2FL  'AL
M+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ W(";
M2*3J)T!" @  BP<  !D              ( !E',  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ W(";2"MB,LAJ!   U1D 
M !D              ( ! 7L  'AL+W=O&PO=V]R:W-H965TF!  !X;"]W;W)K&UL4$L! A0#%     @ W(";2&X6H?E: P  H1   !D             
M ( !*(0  'AL+W=O&PO=V]R:W-H965T
M&UL4$L! A0#
M%     @ W(";2)JN1.Z  P  TQ   !D              ( !*8P  'AL+W=O
M&PO=V]R:W-H965T&UL4$L! A0#%     @ W(";2-:1
M*&@Q @  4@<  !D              ( !MY4  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ W(";2$A>!'5< P  1 \  !D 
M             ( !HYT  'AL+W=O&PO
M=V]R:W-H965T



/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em; 
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}



  3.4.0.3
  
  html
  167
  250
  1
  true
  50
  0
  false
  4
  
    
      false
      false
      R1.htm
      0001000 - Document - Document and Entity Information
      Sheet
      http://www.htareit.com/role/DocumentAndEntityInformation
      Document and Entity Information
      Cover
      1
    
    
      false
      false
      R2.htm
      1001000 - Statement - Condensed Consolidated Balance Sheets (Unaudited)
      Sheet
      http://www.htareit.com/role/CondensedConsolidatedBalanceSheetsUnaudited
      Condensed Consolidated Balance Sheets (Unaudited)
      Statements
      2
    
    
      false
      false
      R3.htm
      1001501 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)
      Sheet
      http://www.htareit.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical
      Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)
      Statements
      3
    
    
      false
      false
      R4.htm
      1002000 - Statement - Condensed Consolidated Statements of Operations (Unaudited)
      Sheet
      http://www.htareit.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited
      Condensed Consolidated Statements of Operations (Unaudited)
      Statements
      4
    
    
      false
      false
      R5.htm
      1004000 - Statement - Condensed Consolidated Statements of Equity (Unaudited)
      Sheet
      http://www.htareit.com/role/CondensedConsolidatedStatementsOfEquityUnaudited
      Condensed Consolidated Statements of Equity (Unaudited)
      Statements
      5
    
    
      false
      false
      R6.htm
      1006000 - Statement - Condensed Consolidated Statements of Changes In Partners' Capital (Unaudited)
      Sheet
      http://www.htareit.com/role/CondensedConsolidatedStatementsOfChangesInPartnersCapitalUnaudited
      Condensed Consolidated Statements of Changes In Partners' Capital (Unaudited)
      Statements
      6
    
    
      false
      false
      R7.htm
      1007000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)
      Sheet
      http://www.htareit.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited
      Condensed Consolidated Statements of Cash Flows (Unaudited)
      Statements
      7
    
    
      false
      false
      R8.htm
      2101100 - Disclosure - Organization and Description of Business
      Sheet
      http://www.htareit.com/role/OrganizationAndDescriptionOfBusiness
      Organization and Description of Business
      Notes
      8
    
    
      false
      false
      R9.htm
      2102100 - Disclosure - Summary of Significant Accounting Policies
      Sheet
      http://www.htareit.com/role/SummaryOfSignificantAccountingPolicies
      Summary of Significant Accounting Policies
      Notes
      9
    
    
      false
      false
      R10.htm
      2103100 - Disclosure - Investments in Real Estate
      Sheet
      http://www.htareit.com/role/InvestmentsInRealEstate
      Investments in Real Estate
      Notes
      10
    
    
      false
      false
      R11.htm
      2105100 - Disclosure - Intangible Assets and Liabilities
      Sheet
      http://www.htareit.com/role/IntangibleAssetsAndLiabilities
      Intangible Assets and Liabilities
      Notes
      11
    
    
      false
      false
      R12.htm
      2106100 - Disclosure - Receivables and Other Assets
      Sheet
      http://www.htareit.com/role/ReceivablesAndOtherAssets
      Receivables and Other Assets
      Notes
      12
    
    
      false
      false
      R13.htm
      2107100 - Disclosure - Debt
      Sheet
      http://www.htareit.com/role/Debt
      Debt
      Notes
      13
    
    
      false
      false
      R14.htm
      2108100 - Disclosure - Derivative Financial Instruments
      Sheet
      http://www.htareit.com/role/DerivativeFinancialInstruments
      Derivative Financial Instruments
      Notes
      14
    
    
      false
      false
      R15.htm
      2110100 - Disclosure - Stockholders' Equity and Partners' Capital
      Sheet
      http://www.htareit.com/role/StockholdersEquityAndPartnersCapital
      Stockholders' Equity and Partners' Capital
      Notes
      15
    
    
      false
      false
      R16.htm
      2111100 - Disclosure - Fair Value of Financial Instruments
      Sheet
      http://www.htareit.com/role/FairValueOfFinancialInstruments
      Fair Value of Financial Instruments
      Notes
      16
    
    
      false
      false
      R17.htm
      2112100 - Disclosure - Per Share Data of HTA
      Sheet
      http://www.htareit.com/role/PerShareDataOfHta
      Per Share Data of HTA
      Notes
      17
    
    
      false
      false
      R18.htm
      2113100 - Disclosure - Per Unit Data of HTALP
      Sheet
      http://www.htareit.com/role/PerUnitDataOfHtalp
      Per Unit Data of HTALP
      Notes
      18
    
    
      false
      false
      R19.htm
      2114100 - Disclosure - Supplemental Cash Flow Information
      Sheet
      http://www.htareit.com/role/SupplementalCashFlowInformation
      Supplemental Cash Flow Information
      Notes
      19
    
    
      false
      false
      R20.htm
      2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)
      Sheet
      http://www.htareit.com/role/SummaryOfSignificantAccountingPoliciesPolicies
      Summary of Significant Accounting Policies (Policies)
      Policies
      http://www.htareit.com/role/SummaryOfSignificantAccountingPolicies
      20
    
    
      false
      false
      R21.htm
      2303301 - Disclosure - Investments in Real Estate (Tables)
      Sheet
      http://www.htareit.com/role/InvestmentsInRealEstateTables
      Investments in Real Estate (Tables)
      Tables
      http://www.htareit.com/role/InvestmentsInRealEstate
      21
    
    
      false
      false
      R22.htm
      2305301 - Disclosure - Intangible Assets and Liabilities (Tables)
      Sheet
      http://www.htareit.com/role/IntangibleAssetsAndLiabilitiesTables
      Intangible Assets and Liabilities (Tables)
      Tables
      http://www.htareit.com/role/IntangibleAssetsAndLiabilities
      22
    
    
      false
      false
      R23.htm
      2306301 - Disclosure - Receivables and Other Assets (Tables)
      Sheet
      http://www.htareit.com/role/ReceivablesAndOtherAssetsTables
      Receivables and Other Assets (Tables)
      Tables
      http://www.htareit.com/role/ReceivablesAndOtherAssets
      23
    
    
      false
      false
      R24.htm
      2307301 - Disclosure - Debt (Tables)
      Sheet
      http://www.htareit.com/role/DebtTables
      Debt (Tables)
      Tables
      http://www.htareit.com/role/Debt
      24
    
    
      false
      false
      R25.htm
      2308301 - Disclosure - Derivative Financial Instruments (Tables)
      Sheet
      http://www.htareit.com/role/DerivativeFinancialInstrumentsTables
      Derivative Financial Instruments (Tables)
      Tables
      http://www.htareit.com/role/DerivativeFinancialInstruments
      25
    
    
      false
      false
      R26.htm
      2310301 - Disclosure - Stockholders' Equity and Partners' Capital (Tables)
      Sheet
      http://www.htareit.com/role/StockholdersEquityAndPartnersCapitalTables
      Stockholders' Equity and Partners' Capital (Tables)
      Tables
      http://www.htareit.com/role/StockholdersEquityAndPartnersCapital
      26
    
    
      false
      false
      R27.htm
      2311301 - Disclosure - Fair Value of Financial Instruments (Tables)
      Sheet
      http://www.htareit.com/role/FairValueOfFinancialInstrumentsTables
      Fair Value of Financial Instruments (Tables)
      Tables
      http://www.htareit.com/role/FairValueOfFinancialInstruments
      27
    
    
      false
      false
      R28.htm
      2312301 - Disclosure - Per Share Data of HTA (Tables)
      Sheet
      http://www.htareit.com/role/PerShareDataOfHtaTables
      Per Share Data of HTA (Tables)
      Tables
      http://www.htareit.com/role/PerShareDataOfHta
      28
    
    
      false
      false
      R29.htm
      2313301 - Disclosure - Per Unit Data of HTALP (Tables)
      Sheet
      http://www.htareit.com/role/PerUnitDataOfHtalpTables
      Per Unit Data of HTALP (Tables)
      Tables
      http://www.htareit.com/role/PerUnitDataOfHtalp
      29
    
    
      false
      false
      R30.htm
      2314301 - Disclosure - Supplemental Cash Flow Information (Tables)
      Sheet
      http://www.htareit.com/role/SupplementalCashFlowInformationTables
      Supplemental Cash Flow Information (Tables)
      Tables
      http://www.htareit.com/role/SupplementalCashFlowInformation
      30
    
    
      false
      false
      R31.htm
      2401401 - Disclosure - Organization and Description of Business (Details)
      Sheet
      http://www.htareit.com/role/OrganizationAndDescriptionOfBusinessDetails
      Organization and Description of Business (Details)
      Details
      http://www.htareit.com/role/OrganizationAndDescriptionOfBusiness
      31
    
    
      false
      false
      R32.htm
      2402402 - Disclosure - Summary of Significant Accounting Policies (Details)
      Sheet
      http://www.htareit.com/role/SummaryOfSignificantAccountingPoliciesDetails
      Summary of Significant Accounting Policies (Details)
      Details
      http://www.htareit.com/role/SummaryOfSignificantAccountingPoliciesPolicies
      32
    
    
      false
      false
      R33.htm
      2403402 - Disclosure - Investments in Real Estate - Acquisitions (Details)
      Sheet
      http://www.htareit.com/role/InvestmentsInRealEstateAcquisitionsDetails
      Investments in Real Estate - Acquisitions (Details)
      Details
      33
    
    
      false
      false
      R34.htm
      2403403 - Disclosure - Investments in Real Estate - Weighted Average Lives (Details)
      Sheet
      http://www.htareit.com/role/InvestmentsInRealEstateWeightedAverageLivesDetails
      Investments in Real Estate - Weighted Average Lives (Details)
      Details
      34
    
    
      false
      false
      R35.htm
      2405402 - Disclosure - Intangible Assets and Liabilities - Summary of Intangible Assets and Liabilities (Details)
      Sheet
      http://www.htareit.com/role/IntangibleAssetsAndLiabilitiesSummaryOfIntangibleAssetsAndLiabilitiesDetails
      Intangible Assets and Liabilities - Summary of Intangible Assets and Liabilities (Details)
      Details
      35
    
    
      false
      false
      R36.htm
      2405403 - Disclosure - Intangible Assets and Liabilities - Summary of Intangible Amortization (Details)
      Sheet
      http://www.htareit.com/role/IntangibleAssetsAndLiabilitiesSummaryOfIntangibleAmortizationDetails
      Intangible Assets and Liabilities - Summary of Intangible Amortization (Details)
      Details
      36
    
    
      false
      false
      R37.htm
      2406402 - Disclosure - Receivables and Other Assets - Schedule of Receivables and Other Assets (Details)
      Sheet
      http://www.htareit.com/role/ReceivablesAndOtherAssetsScheduleOfReceivablesAndOtherAssetsDetails
      Receivables and Other Assets - Schedule of Receivables and Other Assets (Details)
      Details
      37
    
    
      false
      false
      R38.htm
      2406403 - Disclosure - Receivables and Other Assets - Amortization (Details)
      Sheet
      http://www.htareit.com/role/ReceivablesAndOtherAssetsAmortizationDetails
      Receivables and Other Assets - Amortization (Details)
      Details
      38
    
    
      false
      false
      R39.htm
      2407402 - Disclosure - Debt - Schedule of Debt (Details)
      Sheet
      http://www.htareit.com/role/DebtScheduleOfDebtDetails
      Debt - Schedule of Debt (Details)
      Details
      39
    
    
      false
      false
      R40.htm
      2407403 - Disclosure - Debt - Textuals (Details)
      Sheet
      http://www.htareit.com/role/DebtTextualsDetails
      Debt - Textuals (Details)
      Details
      40
    
    
      false
      false
      R41.htm
      2407404 - Disclosure - Debt - Principal Maturity Schedule (Details)
      Sheet
      http://www.htareit.com/role/DebtPrincipalMaturityScheduleDetails
      Debt - Principal Maturity Schedule (Details)
      Details
      41
    
    
      false
      false
      R42.htm
      2407405 - Disclosure - Debt - Amortization of Deferred Financing Costs (Details)
      Sheet
      http://www.htareit.com/role/DebtAmortizationOfDeferredFinancingCostsDetails
      Debt - Amortization of Deferred Financing Costs (Details)
      Details
      42
    
    
      false
      false
      R43.htm
      2408402 - Disclosure - Derivative Financial Instruments - Table of Derivative Financial Instruments (Details)
      Sheet
      http://www.htareit.com/role/DerivativeFinancialInstrumentsTableOfDerivativeFinancialInstrumentsDetails
      Derivative Financial Instruments - Table of Derivative Financial Instruments (Details)
      Details
      43
    
    
      false
      false
      R44.htm
      2408403 - Disclosure - Derivative Financial Instruments - Derivative Instruments Fair Value Table (Details)
      Sheet
      http://www.htareit.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsFairValueTableDetails
      Derivative Financial Instruments - Derivative Instruments Fair Value Table (Details)
      Details
      44
    
    
      false
      false
      R45.htm
      2408404 - Disclosure - Derivative Financial Instruments - Derivative Offsetting (Details)
      Sheet
      http://www.htareit.com/role/DerivativeFinancialInstrumentsDerivativeOffsettingDetails
      Derivative Financial Instruments - Derivative Offsetting (Details)
      Details
      45
    
    
      false
      false
      R46.htm
      2410402 - Disclosure - Stockholders' Equity and Partners' Capital - Textuals (Details)
      Sheet
      http://www.htareit.com/role/StockholdersEquityAndPartnersCapitalTextualsDetails
      Stockholders' Equity and Partners' Capital - Textuals (Details)
      Details
      46
    
    
      false
      false
      R47.htm
      2410403 - Disclosure - Stockholders' Equity and Partners' Capital - Restricted Common Stock Activity (Details)
      Sheet
      http://www.htareit.com/role/StockholdersEquityAndPartnersCapitalRestrictedCommonStockActivityDetails
      Stockholders' Equity and Partners' Capital - Restricted Common Stock Activity (Details)
      Details
      47
    
    
      false
      false
      R48.htm
      2411402 - Disclosure - Fair Value of Financial Instruments - Assets and Liabilities at Fair Value (Details)
      Sheet
      http://www.htareit.com/role/FairValueOfFinancialInstrumentsAssetsAndLiabilitiesAtFairValueDetails
      Fair Value of Financial Instruments - Assets and Liabilities at Fair Value (Details)
      Details
      48
    
    
      false
      false
      R49.htm
      2411403 - Disclosure - Fair Value of Financial Instruments - Assets on Nonrecurring Basis (Details)
      Sheet
      http://www.htareit.com/role/FairValueOfFinancialInstrumentsAssetsOnNonrecurringBasisDetails
      Fair Value of Financial Instruments - Assets on Nonrecurring Basis (Details)
      Details
      49
    
    
      false
      false
      R50.htm
      2411404 - Disclosure - Fair Value of Financial Instruments - Textuals (Details)
      Sheet
      http://www.htareit.com/role/FairValueOfFinancialInstrumentsTextualsDetails
      Fair Value of Financial Instruments - Textuals (Details)
      Details
      50
    
    
      false
      false
      R51.htm
      2412402 - Disclosure - Per Share Data of HTA (Details)
      Sheet
      http://www.htareit.com/role/PerShareDataOfHtaDetails
      Per Share Data of HTA (Details)
      Details
      http://www.htareit.com/role/PerShareDataOfHtaTables
      51
    
    
      false
      false
      R52.htm
      2413402 - Disclosure - Per Unit Data of HTALP (Details)
      Sheet
      http://www.htareit.com/role/PerUnitDataOfHtalpDetails
      Per Unit Data of HTALP (Details)
      Details
      http://www.htareit.com/role/PerUnitDataOfHtalpTables
      52
    
    
      false
      false
      R53.htm
      2414402 - Disclosure - Supplemental Cash Flow Information (Details)
      Sheet
      http://www.htareit.com/role/SupplementalCashFlowInformationDetails
      Supplemental Cash Flow Information (Details)
      Details
      http://www.htareit.com/role/SupplementalCashFlowInformationTables
      53
    
    
      false
      false
      All Reports
      Book
      All Reports
    
  
  
    hta-20160331.xml
    hta-20160331.xsd
    hta-20160331_cal.xml
    hta-20160331_def.xml
    hta-20160331_lab.xml
    hta-20160331_pre.xml
  
  
  
  true
  true



begin 644 0001360604-16-000085-xbrl.zip
M4$L#!!0    ( -R FTACKUO_8A$! ): $0 0    :'1A+3(P,38P,S,Q+GAM
M;.R]69-;28XF^CSS*W1E=I]N*],W^))6E6.^5FI&6TN9W9-/953P*,3."#**
M9"A3_>LO0,9"\G /'@89P>HVI<3E$(##@0]P./"W__77Y<6+;U5_T.EU__Z2
M_\!>OJBZ9[UVIWO^]Y>_?7KE/\77KU_^KY__Y]_^GU>O_F_X^.9%ZIU=7U;=
MX8O8KUK#JOWBS\[PZXO_;%>#/UY\Z?=7?8__[WEU^'PZN??OR1WOIA4)W]<-[[]N/-FS\*
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MWQF],_]+)(?Y7QJ],^]+PWYUOE!.[D=\__:C]$9[9D/S
MK]5EZ_[#G=4??G5'S<__\W_\C7[KI\'HC8_5EQ>CW_[IZXW>M5[=[N ?D(Z7
M-^_2,OS]Y:!S>76!'/U(3QE;N;->=UC]-7S109)+HJ_^.__]UT2_<_L1M,&=
MX7=ZX?:53IM>^]*I^B]&9%13'-RJ97S]?U[^S) /J9EFZF\_SGYY]!L_SO[(
MS6]_=OG CF96B^B<:Y7^^JM;K?WU:7
MGZO^WD1[)[?JG/SHZ*7Q:VW\Y;^N+CIGG>&8IA?M#GYD[)N1G9]FV'GY\PT_
M/\WAYV\_SGWDF((?:R0\T07'C??/7ZK6Q?#K&8KHU_[U8-C[XD>.H?5+[X)P
MSN#-AR/6 &3PIW49?!XJ\7JD$<)?]04OJE8"[1]Z\L_UN(-[A
MW]6!LPVON)A8\=VPC4;@P-F>4?2=K?:=5_LTQ(U#NS=>M :#]U\^#7MG?TSY
M/?00E[WNZ&U_'$;OUL,MY.W>"=:9:\[@[4&;3\OZJ,NZ\]V:1KOU*% \;.;!
M8=>@CG: FF?8\K^ND1'"N;TN_G,P!]0?J?[/XVP6W^]1^]6NC=H$3G^(7=M0
M)<8/&#WX2/5B5W9Q]SI9D^WS""^6:O+)/CT;-5@(OI?J@&^W.T.4<.OB0ZO3
M?MV-K:O.L'7Q))5B*:_'"I*^$5V?
M:X%/L>*QFJ^M,P G^/0Q<7Z+1?X_/ZU>!IALO+
M6'U.2W[*B!SPDFX-0DZK^I0@QM:)L1,6W2\6/=@TV
M;!O_E
MYA^#FS2)/QLU49Y" ?^H\ .43AE]\J1?FV"0-65]CT;F"?N9Z/IM3N1D^P[!
MNS5Y-/QHINQ-Y[(SK-HG4[8/4S9/V,_O?/NDZR==?_)N>Q=!Z0F?'H.B[Q>?
M-AUM/S8>.:GNDU7=@\(CNPJM3HI^4O3'.#\_Z>U);X_M'&X7>ONL5>VPEW<7
MQZPGLW0R2_L^/WY4=WK*23W9G-0^"J!/>GO2VV-*,3UZV'W2V^>@MPTUL#WA
MA)/>'A^^W:G>/OW[&H>BM<=R7^1@:WI/.GO2V7WAVCD7U#_T>_B0X?=7O?1L)\\ANF:S!^+TJK,7Y,ZD;
MF=,JYJ1$QZ9$CWRP/=8A<>_[KC\/JG]=DTG^AG_4E&;F_>-2D@7,W2O&7.[V
MIPAJ,T50KX39K35!Z#]I35ZCV[VL[ISTF]Y9BQI#W"&K4%WT_GS;ZO]1#=]4
MK4'U%5'"K7<^,ONQA-4Q,EJ#UT-U.U-X>Z=NAY2@=+H8_+[I?*M('JWN>>?S
M!?ZS];ES@:\/PO>WK?_J]>K9ME>GC?3(&ZGYHU)U N^'!MZ;GR&@3EC\"%'4T;N*6>D=B;9L
MY"86\'C<+F);4S%K1H]CO;>V#O/9/5Y'\<"DS6GUGV.0=?((C^T1#@HG;*D8
MD8H)+JO^Q^IB].;@:^?J*2K'$CZ?B8)L$H:><@[[S3DT/I7PY",>/VIH,L=P
MVM0'LJF/WN2? ,&16H-M$D6GQ3[2A-&&A[&G8X7G7,I!5N&46SK(W%+32>6'
M+/WI_.GQSR4;NM_PH'/)DTEX/A'$ED5?)USY7/#%E@IRRC4]=<78)!P]A2=/
M"EUL%);.S=+Y;ONINQ#2@RUX/U3._?ZWZEV]ZK>Y8
M0/>E%KWN.89UE_3$6L>&NR_3N\>E2W4)C55H?1$M4ZT-")DGX/L,S!P)'V=<
M/3OC.B)/G6%IG5'B^ON45GVLOO4NOG6ZY].?.2[]JO,W.=1Z"8-[6=Z=-P&>
MXX<>SP;=:U*K>S[]Z;>MOSJ7UY?'I4M/TU9M\+MWZWC_8U,+^4R\_)Q-MG1K
MO.WUA^>M\V/+'RS7LAFFGLG2KPGP[K;@IZK;Z?7?]8;5(%U7@@F^B4V=^/9Q
MJ4.RA??^R:>=P^_/E9V/?=V]4JG2_#[Z7SK3II]ES-
MWEA23T_!]U$;>4*"3\V9;IL:61;V=KK'%_8VDD)Y8-0Y*<=GXA@/"NX]-1U_
MFK#PM,D>T0T4KY+)/+*>73! ;87WS\7$YYGD0$5$Z_X$[>JQZ(J3]I:/ATSMJ_\UC$Z_$/,;ST_
M1WN05OBYI+F>A+4^9;L>VM7KA&L?%]GD7BYR&GS+77R8P/WG<_
M5JV+/*!;'/3"W5/(P_Y'J]]I?;ZH/N*;S_W,>H/?7$O 8X^[1,)/0T-/ON0Q
M?4GCHX<:-D"E\U?5/EF?IJS/(O$>+\Y96S>/.-=V0+FM@UG.$VP]]*5<&[:>
M=N8)!)RBD&<5A3RNP3G!U -7ST>%J8U'R*%UT>J>59^^5M7\UI8)G_\-7_Y6
ME4X7/]JAGAJWR?O!;;?93DU_[[]W__&/G<$?4P^_[1)(XOWT9^MJYAF_5.US
M#&!3->B<=^NDO>MUVS=O5>WCTOE%8K_7^PWEOJ-]L6S5[FF;OVP[(F'^HM__
M^)Q5/]ZM. ED3EOQM!5/6_$@HOV%6W'<,^NLPI5!Q#IH==OOAU^KOA\,JN%I
MV^UFVXV;=RV5\6F+'>466PMXGK;8:8L]BRW6>&QW+_OP_5UK>-V_SQE,"IQ9
MO;MM=2Q[8[YLQCMCKG .?#\9),8^R4G$+^\J%.JGQ(C6^$\Z3
M5N/#M*][M_O
MGP#I

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email protected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email protected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email protected]@W%$ MH@[M<.WJ0X/L;3C^(Q0Z;^%!XP8#18?VS'#NC12>$.FRKNFS/[P94U_MJY6)K=BB5PE#3881([@J4DMPMQ(MU286)!ZQETX M3UP+1?)@"4YG7 Y*@IX'@5LUHDU*4+AR&J/!(*BU4N9R:M_N7()WXP9H@-*4 MTFX8[U)#B12Y$U:# A$2M6FV*GGO"XOU$]2%]G4Q13OAX-XSMBXHMOKTM:JF M)XR-QY;=Q06M;OO]\&O5'^_DW>G#W=N_5.US=,NI&G3.N_5!9^@UVS=O5>U5 ME\-DIAEF&,5Q \$C9#%:1<>4\ +W9@UR/_XJK+D5N5#-[,29)KB) MSBI95:AG$@O*)36:?2.+-3E'J41 XQ=SJ34V/79!B\<2M+,YVZ@9*QC=6:\Q MFBW!!1NM\[S44R9/0JUG#TGV)FVTO3J "2$P $2SWO$@[email protected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email protected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email protected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email protected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email protected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email protected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email protected] T03P X M8S$(HW_5^+T'%E5??[E:^0F(4G[]"3 VZ)7[E MNU\K2>^9!UT%\O2T2[?IENWM7=UY9+^!MBB_1&F.7MS'*"$+GVZ+%[>'1X8= MTH@*;[BWG!%O',:D"6X97RR.R:J&7L22F$I\/,;!94-E6 M77\C;_( X- 5LJZ0:DNG3\\MK'IY_NCD+O_>A^O +[ MFL)_V@5JJ:AQ;ZAD7Z/VF\&\]$@L'3BGJNRDP(ZMP'A?D?;' 9\$U[Q4 M@1WNQ+T]7VV1GWV!JW;.A:5])'13HG@N0I5"\[2XBD9(%+P#? M%U?%9/)0K5#51TQG[=FA\RGQY'VLT_BL%,YVR**=DW!QDF:-IE"K!4L7;PVU M;^=.3N*PZK/FA=KVZK&64?) M[)V/TR?B\6&ZDII"[email protected]+HBI6&/6[.REZQ1CJB;Q^S7>3BPO[QHP@/VZ M+*J;8_"O>'7N-EX(>:C03X'40U]"D+/&SI"[[email protected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email protected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email protected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email protected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email protected]?6I?Q30APACA!'B"/$$>((<72K0WFF MQL=/@Q5:[45Z>"Z,Y\\0[IFSSLX\6MJ_U]8;,2T8,MLJ)_:J%:T(5X0KPA7AJBJT(EP1K@YV'KEP"6[;P\FRR+=LX2^\ MU>K.%Z\D7HA/F,,8W&[%*]C/H(K8'!XU=A8N1MJ&@_<"+CM MWWDPQ-A@Q@^URYX!;W =WS.6BP MNX!S,04?;Y ZH7S/'GBIV$7Y4B^-WXI+V5-VC[>8N6=XL*\!\\()#\0V)?>8 M_\-/H 7\MKON&L-G_XL8#8$5 * #X>(]&&-O3PE@L$H"!+<5A\9^! MN'N/&SR'Z?ECO#;\,'7@*88H\^X$GN -N.6V'<,@T12&"7@8NS G!S&2O@#F MT'?Q7O'=%*$L%C3F$0]F0-ZQ?!!?.F-_^4"+QW02CC>/8:P880>83F >3>S3,R@P"QH_2O9^G@R\OCJ'F0 MQOF/X.&-&V/,_=#!7\O9/PF#YW<".,+SH\)"HD3>P<:NS N1!\\DL#2?1-_F MN6=#ALD->@?E=>0$'/"*D[)=(#3,B M>V0)VERM": \ULJ5NWE:DJ;0=Y)_X M\WV*?PR=T';]<+GZAY)5-LL6W"!Q;4"* _A9HXFE"&#A5+"!^ ?_3PQ S%;B(;0F+-' M?-1,/PUB>+2@,$SD'S:?!_YW(:&*8)WX02+KUA;+!5UC,Q#/*'Y MA GAV6K YG914@B9/XH,)RS8:G&(.!KY 6PX_BL0.H7=,\<5-3!@+T$[""45 M.O!&,"M1U$GZPA!@J75JIQ:UD4" [J-U 6C;KK755DV^W.Y<-I9-7"XRRBN$<"!MM MJW?9J2HV6KV:XLFOFC4+3E_R[Y_>QN'%'6/S=ZC;A6I/-'X,"NX6I.S ]>UO MO_S];S^E/WSOH;?A!X]?0"U_; MX2O#&<,'8-M>#!LW]:L;R[IJ-WNM1K/=O>XTA]?=8;_?;@R&5\U7ORPI@N)J M-]0(6A=;>-[(:J2*I*1K@5L874C,U*0&MDE'LN#@KJ?_ TPG 1Y#+3FP;-:P430,.#BQ\,PV3.$X)^DXL0LE( M"L6L.EE:;ZD6I,KH]4.]H5B'"DL>#5WP+MW'3;&R%;'YI#0LBLS?T-[CGR:? MP"1/G-?-LK(Y[ TZ-_WK7K?>;#5;K<%U;]!LMP'EY6JI2-*Y+P M4W#'O,3+$'@9HC?ES%,_98 6-P_78%S+F.&OMWWP]%#X/+K"O?2#N2\WWU3' M#O"6#Y\5L0$#BKOL 7TW%SP6='(PFN7Q()PZ5)9GRY?G\KM5@H]-8=]S#:E1)+F56H(F&WWKQ1W5.S:@R=<:25#]KJ7[7^HT84%HN>QSCS(M,Q[)O*<&\M# M'G\FK"E87I::V_DQ-,8.&%V@A.#'_#NW8Q$I]2<3QQ:G"EE$A\%'+H;/X8>2 M//*,8<8<;PD/^=1>Y^_'7W^X??_9B#TG"M^@Q:H9U"6,10S,=ZO!FXC5*9.3 MGL2NBWL(! ]Q#Z7FF,U='G%AIV",2 0,'X7=K-EB%D')'D'57L#_&2 >V)T\ MEY0K\J+ =Y>E*YY5>48\&P7<==D"&(7,Q?BBC894?@BFV?JE6@"?)HQ'H3-V M6( '@5.P<<0G$?,BA[GNH\&R&&IR>"AIL4 _WW.1'>CWV@#QXC 23&L+G@)R96'BR3NQ,S$8K1%) !1C$* M(58Q_G;",!;"-1Z!?22.&)![ W\FX_(86\+_1^SAM);R6H4N:;R&> MIX*K7L,2 &'VI_7CF[30^>^>,&N^1D+6%Y_X_?+KY<(3,L$%7G@7^+!9+F>A M.%,!UX0M//G/#_WB@S+' AT8\ EF('S=Q^+TF0T[AYD^PO@1H@2MKLP:GL(. M&?^)F="NN QY)BW'XV-_AF==$8SI^K;T?[PD*CR;PSL092;Z1&(GDPP%TY G M;4+J^WB$>)?^5<@DFG+F1E,;WQ0^AA&?H3YXCP?N8T=ZC.F!.>A 'Z8*X(CA MGSB(*R$.TC]$'RZ4)=AQ90!!4 OR*#PYRYPYWY/S1XS.P8>9E<%$ $322&8' M&!Z/'OS@&TSE4QPD)(5%C/Z2P1+A3OB@H;Z#Q?I?G)IO?T-=Q]-(OSC]&CNA M[4>D))Y]:.*;";(@U^!UB+%LPA7VP1 MWM6!]\"+(N1%W*>QX-MQ<4/DZ1WB$E@*]N(;)AU)&B?87 ,DN=WB5P5"COG, MOPO8'(RHA.#2RI1SBO'L%T@GM)8?1!/?=7QIW, D898LB98E*Q%/C)@KDEG" M*>>1! 80#/77Q(71$J-53 1WA@=)0@>F1P4P2&(-HM 5/"AAZQLC;"#Q'2F1 M.=^XXQ,^%IH? Q(S\1/PB7A-Y+XL M1QDFMO>#Z.GA\'N>G/<'P# V'FOC;S%G (_+83:)6'9#7TICG!PBYAM_S& L M%B D7&[U9!!-SLSMP+\ F>D!V&TC"L3V"G G/5-@C5Z6_R4SB0##42SE[UKV MP\=3%IV#),5P%L)$VI51)F\3\;D@;9>TA^W#?G#4C [W;)D#)N1FRD"I0,K9 M.'?Z)\Q.TP8%)9 ]9.Y9@:,SH2^YV <@1!;X<%DX[)CC%0>!*0R M4\EH)82.GC\UU2:ZG"ADP-DL7 :PA_Z,BD* MZ/49^ O^:T&@RH9)LT9DZ=FKYU+?FEB MHB'N[QL<1JIJ^5,Y.9G5%R;&$*;.1J[,E>7?DXQR>2(/IM3JU%*_!*"%:UZ@ MMWP#ZK 9P]QH&-T1VHV)N";:Z^#/)4>MPM) &DI#;_$[D07)[*E\V__$[F-R M 2/;[S$'X@5) !NT;O+@&)4AD+2XI4GNSL0)A,&$\;19FAN9)*.)UW%"3R8ITCA9. %'3!KT#Y(D]$-EMBYF$+. HST(:F2ZQPB*"&S M+]VE24L;:>R+8!B&"5&RPUH*@Z3GH@_2WDHRU-.P?)X\OFYS4I,+\8+URN5U MDRQW4YAI0B9L./_662K<\%$0HX>Z!)5%T="ZJ-5!O<%BQXF[*>%QE5$&Z=R' M'7H4#>R*S^'YB>"='"B"?S*S#?=%"@3INV2W",!$3>*88/.&4S]VQ\6]R(Q> M%\PY-QLTN2#$\LG"3U;G(^'MNZ[,1,4H22C=UC7GN-+J3%-2%]^7^* %9$TX M1LB8(U;#@.ML\$51]K%O*+N0A1/)D'KL@?2L[L%-$8&(-"+]8^(ZYOR*6(7Q M8;X!2IV%BPUIL&$$=CA:U/CO]*Z V"$<[GYY-&&>)\O%/=E^,.':PGCI/N3Q M"!!=X&62[>9B[$@( M$'FD#8-A/!^G)P],BDFXTBJ2BI5%2^\U"_&_)$B&WV,T4MA2TK3HQW=@9VTB M/+ ?K$(>@_-5P@F!&H]"H!*^+&EG*D-IZVFZ?(U-X-&?7"0WKI;9JK![^*YT M3L(*6!!#TLXIB**-_%!2.8FY/":930 WO#DF M'\5-@WG]OOGI[+48[BQ>/D,4>TE$>)WUM8#Y))"%MT.7HI4 VLMTTR;BA +#80[\*]5-&7\J#H <4(9^Y8 ^@:Q-[-PV M\VS"*W\V2LR T+A8D:\%YQD)]S'G[8O/TH7HYY[F7NF'(<7Y#?OD>LC!ILWN"PPN#/PAS602'Y=5IJ44R R+%L).\+]\R-&S$C>TTAV:<7K$NGG,E_E=Q MZYXW\#9*U2?D(0S\E#WVC 18%C\ M5,K?, :R@1J04,[.P3+YBFC (X,%H D3($I8/3E-DZ$0,>9HT2W,V2X92-8/ M2 \C^$(9@<2)63*1Q/&NO)DKSE$<#X\N$GMDY,=1?O*XUI@0Z\U4A3STEN=Q M.#3\C2ZA_&"-"4E2V*F3-Y 9E(3^R=&'2+Y!+I4M6 M)(H+ AA59+ZY4M\F]3G _HD].=IX?3!, NQY!&!P;&/T*X=:@BH!1GE$)X@C M[HJ"/^8G9DLJ &1"_*F]6H+*BD#O;JQNMW;5K5\U#GH84OJQ^.U"\"M)<0\+ MI,R3/1:D)%T[4S*EUS*B%80W/[^JO1)_AR!\G?I/U9,I7Q2 M:\MV==?6U-J^,JV<4KNS6QO[Y>>M%S[>/.[KSVGQ%:U4K%)/O*S2X)-U\DKL M0JU7HV"AX3Y*#7>]J.&V)2BA4)/NU"?4"WVM<579,JL$-;VAMFHTJQ1U&C4D M+;/MPOOT9BDF%AR3=Y^DMRZ44M9H9".RJM"!Q&J8M7:]=)+HLOGX7)D=BC22 M-MJI01(U9R]JZHTNB9K3VA)QN0^1G>]A'X&.YC0ZOFHJXR'=-GG MLK4R*=\39H=>C]CAM/QD?7N_[!3,.2!!JT9$;0A'2#QG))ZWB;T^(%M,F#'R MC!E, _K-]T3:1S_+$WM7!ER/@\JCL[-FH-../H2?$S;YRHTBX+U#D;Y8KN#2 M3,\>G6.U(=;)BCI"G%IKKG8,6;;[5T,%Z7?(B>10XHUC6P!AC'90 >SIA#7R\C7OL M-%U=%,A9FEF-KMGIDIU%WA9Y6V92#6 M5Y+ ZG\[EXNPZC>]6OW:&O0;M5:KV1C4VM9-M]_OWMQTFO5:O_1R$24W)!Y% M62G <5H4I5 M54EGI2,V.U17%**<_N_+%2*>Y:WG8+(%M!;4"A6$H((0%7J< M"D)4P:JE^]%/WX\6RBVGZI-:CGPJ0I]Z]*76RPH 2[JS#Y32*7A=IINT11GD M8S+YD[N0<(&P[%980!?B:G'QM@Q*J0]"U'MM$R94.L$J@9NR0Y@:R3;M]/#A M1)@N:--"2NDCB*SN0021+KNO,$ZZI65UJ@84ELDW7)]YNZ2OGNZ%Z&:KI9*1 M=-GOLG4SJ6#BB7/C"?+.-RJ7D'O8T\?SHYUN1VS-2DH)>E0>:]=J9,"1LZB7 MIB+V.E?V.G?_Z,;YCL%E[/>"[>[NV%TY"JQRC(01ST9/6:)KUAKD'Y%_M!UA_TA;D9>O7S8=NY^.A5?OFEUUUR_WIILN&"/_J@*:[JRX MLZ>N1,+9&]3KON$V+2V"_7D>=XMN2.*?-@^3/$;L] MPVX*=1VQ&SF*3U/PUL?RS^6 K0%@&_LQ'A&^A!6U#X.KN\.SB7PG<>O_?"*(BQ5%RX2\6WZ_9U=]#J7+=:M:O6S55K4*M9]4&MT^D- M!NW^5:_TBF]%KFG/OY=; >YVH=Z;+.KE.F$4BDIPXXR8Z5$#V)E.1E>#A2&' MGV*1M=>NPT98[<+AX1MCRMVQ,7HTXO $:LA1C;:EF9=0H\UJ*RG2]M(Z8_5* M5TEK'_?UK4H3KU(5ZDX,.3N65GQ*%% %L*]6=X?J+*W"4G M5#O(;>\ZE ^_]V#"?">LG<:YBN:B[@N+.$%-/=1(JZY [88Y@?$'FO:Q\Y>?OFR5OU")DQ6J=T+GP%I(;FUPCK82JJ>^M5IO=^F]=M12&FS119N5'5,AZ:(;?2H4(2'PJ*>/-OK&NFQ09W=B"*ICE5?Q:"LS M+\C#)G;1D3[5\9<).[K1IU3AVWEK==#[W=HD>9GW>SJUIZR:TKYAVI\6E&WB M:11NJI9 THAP%7*Q-:+:&<--&S5H7=;5M5<@44Z\154Z<__>,NN=\@TEJIQOK+;-+#2?UC\%52[J>-ULU94EGI"S30RC(WVJXSH3=G2C3[E9U&\M M\(.WKVZ^9<2HQJP5 .6:L!6&VJD5:D&+.G18^M1J@%+ M@*,:L+HG;E,-V,+U*ZH!FZVS3 *0)*\,X>CZ%<&MFME:5 .6:L#JSGED4;X( M5E400Z^MIK)<_-,40W1/[=AB2"/"52?93B.B$=IT3,^C(K!4!)8N5%3!I-99 M95$16,W!HXV^H2*PQ!!T/:WH>G;N$4W^E3'72;LZ$:?4RK2547[UMUJC$J_XAMFI)EU-3653BM2HHTD;Q4(E78@@Z0R^> MH==-JZ7,SZ9C=&(8'>E3'=>9L*,;?:I=XC7]]T]OX_#BCK'YNZ_VE(]CEW^: M#+.ZJGDQC_ 6ECMP??O;+W__VT^KSURSP -:AI]Y\'7* CY@H6/WO?'0<>.( MCV]Q3MD00%D/R?>%3WY^=3/$7/G_M?Y]._QSS)T_/_ [YEY[D1,]]K\[X9_3 MB/WY*V=N-+5AW-L@#B-_TI_!'&WVJ^_B#H8?/G\4=55?&E:C>]7NMZZNVX.&9?4[-_5NIW7=K-_47_VRM)_%K=E07G0=''0JE.O(^K@! M!SK;CNN(,K18YQ8_]6 _ Q;Y@2B,"]/Q9XXG_HY#/C8X9/-E= M8\[A9YX3J2B:*R;^ZVW_PVUB>A,'=,4@E M*U=0NPK[(O6 5*T" MBVM#K-.5C80XI29?[1@2;V$*5G[<_6Q*3T/V37MSY8 ME1(+K)I9:[email protected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email protected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email protected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email protected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email protected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email protected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email protected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email protected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email protected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email protected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email protected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email protected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email protected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email protected]'5F^UFAG)8$@VQ0-QMWY>4YO10*P-$=FN<["(I.3_I MZKI:NWESW &X=)IU:YOL!*9GAI4:Q7ZMDI:!G%['Y$J=13%ID^03$'FT1_8! M=AJ$%,629UHB^Z/CTPS92KNNUVW&YLQ\>')[IJ0N#,9'7:#P M(ZB8$I,3U:,+1_S;Y:*A>IZI!H>S'V.YZ^A_N+K#MK[\ZXR5FA>0ZYQS M4UJ1C.A6KI04E/WKAR'2$EY%B=%KLM&R6SCM(Q100R"N$_],!6ZL:J' M._VR#V>!';!V>()7<.6P"]8327OCV>-5->R.5!=F^S!?6IGM

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email protected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email protected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email protected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email protected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email protected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email protected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email protected]$[TBJ>)YL74MQ4[3*-O#>9=R]* M4J1DT5]3-X>#).^7J^K=MKK?S$0)8,AL5"9#.+25Q13TQ@J@4\8S'YMP&4MNM$$[Q6FG.2M#\-3$[->OIR5KOX, M>9^55H=W537[]L2YJFT#= 1K < ME05F)1$ 8IH#97(&O=*,H%?63T97??-ZPA%X&#F,6S?A&HY4/^$Z8?,$6?;K M:/=%+A)U0;?B$#P-W8KDR[FCLA$88+:]X00P 3R(XTB"!R'&).MLJ"*$DISA&B2%M=+DI& MH>9 2*($2[C-> HO:_!E#<"L0YC]VF$<>,"YT'9AW$5E?1K#+ZY+=<)>ZCD8 M#P^/=H9/P9RJPM.71PF26"&9"Y$S61+)29EWXU,RZG4V/12#4A)PKB5BP#)B MJ#"0FK)$B#&K3T7J&=+I2[YG!O*[U4V]O@\H.)*L61QEA%57M3Y]$?K#C:INJO6Z6KRO MYIOEZM94U68F!8<"4XQ)*: U;>>8-H=#A!EH%#;(;]KWMCV .&92%CGD#)4Y MXSG)";:N*D9UP67RJ=^39].K_;/IZ^JN/3.ZK;/%'G1VMT.=7=<;W]E@!-K= M='=8OOT4]@G15F4[=-D>7M;@&U9$WZ3K@ES&HWH:PAC1GSI5I^PC=OM%G=6M M;,;OC HL2YL,*U@PS5!!,9#=@"L@E7UT[IDIH(AA.256TA$"N6)"*%Q';Z)NT\G5,%86&T;MX_ M48A.1P^#[DQ$8SZ2)B8@/94JCG*_PI' /LKHV00_B#;Z>N6KCD&LN=S),,O? MJ\4G:ZF#T!UN*XTIB,YA#E6.).(&"MT-28"P\V6,LP8P%A0IC'+!",)0<-*\ M72BI =8= 5(_1][BRM866';?(7._,1!.VV4E&XPQSQ,9+5D-INP *N">13AK M[A]_=M\O6QV:EZS)JV> M%XS:N2'1" &=4W.8&6I1.DON)1LBYXS!$AHD$,H98D)KK &%J, V"4O]-&X' M+5AX>_'WMO8.19V?_!Y8ZZW O>AS%^&A: S3X6 Z7:3X@NMGU#@&6>,+$&*$5Z08#0M1)BU_]8!M&+&XE M"X@IXD (37"N(4$D1XKQU-?0&BS--L-UBR:[F5\W=UJ^7V7S]N75K'["7PT_(N# !#^)L&K/L,.C/7^T. M]S_*2]RX0!"5VAAHDT5CAP"W,YE]UY/^TC:G1[8;8E6[8;HS]5V)JGMG'EA@ %E65"@.#X,(HHTL(/HMCF! MX#J07K<"RU)(967!*(5TGE.FB,@U4;00B#B^&W480T= SN-(G3D\<979(3GT MF'J5HXO#J1^K4QE)/;UX,8ABL!(6B?ZZFN\.&E2+YF!H,VX_KJO[Y>-]@T 8 MS(2@"AJMI %$%?RPQH9+P+LQ]=GG K&[>5KD15E )9&P"7M)A+:C.K=_"EF6 M5.. P?8YX%;Q'MCE$9:>:[?\=W!^ ^\9?]F>W'2\RDZ 9AW2[ ][K'^\RGX> M7MR<>73.'^*TQE1$,(%G%[.+F.PYS^_M-,Y*QGV#9$:-*6W:(@P%N,RE89@> M=IRY+LULV^2XCO/[TP]F0%%,E>:$2XUE[D&!/MMZ!\P^*7F T], M3]R_-#$-86D:XR,,^O.):;C_O8KK'>^('&^'Z%R6>9$;CI""-HW7%)'=!7() MF]K';J>7O9+MZ!CW*9Q9_!"VIR@&::15*=P['EU MZU3<^5>WZ*"D%EDS7.-+0VG7MG MRU4DX=&]Q->73?6/1SOIT=_L'X?[1880: J1%TJ 0C*HO&BL%D,5GJH M3G=OQ\ZO3:Z!-@B2@E!8"M/9 Z /77'T,DY<77A\O2$L2([R+_R2SN_:'( M/$-"@H)1 :C4.9(&Z8.2<0F-UY.2?0PE%IG7%D37,(GP$?GIL1GZJKNO;57/>[-W"RN3RIKU^;$_>[QO3G2O%C. A"DQT$*BO* $4H)5!U,+[I4Y#0XNL1XV M&'KO929NGN =S^FT3(Q]T:,WV:D[W1F=SJ'V8,CI\VA[GZZRBVT]U!YJKS;Q MVVD=IOFG)?[#N__VKNV0[3!&D!&/R[OFRNUFAHD6!#?GUBCA6K!",G((B(;+ ML2*-.\+DZ?<.2"M2R_N'=?VM"GA@::36&SX0I6FX242C@VL_;D@ZN#!07/+O M#?]\P2F @X01*K1%7.X$!.*%.'48:\!E]RVZ]FF(%EZV[/"Y'XR?#F4.5QFF M _;'BW9MC]GYFQT,J2/NW?(.)T"'Q]EX@RJ M!?0D@QHI! :TW[")4MJFFT1RM.L,IZ'MQ^D,X^1 :3O%I/(>G\XQ=*KSHAD& M2&_"F_Z?*Z7IP4.B-*9ORPR=NKQ;?;R;7U=[K!"75%%:Y-Q 23 WBH$.:T$! M'B-M\4.8.&5YM\H>&C2CIBN>;39LJI*NN2:[email protected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email protected]@7JA",%$6-A,F4-N\UPC&"UT6I:309[W*S2(& M&)4 *9MW0X1D07.NBSS'Q&H/*(O45\%V(/\M^^F#\%N.BL2GVWK4\%3ZA;P= MOJM3@3QB?"J/PRY5.1%W8:TJ+O'36*R*[%.=LJMZ7NNX?[!VFYC\X>9]O;IM M'S#> ?IHPP"W;C,E?"[\.%L56HD$ -8 MEA(CP1&53<'F/(<\,?/?$E<(+ AF_ M&:8AD@G\>GZ3)1%SOG=<3J]F'-5ZM@=E?YDNZGC*#S[B>/) MG9,SMX.:QR]#'O".>;'D+0(O'HZ+W ;34,;X;IVY$!*9-U==U//URB9$FX_5 MNBW5286QUI'/U7W7ZKU3"A8*L 4TH4J-0=(:E,[email protected]:\P"I_^H/Z$G^W4'9^AX_IR.2X$[F+II2$@/_,]#<4\FG!>G M%XMEDU3/[YI3[^]6^_/Q>YN\P$SJD@*4Y[G$90YSU-DTL#1>B]*]+*5>C#Z M:Z^#_.E=>Y-MV/3L#??+K\U*Y;=^6,[N/3OU]5FT\P4.KQ^8A5*J)M*#<"EGSQU@ YLC:1* MKQ-S08YZ,CD-'>KK1!VU=_DIS\=Y<])[;T(K;>Q$#11< 5%[email protected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email protected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email protected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email protected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¥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end


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings